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ABSTRACT
The basic aim of this thesis was to identify a suitable approach for prevention of
thalassaemia in Pakistan. The overall carrier rate for 3-thalassaemia was 5.3%. The rate
varied by ethnic group, i.e. Punjabi: 4.5%, Pathan: 5.2%, Sindhi: 1.3%, Baluchi: 9% and
Mohajir: 5.2%. The annual birth rate of affected children was estimated at 1.35 per 1000.
Screening for a-thalassaemia showed 6% carrier rate for cC 7cdcia genotype. Approaches
for identifying carriers and at risk couples were investigated in pregnant females, but
proved to be technically difficult and cost ineffective. By contrast screening in ten index
families with haemoglobin disorders identified 2 1-70% (mean 31%) carriers per family.
No carrier was identified in five control families without a history of haemoglobin
disorder. Follow-up for one year in the families screened showed a significant effect on
the marriage choices.
Molecular basis of thalassaemia was investigated in 1240 mutant alleles in all ethnic
groups. 19 different mutations were found including one novel allele. The five commonest
mutations accounted for 81% of the alleles. The pattern of mutations was significantly
different in the ethnic groups studied. 7.5% of patients on blood transfusions had
thalassaemia intermedia, and its genetic basis included Xmn-1 +1+ genotype (36%) and
mild mutations (31%). Coincidental a-thalassaemia was found or suspected in 38% of
cases of thalassaemia intermedia. Prenatal diagnosis of thalassaemia was introduced for
the first time in Pakistan and in the two years of the study 158 couples used the test. All
couples, except two, already had at least one affected child. They had better education
and socio-economic status than the controls and 93% requested termination of pregnancy
when the fetus was affected. Over 98% of the diagnoses were done by direct mutation
analysis. A multiplex polymerase chain reaction for mutation analysis was developed and
significantly reduced the total cost and time required for prenatal diagnosis.
Consanguineous marriage and recessive disorders were studied in the nine index and the
five control families. In 319 couples studied 46% were consanguineous, 52% were
Biradri/Tribe members, and only 6% were completely unrelated. Consanguineous
marriage (2w' cousins or closer) had increased from 12% in the 1St generation to 45% in
2
the 2nd generation. Antecedent consanguinity had significant effect on the kinship
coefficient of the close as well as distant relatives. There was only a marginal difference in
coefficient of inbreeding, calculated in a random population sample by conventional
methods (0.0257) and by allele frequencies at the D2JS1 1 locus (0.0272). Morbidity and
mortality from genetic causes was significantly higher in the children of consanguineous
than the non-consanguineous couples living under similar socio-economic conditions.
This pilot study appears to have identified a suitable approach for prevention of
thalassaemia in Pakistan.
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Globin genes:
Haemoglobin contains two ct-like globin chains and two 13-like globin chains, each forming a
complex with one molecule of haem. The globin chains are encoded by a and [3-globin gene
clusters located on chromosomes 16 and 11 respectively (Them and Weatherall 1988).
a-globin gene cluster:
Human a-globin cluster resides near the telomere of the short arm of chromosome 16 and
encompasses approximately 30 kb (Fig: 1.1). It includes an embryonic gene (0, two adult
genes (ctl and a2), three pseudogenes pa2, jicti) and a gene of unknown significance
(si) (Higgs et al, 1989).
3-globin gene Cluster:
The 13-globin gene cluster spans approximately 60 kb on the short arm of chromosome 11
(Fig-i. 1). It is composed of an embryonic gene (c), a duplicated fetal gene (y), a pseudo 13-
gene, a minor adult gene () and the adult 13-gene (Bunn and Forget 1986).
Structure of globin genes:
Throughout the vertebrates, the basic intron-exon structure of the globin genes remains
constant. The globin genes are compact (ito 2 kb) and have three coding regions called exons
that are interrupted by two intervening sequences (IVS) of variable length called introns
(Collins and Weisman 1984). The two IVS regions in the a-globin genes are located between
codons 31 and 32 and between codons 99 and 100. Whereas, in the 13-globin genes the IVS
regions interrupt the sequences between codons 30 and 31 and between codons 104 and 105
(Fig: 1.1) (Them and Weatherall 1988). The IVS-I is shorter than the IVS-ll in both a and 13-
genes whereas the IVS-ll in a-genes is considerably shorter than in the f3-globin genes.
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Fig: 1.1. Organization of the human a and J-g1obin gene clusters on chromosome 16 and 11.
The genetic control of various embryonic, fetal and adult haemoglobins is also shown.
Hatched boxes in the individual genes represent 3' and 5' untranslated regions, black boxes
represent exons and the white boxes represent intervening sequences (IVS) (Them and
Weatherall 1988).
Globin gene expression:
The a- and f3-globin loci are activated towards the end of the third week of gestation. There is
a transition during development from the production of embryonic haemoglobin (Hb Portland,
c272; Hb Gower-1 ç2E2; Hb Gower-2 a2c2) to fetal haemoglobin (Hb-F, a2y2) to adult
haemoglobins (Hb-A, a2 32; Hb-A2, a 2) (Fig: 1.1) (Peschle et al, 1985). The a-globin gene
expression remains constant throughout life. The protein products of al- and a2-genes are
identical, however, the steady state level of a2- mRNA predominates over the a 1- mRNA by
approximately 3:1 (Liebhaber et al, 1986). On the other hand c,-, e-, and y-globin gene
expression is down-regulated and 3-globin gene expression increases with the transition from
fetal to adult haematopoiesis. The 
'y to -globin switching is normally complete by six months
after birth (Cunningham and Jane 1996).
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Temporal control:
The globin genes are expressed in a developmental sequence. As development proceeds the
site of erythropoiesis shifts from the yolk sac in the early embryo, to the liver in fetal life, and
finally to the bone marrow in the postnatal life (Weatherall and Clegg 1981). Tuan et al,
(1985) observed that cis-acting erythroid specific DNAase-I hypersensitive sites are present in
a broad region of more than 20 kb 5' to the c-globin gene. The DNAase-I hypersensitive
region confers a high level, position independent, expression on linked globin genes (Grosveld
et al, 1987). The term Locus Control Region (LCR), has been used to describe the cis-acting
sequences responsible for this effect (Orkin 1990). It is postulated that temporal regulation of
13-like globin genes results from competition between embryonic, fetal and adult globin genes
for interaction with a common LCR (Townes and Behringer 1990).
Trans-acting factors like GAlA binding proteins, synthesized in the yolk sac, fetal liver and
bone marrow, may bind to a DNA sequence motif (T/A)GATA(A/G) present in the e, y and 13-
globin promoters for the ordered expression of the respective genes (Orkin 1990). Two such
proteins, GATA- 1 and GATA-2 have been shown to be essential for transcriptional control of
erythroid specific gene expression (Shivdasani and Orkin 1996).
Existence of an LCR for the a-globin cluster has been suggested in the sequences upstream
from the -globin gene (Higgs et al, 1990a).
Promoter function:
The region located upstream to the coding sequence of many structural genes which controls
individual gene expression and provides a site for binding of RNA polymerase is called
promoter region. At least three preserved definable elements contribute in varying degrees to
the promoter function of globin genes (Collins and Weisman 1984). The first preserved 5'
untranslated sequence is the "TATA" or "ATA" box located approximately 25-3 0 bp upstream
from the initiation site in both a-like and 13-like globin genes (Fig 1.2). The "AlA" box is
thought to play an important role in locating the site at which the transcription initiates. The
second important component is the "CCAAT" box located approximately 80 bp upstream
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from the transcription initiation site. Its position is somewhat more variable than the "ATA"
box. The third component of the promoters is the "GGGGYG" (Y: a pyrimidine nucleoside)
or the inverted type "CRCCC" (R: a purine nucleoside) sequence that is located 90 bp
upstream from the initiation site (Collins and Weisman 1984). The normal human -globin
gene does not have a perfectly conserved "CCAAT" sequence and this, in part, may be
responsible for the low normal expression of the gene (Bunn and Forget 1986).
Transcription:
The transcription initiation site for globin genes correspond to the Cap site located 50 bp
upstream from the initiation codon (AUG) which also marks the 5' end of the mature
cytoplasmic mRNA (Fig: 1.2). The transcription goes on to include the exons introns and to
the sequences beyond the highly conserved 3' "AATAAA" polyadenylation site (Collins and
Weisman 1984).
Post transcriptional processing:
Following transcription the 5' end of the transcript is capped by addition of a methylated
guanylic acid residue. This process is essential to prevent exoneucleolytic degradation of the
nascent transcript (Nevins, 1983). The mRNA transcript is also cleaved and subsequently
polyadenylated at a site marked by the "AAUAAA" sequence (Collins and Weisman 1984).
Another important posttranscriptional event is splicing in which the introns are removed from
the transcript. The process begins with cleavage of the 5' junction between exon and the intron.
This results in looping back of the 5' end of the intron to form a 5'-2' phosphodiester bond with
an "A" residue about 30 nucleotides 5' to the 3' splice junction (Padgett et al, 1984). The
resulting structure is called a lariat. The first two nucleotides at both 5' and 3' end of the intron
are essential for splicing. Nearly all eukaryotic genes have a highly conserved "GT" sequence
at the 5' end and "AG" sequence at the 3' end of every intron. Marked similarities in sequence
have been observed at the exon-intron boundaries in all eukaryotic genes. These identified
sequences are called consensus sequences. For donor splice sites (5' consensus sequence) they
include the last 3 nucleotides of the exon and the first 6 nucleotides of the intron and for the
acceptor splice sites (3' consensus sequence) they are the last 10 nucleotides of the intron and
the first nucleotide of exon (Shapiro and Senapathy, 1987).
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Translation:
Once processed the mRNA transcript is transported out of the nucleus and acts as a template
on which the amino acid residues are sequentially added to form the polypeptide. The process
is initiated at the initiation codon (AUG) and is terminated when a stop codon (IJAA) is
encountered (Bunn and Forget 1986).
Thalassaemia:
Historical background:
(Bunn and Forget 1986):
Thomas Cooley gave the first description of thalassaemia in 1925. He described a syndrome
among children of Italian decent characterized by profound anaemia, splenomegaly, and bony
abnormalities. The term "thalassaemia" derived from the Greek OcX(xcYca (the sea) was
introduced by Whipple and Bradford in 1932 to show the apparent association between the
disease and the Mediterranean. A number of Italian workers, between 1925 and 1935
described the syndrome of mild anaemia and increased osmotic resistance of red cells, who
described it as 'la malattia di Rietti-Greppi-Micheli". In 1936 Caminopetros in Greece and in
1937 Angelini in Italy concluded that the Cooley's anaemia is a recessively inherited disorder
resulting from homozygous inheritance of the Rietti-Greppi-Micheli syndrome.
Definition and classification:
Thalassaeinias are a heterogenous group of genetic disorders of haemoglobin synthesis, that
result from a reduced rate of production of one or more of the globin chain(s) of haemoglobin
(Weatherall 1996). They are divided into the a-, -, ö3-, or yö-thalassaemias according to the
type of chain(s) affected (Table: 1.1). The quantitative reduction in globin chain synthesis in
thalassaemia syndromes differentiates these from the structural changes seen in abnormal
haemoglobins. The structurally abnormal haemoglobins are mostly produced in normal
amounts. However, some abnormal haemoglobins, Hb-E and Hb-Knossos for example, are
also associated with reduced globin chain production.
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Table: 1.1 Classification of thalassaemias (Weatherall et al, 1989; Weatherall 1996).
a-Thalassaemias:
a° -Thalassaemias
+ -Thalassaemias
Deletion
Non-deletion
With a-chain Hb variants
With 3-chain Hb variants
With 3-Thalassaemia
13-Thalassaemias:
t3° -Thalassaemias
-Thalassaemias
With n-chain Hb variants
With a-chain Hb variants
With a-Thalassaemia
ö13-Thalassaemia:
(ö3)° -Thalassaemia
(' yö l3)° -Thalassaemia
(cyöl3)° -Thalassaemia
-Thalassaemia
y-Thalassaemia
Hereditary Persistence of Fetal Haernoglobin (HPFH):
Deletion
(öf3)° -HPFH
Non-deletion
Linked to .3-globin gene cluster
Unlinked to 3-globin gene cluster
World wide distribution of thalassaemia:
Disorders of haemoglobin are considered to be the most common genetic disorder world wide.
About 250 million people (4% of the world population) carry a gene for an
abnormal haemoglobin (WHO 1993). cx-thalassaemia is the commonest globin mutation. Each
year about 240,000 infants are born with a major haemoglobin disorder. Sickle cell disease
accounts for nearly 78% of the affected births, -thalassaemia major or Hb-Efl3-thalassaemia
accounts for about 20%, and about 1.6% is accounted for by Hb-S/3-tha1assaemia (WHO
1985).
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The disease has a high prevalence in a broad belt including the Mediterranean the Middle East,
Indian subcontinent and the South East Asia (Weatherall and Cleg 1981). The highest
concentration of ct-thalassaemia is found in the Southeast Asia where up to 17,000 severely
affected cases are born every year (WHO 1987).
Population genetics of thalassaemia:
The world distribution of thalassaemia and other major abnormal haemoglobins coincides with
that of Plasmodium falciparum malaria. It is thought that heterozygotes are resistant to
falciparum malaria and the selective advantage this provides compensates for the continual loss
through the death of the homozygotes (Weatherall and Clegg 1981). The high frequency of
thalassaemia genes, in populations where these are prevalent, exist in a state of balanced
polymorphism due to heterozygote advantage on one hand and continuing loss through
homozygotes on the other hand (Modell and Berdoukas 1984).
The heterozygote advantage against falciparum malaria may be the result of an increased
susceptibility to red cell damage by oxidative stress in thalassaemia that leads to premature
destruction of the parasite (Friedman et al, 1981). A strong correlation between the degree of
parasite invasion and the lack of deformability of thalassaemic erythrocytes may also contribute
to resistance against invasion by malarial parasite (Weatherall et al, 1989).
Molecular pathology of a-thalassaemia:
Most a-thalassaemias are caused by large gene deletions. Two a-thalassaemia phenotypes are
recognized (1) a°-thalassaemia or a-thalassaemia- 1 is characterized by complete absence of a-
globin chains and (2) cttthalassaemia or a-thalassaemia-2 in which there is mild reduction in
a-globin synthesis. a°-thalassaemia results from deletions that involve two a-globin genes (--
/aa), whereas a-thalassaemia usually results from deletion of one a-globin gene (- alcta)
(Higgs et al, 1990b).
a-thalassaemia-2 is the commonest type of thalassaemia. It has a frequency of 30% in some
parts of Africa (Dozy et al, 1979) and 3 0-50% in some parts of India (Kulozik et al, 1988;
Gupta et al, 1991). The commonest ct-thalassaemia-2 determinant (-a37) results from deletion
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of 3.7kb of DNA extending from IVS-ll of a2-gene to the corresponding part of a 1-gene.
Another a-thalassaemia-2 determinant (-a42) results from deletion of 4.2kb of DNA extending
from the 3' end of va-gene to the 3' end of cx2-gene (Embury et al, 1980). Less common
deletions causing a-thalassaemia-2 include -a35 (Kulozik et al, 1988).
al and a2-genes are embedded within two highly homologous 4 kb duplicated segments.
These regions are divided into homologous sub-segments (X, Y, and Z) by non-homologous
elements (I, II, and ifi). Reciprocal recombination (Fig: 1.3) between Z segments, which are
3.7kb apart, produces chromosomes with only one a-gene (-a37, rightward deletion) that
causes a-thalassaemia (Embuiy Ct al, 1980) and others with three a-genes (aaa 37)
(Goossens et al, 1980). The events can be subdivided, depending on exactly where within the
Z box the crossover takes place, into -a3 , -an", and -a3	 (Fliggs et al, 1984).
Recombination between homologous X boxes, which are 4.2kb apart, gives rise to -a42-
thalassaemia (Embury et al, 1980) and aaa 42 chromosome (Lie-Injo et at, 1981).
a°-thalassaemia is caused by deletions of both a-globin genes (--/aa). A large number of such
deletions have been reported in people from Southeast Asia and Mediterranean (Higgs et al,
1990b). These deletions appear to have resulted from illegitimate recombinations that are
poorly understood (Lukens 1993).
Less commonly a-thalassaemia phenotype is caused by mutations affecting the function of
intact gene. Non-deletional forms of a-thalassaemia have been reported in the Mediterranean,
Southeast Asians, Indians, Blacks and Saudi Arabians (Higgs et at, 1990b; Baysal et at,
1995b). Most of the mutations occur in the dominant a2 gene that produces a more severe
phenotype than mutations affecting the al gene (Higgs et al, 1989).
Molecular Pathology of J3-thalassaemia:
In contrast to a-thalassaemia majority of f3-thalassaemias are caused by point mutations
affecting gene regulation or expression. The study of globin chain synthesis in thalassaemia
homozygotes reveals two major types of f3-thalassaemia (1) with some residual a-chain
synthesis (j3-thalassaemia) and (2) no a-chain synthesis (f3°-thatassaemia) (Lukens 1993).
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Fig: 1.3. The duplicated XYZ box arrangement containing the a genes. Nonhomologous
regions (I, II, and ifi) are indicated. The extent of each deletion is indicated by the solid blocks
and the limits of the breakpoints are represented by solid lines. Misaligned chromosomes
crossing over to produce the -a37, aaa 7 and -a42, a 4.2 haplotypes are also shown
(I-Iiggsetal, 1989).
Studies on the effect of thalassaemia mutations on globin gene expression
demonstrate abnormal RNA processing (Tnesman et al, 1983). Over 150 different mutations
have been identified as a cause of 3-thalassaemia (Baysal and Carver 1995). Studies on the
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molecular genetics of thalassaemia in various ethnic groups have shown that each group tends
to have its own set of common mutations (Kazazian et a!, 1990). These mutations affect the
gene expression by a variety of mechanisms.
Transcriptional promoter nutations:
The mutations resulting in reduced promoter function are mostly concentrated in the "TATA"
box (Fig: 1.2) and in the proximal and distal "CACACCC" sequences at -90 and -105
neucleotides upstream of the gene (Kazazian et a!, 1990). The promoter mutations tend to
reduce the binding of RNA polymerase and lower the level of transcription to 20-30% of
normal (Leukens 1993). The mutations in the promotor region of3-globin gene, for example
C-T substitution at position -88 relative to Cap site (Orkin et al, 1984) produces a mild
phenotype. A mutation at the Cap site of the j3-globin gene also affects the transcription and
capping with secondary effect on translation (Myers et al, 1986). Several mutations in the
promoter region of 3-g1obin gene are known to cause 3-thalassaemia (Baysal and Carver
1995).
Chain termination mutations:
Premature termination of transcription may be caused by a nonsense mutation. A single
nucleotide substitution in a codon, normally coding for an amino acid, can change it to a stop
codon. CAG-TAG substitution at codon 39 is a classical example of nonsense codon
(Trecartin et a!, 1981). Premature chain termination may also be induced when the reading
frame is shified either by an insertion or deletion of nucleotide(s). The four nucleotide deletion
(-TTCT) in codons 41 and 42, for example, results in premature introduction of a stop codon
in the new codon 59 (Kimura Ct a!, 1983). All chain termination mutants tend to produce t0
thalassaemia phenotype (Lukens 1993). A large number of nonsense and frame-shift mutations
have been documented as a cause of 3°-thalassaemia (Baysal and Carver 1995).
Mutations affecting RNA splicing:
The normal splicing may be disturbed by mutations involving the critical sequences at the
exon-intron splice boundaries (Kazazian et a!, 1990). Consensus sequence changes have been
observed in donor site of IVS-1. G-C substitution at position +5, for example, results in
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production of normally and abnormally spliced RNA that causes severe 13-thalassaemia
phenotype (Triesman et a!, 1983). T-C substitution at position +6 of the IVSI, however,
results in a milder f3-thalassaemia phenotype (Orkin et al, 1982a). The altered mature RNA
resulting from these mutations is ineffective as a messenger for 3-globin synthesis. Nucleotide
substitutions can lead to appearance of a consensus splice site sequence within an intron or an
exon, the new splice site competing with normal splice sequences. G-A substitution at P/SI-
110 creates a new acceptor splice site that resembles the normal acceptor splice site. The new
site is used preferentially by the normal donor site that results in a t3-thalassaemia phenotype
(Spritz et al, 1981). A cryptic splice site, that mimics the consensus sequence for a splice site
but is never used, may become used due to a mutation. A substitution at Codon 26 (Hb-E), for
example, leads to use of a cryptic site at a low level of efficiency (Orkin et al, 1 982b). At least
38 mutations result in abnormal RNA splicing and cause thalassaemia ranging in severity from
mild 13 to t3°-thalassaemia (Baysal and Carver 1995).
RiVA Cleavage and polyadenylation mutants:
Six mutations in the polyadenylation site, all causing -thalassaemia, have been reported
(Baysal and Carver 1995). Mutations at the poly-A site, AAfAAA-AAçAAA in American
Blacks for example, can result in cleaving of only a small percentage of the RNA transcript
(Orkin et al, 1985). It is presumed that deficient 3-globin synthesis is secondary to abnormal
elongated transcripts (Kazazian et al, 1990).
Deletions as a cause of f3-thalassaemia:
Deletions causing f3-thalassaemia are rare. However, 13 different deletions of varying lengths
have been reported (Baysal and Carver 1995). The commonest deletion removes 619 bp of
IVS-H, exon-3 and sequences 3' of the gene (Spritz et al, 1982). Some deletions involving a
large portion of the 5' untranslated region of 3-globin gene are associated with an unusually
high Hb-A2
 (Motum et al, 1992). Craig et al, (1992) have reported a 10.3kb deletion involving
the 5' untranslated region of 3-globin gene in an Asian Indian which is associated with an
unusually high Hb-A2
 level. These mutations probably remove competition of 3-globin gene
promoters for the common Locus Control Region.
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Dominant f3-thakzssaenzia mutations:
A dominant form of 13-thalassaemia, in which heterozygotes also become symptomatic, has
been identified. A total of 27 different mutations, mostly involving the 3rd exon, are associated
with this uncommon phenotype (Baysal and Carver 1995). At the molecular level they result
from different mechanisms including a highly unstable 13-variant as a result of single base
substitution (Them et al, 1991) or deletion of intact codons (Park et al, 1991), truncated 1 3-
chain due to premature termination, and an elongated 3-globin with an altered carboxy
terminal end as a result of frame-shift mutation (Them et al, 1990). The dominant thalassaemia
mutations in a heterozygous state form hyper-unstable haemoglobin variant that precipitate in
the erythroid cells and lead to a syndrome of thalassaemia intermedia (Them 1992).
/3-thalassaemia due to unknown mutations:
Sometimes cases of typical 13-thalassaemia are seen without any detectable mutation in the 13-
globin gene or its immediate flanking regions (Semenza et a!, 1984; Kazazian et al, 1990). It is
thought that these result from a mutation in another gene located elsewhere in the genome,
which is important in [3-globin gene expression (Cao et al, 1994).
World-wide distribution of f3-thalassaemia mutations:
The spectrum of 13-thalassaemia varies widely in different world populations. Each population
has its own set of common mutations that account for most of the mutations. However, a large
number of rare alleles are also observed in each ethnic population (Kazazian et al, 1990). Allele
frequencies vary from one country to another or even between different regions of the same
country (Rosatelli et a!, 1992a). Because so many alleles are found in each region, many
individuals with 13-thalassaemia major carry two different alleles (are compound
heterozygotes). However, in populations where the number of alleles is very limited or
consanguineous marriage is common the incidence of true homozygotes is increased (Rosatelli
et a!, 1992b; Varawalla et a!, 1991a). The prevalence of common mutations in various world
populations is presented in Table: 1.2.
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Table: 1.2. f-thalassaemia carrier rate and mutations in various world populations.
Country: (n)	 Carr4er rate:	 MutatIons:	 %
(Reference)	 (%%11O 198S)	 _________________ ________
ilaly.(914)	 2-15%	 Cd39(C-T)	 400/.(Ro.ateHiaJ,1992a)	 IVSI.II0(G-A)	 23%
P/SI-i (0-A)
	
10°!.
IVSI-6	 10°!.
Others	 17°!.
Greecc (642)	 80/.	 P/SI-i 10(0-A)	 43%
('°'°° '	
1(0-A)
IVSI-6 (T-C)	 90/•
Others	 13%
Sariinia(3000)	 13%	 Cd39(C-T)	 96%(Rosatellietal, 1992b)	 Fr6(-A)	 2%
Fr76(-C)	 1%
Others	 1%
Spain(58)	 <1%	 Cd39(C-T)	 64%(Antselem et al, 1988)	 IVSI-6 (F-C)
	
15%
IVSI-110(G-A)	 9%
Others	 12%
Cyprus, (Turks): (232)	 16-18°!.	 IVSL-110 (G-A)	 74%(Baysaletal, 1992) 	 IVSI-6(T-C)	 8%
IVSI-1 (0-A)
	
7%
IVSI-745 ((>6)	 7%
Others	 4%
Cyprus, (Gieeks): (705)
	 16-18%	 P/St-I 10(0-A)	 80%(Baysaletal, 1992)	 IVSI-6(T-C)	 6%
P/SI-i (G-A)
	
5%
IVSI-745 (C-G)
	
5%
Others	 4%
Turkey. (429)	 2-4%	 P/SI-I 10(0-A)	 42%(Basaketal, 1992)	 IVSI-6(F-C)	 10
Fr 8 (-AA)	 5%
P/SI-i 0-A)
	
5%
Others	 38%
Malta: (32)
	 1.2-3%	 IVSI-6(T-C)	 780/,(ScemetaL 1993)	 Others	 22%
Azerbaijan (135)
	 6%	 Fr 8 (-AA)	 33%(Kuiiev at al, 1994)	 WSII-1 (0-A)	 21%
IVSI-110(G-A)	 13%
Others	 33°k
Bulgaria (128)
	 3%	 P/SI-i 10(0-A)	 24%(Hutnan 1990a)	 Cd 39 (C-i)	 22%
IVSI-6(T-C)	 10%
IVSII-7S4 ((>6)	 10°!,
Others
Ierae(:(122)	 1-20".	 Fr44(-C)	 20%(Rund at al, 1990)	 IVSI-1 10(0-A)	 18°!.
-28(A-C)	 15%
IVSII-1 (0-A)
	
14%
Others	 33%
EipC(48)	 2.5%	 !VSI-110(G-A)	 27%(Novellettodal, 1990)	 IVS1-6(T-C)	 19%
IVSI-1(G-A)	 10°!.
Others	 44%
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Table: 1.2. (Contd...) 3-thalassaemia carrier rate and mutations in various world
populations.
Cowitiy (n)	 Crricr rate:	 Mutations:	 %(Refernsce)	 wtio 198
ena. (172)	 5-6%	 Cd 39 (C-T)	 26%
,ai, 1990)	 1VS1-110(G-A)	 25%
Fr6(-A)	 180/.
IVSI-1 (0-A)	 15%
Others	 16%
UAE: (50)	 3%	 IVSI-5 (0-C)	 66%ifedal, 1994)	 Fr8-9(+G)	 8%
IVS1-25bp	 8%
Others	 18%
Iran. (50)	 2-4%	 LVSII-1 (0-A)
	 22%(Taghi personal a,miuucatlon)	 IVSI-5 (0-C)
	 13%
IVSI-6 (F-C)
	
90/,
Others	 56%
Noulh West Pakistan: (167) 	 2-6.5%	 Fr 8-9 (+0)	 35%
(Varawalladal, 1991a)
	
IVSI-5(0.C)	 44%
Fr41-42(-TTCT)	 10°,'.
Cd 15(0-A)	 7%
Others	 4%
India: (535)	 1-17%	 IVSI-5 (0-C)
	 39%(Varawalladal,1991a)	 DeI6l9bp	 25%
IVSI-1 (G-T)
	 13%
Fr41-42(-TFCT)	 10°/a
Fr 8-9 (+0)
	
80/.
Others	 5%
Buima:(170)	
1hal13%	 Hb-E	 41%(Brown etal, 1992) 	 Hb-E: 1-25%	 IVSI-1 (G-T)	 20%
IVSI-5 (0-C)
	 16%
Fr41-42(-TfCT)	 12%
Others	 11%
Thailand: (128)
	 13-Thai: 3-9%	 Fr 41-42 (-TI'CT) 	 25%(Winichagoon d al, 1990)
	 Hb-E: 0-40%	 Hb-E	 19%
Cd17(A.T)	 13%
IVSII-654 (C-i)
	 6%
Others	 37%
China:(93)	 2-4%	 Fr41-42(-TTCT)	 48%(Chan ci al, 1987)	 IVSII-654 (C-I)
	 22%
Cd17(A-T)	 10%
-28 (A-Q)	 8%
Others	 12%
Malaysia: (?)
	 13-Thai: 1-10%	 IVS1-5 (0-C)
	
49%(Yangetal,1989)	
Hb-E:0-30%	 Cd19(A-0)	 15%
Fr41-42(-TfCT)	 12%
Others	 24%
Indonesia: (72)
	 13-Thai: 3%	 IVSI5 (0-C)
	
44%Ujodal, 1989)	
1-8%	 Hb-E	 18%
IVSII-654 (C-I)
	
10%
Others	 28%
Blacks: (38)	 1-3%	 -29 (A-G)	 55%(Gonzalez-Redondoetal, 1988)	
-88(C-I)	 21%
Cd 24 (F-A)
	
8%
Others	 16%
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Pathophysiology of thalassaemia:
(Weatherall and Clegg 1981)
Quantitative reduction of one or more globin polypeptide chains has two major consequences:
decreased haemoglobin synthesis and an imbalance between a and non-a chain production.
The former is a major determinant of red cell hypochromia, but is of little clinical significance.
Unbalanced globin chain production is the major determinant of the clinical outcome. In
the absence of a complementary globin chain the free normal chains aggregate and precipitate
within the cytoplasm, damage red cell membranes, and lead to premature destruction of
erythroid cells. 13-chain tetramers seen in a-thalassaemias (Hb-H) are unstable and lack the
physiologically useflul properties of normal haemoglobin. They tend to oxidize easily and
precipitate within erythroid precursors. However, these tetramers remain soluble for a while
and therefore result in a clinical syndrome that is not very severe.
In 13-thalassaemia deficiency of 13-chains result in accumulation of unpaired a-chains. Because
of their great instability free a-chains aggregate to form insoluble inclusions in erythroid
precursors. The burden of inclusions is sufficient to cause large scale ineffective erythropoiesis.
The spleen traps inclusion bearing red cells that enter the circulation, where many incur
irreparable mechanical and metabolic injury. In response to the ineffective erythropoiesis and
shortened red cell survival there is an enormous increase in marrow activity. Expansion of the
medullary cavities by erythroid tissue occurs at the expense of cortical bone.
Clinical and Laboratory features of a-thalassaemia syndromes:
Carriers of single a-gene deletion (-alaa) are clinically normal. About half have mild
hypochromia and microcytosis. Heterozygotes of a-thalassaemia- 1 (--faa) or homozygotes of
a-thalassaemia-2 (-al-a) usually do not have anaemia. They have distinct microcytosis and
hypochromia (Huisman 1996). nb-H disease (--I-a), on the other hand, has clinical picture of
chronic haemolytic anaemia of variable severity. The syndrome of hydrops fetalis results from
deletion of all 4 a-genes (--I--). The affected fetus is usually delivered prematurely and is either
still born or dies shortly after birth (Lukens 1993). The haematological picture of different
types of a-thalassaemias is summarized in Table: 1.3. Carrier detection for a-thalassaemia is
difficult by routine haematological methods. Gene mapping by restriction endonucleases or
34
detection by PCR are reliable for detection of a-thalassaemia carriers (Kulozik et at, 1988;
Baysal and Huisman 1994).
Table: 1.3.	 Summary of haematological findings in individuals with a-thalassaemia
(Adapted from Hlggs et a!, 1989).
Phenotype	 No of	 Hb-Barts at Rb-H %	 MCV	 MCII aJ chain
functional	 birth (%)	 synthesis
a-genes	 ratio
Normal	 4	 0	 0	 85-100	 -30	 -1.0
c-thalassaemia trait 	 3	 0-2	 0	 75-85	 -.26	 -.0.9
a°-thalassaemia trait 2 	 2-8	 0 (occasional) 65-75	 -22	 -.0.7
Hb-H disease	 1	 10-40	 1-40 (many)	 60-70	 -.20	 -0.4
Hydrops fetalis	 0	 -80	 +	 110-120 low	 0.0
Clinical and Laboratory features of 3-tha1assaemia syndromes:
Heterozygous 3-thalassaemia (thalassaemia minor) is mostly asymptomatic but causes
prominent abnormalities of red cells. A typical case has haemoglobin in the normal or lower
normal range, MCV is 75 fi, MCH 25 pg, and Hb-A2
 is ?3.5% (Lukens 1993). The most
severe form of homozygous r3-thalassaemia is recognized as thalassaemia major. The infant is
normal at birth but usually within six months of age progressive pallor develops and the patient
fails to thrive. In the absence of transfusion therapy haemoglobin concentration slowly falls to
3-5 g/dl and the characteristic clinical picture emerges. The child has a small stature, relatively
large head, and moderate to marked hepato-splenomegaly (Modell and Berdoukas 1984).
Table: 1.4 summarizes the clinical and haematological features of 3-thalassaemia syndromes.
Thalassaemia intermedia:
The term Thalassaemia Intermedia (TI) is used to describe patients with the clinical picture of
thalassaemia, which, although not transfusion dependent, is associated with a more severe
degree of anaemia than that found in heterozygous carriers for a- or J3-thalassaemia
(Weatherall 1996). The intermediate forms of thalassaemia show a markedly heterogenous
clinical picture. At the molecular level several factors may be responsible for the mild
phenotype of thalassaemia that may exist in each patient either independently or in
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combinations. These are summarized in Table: 1.5.
Mild 3-thalassaemia mutations, for example C-T substitution at -88 (Orkin et a!, 1984), C-T
substitution at -101 (Gonzalez-Rodondo et a!, 1989), and A-C substitution at the Cap site
(Wong et al, 1987), when co-inherited with another severe -thalassaemia mutation are often
associated with a mild (intermedia) phenotype. Many of the promoter region mutations in
heterozygous state are associated with minimal or no increase in Hb-A2
 level.
Table: 1.4.	 Clinical and haematological features of 3-thalassaemia syndromes (Modified
from Lukens 1993).
Thalassaemia Major Thalassaemia Intermedia
	 Thalassaemia Minor
Seventy	 I I I I	 ++	 +,±
Genetics	 Homozygous/double Homozygous/double
	 Heterozygous
______________ heterozygous
	 heterozygous	 __________________
Splenomegaly	 I I i	 ++,+++	 +, 0
Jaundice	 +	 -f-f	 0
Bony changes	 I I ,++	 +, 0
	
+, 0
Haemoglobin	 <7 g/dl	 7-10 g/dl
	 >10 g/dJ
Hypochromia	 I I I I	 +-1-+	 ++
Microcytosis	 +++	 ++	 +
Target cells	 10-35%	 -H-	 +
Stippling	 ++	 +	 +
Reticulocytes	 5-15%	 3-10%	 2-5%
Nucleated RBC +++	 +, 0	 0
Hb-F	 20->94%	 30-100%	 1-2%
Hb-A2
	1-8.7%	 <1-10.0%	 3.5-8.0%
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Table: 1.5. Molecular basis of thalassaemia intermedia (Cao et a!, 1994).
1. Mild defects of /3-globin chain production
a. Homozygosity for mild -thalassaemia
b. Compound heterozygosity for mild and severe 13-thalassaemia
2. Homozygosiy or compound heterozygosiy for severe /3-thalassaemia associated with
a. a-thalassaemia
b. Genetic factors enhansing y-chain production
(3y promotor mutation (homozygous Xmn-I polymorphism)
Heterocellular HPFH
3. /3-thalassaemia chie to large promoter region deletions
4. Homozygosiiy for 8/3-thalassaemia or its combination with /3-Ihalassaemia
5. Double heterozygosllyfor/3-thalassaemia and tr4ilicated a-globin gene
6. Heterozygosizy for hjperunstable Hb variants (Dominant thalassaemia)
Co-inheritance of a-thalassaemia in the form of deletion of two genes (--/cta or -a/-a) may
raise the MCV and MCH in a 13-thalassaemia heterozygote to a normal range (Melis Ct al,
1983). The severity of homozygous t3-thalassaemia is also reduced by co-inheritance of two
gene deletion ct-thalassaemia (Cao et a!, 1994). Co-inheritance of single ct-gene deletion (-
a/act), however, affects the phenotype of only l3-thalassaemia homozygotes (Gringras et al,
1994). Co-inheritance of triplicated a-genes (cta/aact), on the other hand, may increase the
severity of 3-thalassaemia (Galanello et al, 1983).
Some patients of typical 3-thalassaemia major produce larger quantities of Hb-F that
compensates the globin chain imbalance created by lack of j3-chain production. Studies in
Sick!e cell disease (SS) and t3-thalassaemia heterozygotes have shown that A-T polymorphism
at position -158 relative to G7 Cap site (recognized by Xmn-I) is associated with 3-11 fold
increase in production per Gyglobin gene (Gilman and Huisman 1985). Patients of
homozygous [-thalassaemia associated with homozygous Xmn-I polymorphism at position -
158 usually have a thalassaemia intermedia phenotype (Them et a!, 1987; Gringras et al, 1994).
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Management of thalassaemia:
The mainstay of thalassaemia management is regular blood transfusions, iron chelation therapy
and provision of other support facilities. A hyper-transflision regimen that maintains a mean
haemoglobin of 12 g/dl is recommended. Hyper-transfusion allows normal growth and
physical activity, reduces marrow hyperplasia and the associated bony abnormalities and
prevents splenomegaly and hyperspienism. The main disadvantage of hyper-transfiision is the
accumulation of excess iron in the body that damages many organs including heart, liver and
endocrine glands (Cao et al, 1992). Iron that accumulate over a period of time due to repeated
blood transfusions and increased absorption from the intestine needs to be removed by regular
use of iron chelators. Desferrioxamine is the most extensively used iron chelator (Giardina and
Grady 1995). Its main disadvantage, other than the high cost, is a continuous subcutaneous
route of administration. An oral iron chelator Li is also available but the associated risk of
agranulocytosis has limited its use (Brittenham 1992).
Splenectomy is considered for patients who require more than 200 ml of packed red
cells/kg/year (Piomelli 1995). Thalassaemia patients on regular treatment protocols also
require hormone replacement therapy (Kattamis and Kattamis 1995). Allogenic bone marrow
transplantation is the only curative treatment available at present. Success rate of over 92% in
selected cases has been achieved at some centres (Lucarelli et al, 1995). Reactivation of fetal
haemoglobin production by 5-azacytidine or hydroxyuria may have some benefit in patients of
thalassaemia intermedia (Olivieri 1996). The prospects of gene therapy, for the present, appear
to be remote (Beuzard 1996).
The intermediate form of thalassaemia requires careful surveillance. The patients should be
watched carefully in early childhood, and if there are signs of growth retardation or increasing
bone deformity, they should be put on regular transfusions (Cao Ct al 1992). Patients of
thalassaemia intermedia, who are kept off transfusion, usually develop splenomegaly that
becomes a source of pooling of blood. In such patients splenectomy can be beneficial.
Thalassaemic children who are not given any treatment usually die before two years of age.
Those who get adequate treatment reach their adult life. The prognosis of children who are
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inadequately treated is poor.
Prevention of thalassaemia:
Although thalassaemia patients can be managed to a great extent by regular blood transfiisions
and other supportive measures, the high cost of treatment creates severe health burden in a
community where the disorder is common. The burden has gradually increased because of the
nse in life expectancy following introduction of modern supportive measures (Angastiniotis Ct
a!, 1986). Nowadays, therefore, a fundamental aspect of the management of these disorders is
prevention. Several thalassaemia prevention programmes in the Mediterranean have shown
that the birth rate of new thalassaemics can be brought down to almost zero (Cao 1987). The
cardinal features of a thalassaemia prevention programme include (1) public education, (2)
population screening, (3) genetic counselling, and (4) prenatal diagnosis (Fig 1.4).
Prerequisites:
The planning and organization of a comprehensive thalassaemia prevention programme has
certain prerequisites. Political will and commitment by the government who is also the public
health planner is essential. A basic situation analysis at the National level is necessary to
determine priorities. In the absence of reliable epidemiological data preliminary information on
trends and hospital statistics may be useful. The funding resources may be made available from
governmental as well as non-governmental sources (Alwan and Modell 1997).
Public education:
All programmes for prospective control of thalassaemia in the Mediterranean had an intensive
awareness campaign and involvement of population. Public education was achieved by means
of mass media, posters, informative booklets, and by special teaching on thalassaemia in
schools. More personal approaches through lectures and discussions with the community
leaders of the population were very useful. The health care workers and the paramedical staff
played a major role in implementation of the preventive programmes (Cao 1987). In addition
to the public awareness campaign it is also essential to create an awareness amongst the state
authorities about the possibility of an ever increasing expenditure on new cases of thalassaemia
if no control measures are taken (Loukopoulos 1996).
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IPOPULATION AT RISK I -* unformed populationi
4,	 ___________
Education and information -* -ye result -* iReassurancel
4,
Screening
4,
Positive result
4,
Information and counselling
4,
uNFORMED CARRIERS I
4,	 __________
Invite partner for testing -* -ye result -* IReassurancel
Positive result
4,
Information and counselling
4,
I INFORMED COUPLES AT RISKI
4,	 Separation (rare)
ICHOICEI
	
Use Artificial insemination from doner (rare)
4,	 No children (only if no prenatal diagnosis)
IPREGNANCYI —*Declined PND I75% healthy chi ldrenj
4'	 125% Accepted homozygote
Fetal sampling 
— Loss of pregnancy (few)
4,	 _______________
Fetal diagnosis —*Tjnaffected -* ihealthy child 75%lFurther	
4,counselling	 Affected (25%)
4,	 _______________________
Counselling -* No termination - lAccepted homozygote 25°/
4'	 of pregnancy
Termination of pregnancy
Fig: 1.4. An outline of the basic principles of thalassaemia prevention including
public education, carrier screening, genetic counselling, and prenatal diagnosis
(Based on Petrou et al, 1990).
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Carrier screening:
Programmes designed to reduce the frequency of f3-thalassaemia major births include the
couples who already have an affected child or who are in their first pregnancy (WHO 1983).
Retrospective diagnosis i.e. identification of a couple after the birth of an affected child,
although very useful for individual couples, has only a limited effect on the number of affected
children in the community (Cao 1987). The retrospective approach, however, may be useful in
communities where final family size is large because a cessation of reproduction can reduce the
birth rate of new thalassaeniics to almost 50% (Aiwan and Modell 1997). Initial programmes
in the Mediterranean involved parents with an affected child and prospective diagnosis i.e.
identification of the couples at risk before giving birth to an affected child, was instituted at a
later stage (Cao et at, 1981). The choice of testing varies between premarital or at marriage as
in Greece (Fessas 1986), mandatory screening of couples before marriage as in Cyprus
(Angastiniotis et at, 1986) screening in the antenatle clinics as in the UK (Petrou 1994), or
school leavers as in some areas of Italy (Bianco et at, 1985). An obvious disadvantage of
screening during pregnancy is the finding of a couple at risk when the pregnancy is already
advanced. Late testing may produce dramatic emotional stress on couples.
Screening the relatives of known carriers can also be an efficient approach for detecting
thalassaemia. The approach can identify a large number of carriers (Mouzouras et at, 1980;
Cao 1987). A useful and cost effective strategy adopted by several programmes is to test one
member of a couple, the other member being tested when the first is found to be a carrier.
The carrier detection methods should be able to pick up 3-thalassaemia trait, as well as 6 t3
-thalassaemia, y63-thalassaemia, Hb-S, Hb-E, and Hb-C which, when co-inherited with 3-
thalassaemia, may result in thalassaemia syndromes. The methods should also be able to
identify silent 13-thalassaemia alleles and co-existing a- and -thalassaemia trait (Cao et at
1994). A scheme (Fig 1.5), that can identify almost all carriers, should include red cell indices,
haemoglobin electrophoresis, Hb-A 2 and Hb-F estimation, and globin chain synthesis studies
(Modell and Berdoukas 1984). Molecular genetic studies can supplement the identification of
silent 3-thalassaemia carriers and those with co-existing cx-thalassaemia (Cao et at, 1994).
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Data from various populations suggest that MCH is a more sensitive indicator than MCV for
identi1ying unusual forms of -thalassaemia (Modell and Berdoukas 1984). A Cut off limit for
MCH below which Hb-A2 estimation should be done to confirm the diagnosis of thalassaemia
trait may be 27 pg. An important diagnostic problem, especially in the Asians, arises from the
high incidence of iron deficiency that is the commonest cause of severe microcytosis. Hb-A2
level in -thalassaemia trait with concomitant iron deficiency, however, remains in the higher
range unless severe anaemia is present (Cao Ct al, 1994).
In large scale population screening for thalassaemia in a developing country red cell indices
may be replaced by a cost effective one tube osmotic fragility test as a screening method and
confirmation by Hb-A2 estimation (Kattamis et al, 1981; Bianco and Silvestroni 1983).
Genetic counselling:
Genetic counselling aims at replacing misunderstandings about the cause of genetic disease
with correct information and increasing people's control on their own and their family's health
by informing them of the resources available for diagnosis, treatment and prevention. The
basic principles of genetic counselling include autonomy of the individual or couple, right
to complete information and highest standard of confidentiality (Harper 1993). The main
components of genetic counselling are correct diagnosis in the presenting family member,
explanation of the nature prognosis and treatment of the disorder, estimation of genetic
risk for parents and family members, the options for avoiding genetic risks and supporting
the individual or couple in making the right decision. The ethical principles governing
genetic counselling need to be reviewed in the light of social and religious structures
particularly in relation to the issues of prenatal diagnosis,. nd counselling in relation to
customary consanguineous marriage (Aiwan and Modell 1997).
Counselling is generally based on a private interview with the individual carrier or the couple.
It should be non-directive and any mandatory measures restricting the individual freedom
should be avoided because this may have negative effects (Angastiniotis and Hadjiniinas 1986).
In countries where high-risk ethnic minorities exist, in the UK for example, it may be difficult
to provide adequate counselling because of problems of language, culture, and trust (Modell
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and Berdoukas 1984). In a situation like this the services of a trained counsellor with the same
cultural religious and linguistic background can be of great help (Petrou et al, 1990).
Prenatal diagnosis:
The basic objective of prenatal diagnosis is to give an informed choice to the at risk couple
(Fig 1.4) (Petrou et al, 1990). The affected pregnancies are terminated only on the parent's
request, the main consideration being for the future and quality of life of the child. The concept
of prenatal diagnosis and termination of pregnancy has been accepted only slowly over the past
25 years and there is ongoing debate about its ethical and social implications. The decision
whether or not to terminate an affected pregnancy is never taken lightly even in countries
where prenatal diagnosis is filly accepted (Alwan and Modell 1997). Thalassaemia preventive
programmes carried out before prenatal diagnosis was available and thus based solely on
heterozygote detection and genetic counselling have not been effective in reducing the birth
incidence of new cases of thalassaemia major (Barrai and Vullo 1980a). The introduction of
prenatal diagnosis (Kan et al, 1975) gave a new dimension to thalassaeniia prevention.
Prenatal diagnosis was initially done by globin chain synthesis ratio on fetal blood obtained in
mid trimester gestation by fetoscopy or placental aspiration (Fairweather et al, 1978) and then
by cordocentesis (Cao et al, 1986). With the development of sophisticated ultrasound scanners
the practice has now shifted to first trimester fetal sampling by chorionic villus sampling (Ward
et al, 1983). The rate of miscarriage with chorionic villus sampling is less than 1% (Centre for
Disease Control and Prevention, Atlanta 1995). The laboratory diagnosis is now carried out
by DNA analysis. Polymerase Chain Reaction (PCR) has simplified the process of mutation
detection in the fetal tissue (Old et al, 1990).
In-vitro fertilization and embryo transfer has also enabled diagnosis to be carried out on just a
few cells obtained from the embryo prior to implantation (Monk and Holding 1990). However,
the present method of pre-implantation diagnosis are cumbersome, expensive and
experimental, but if successfiil may be made acceptable reliable and simple (Aiwan and Modell
1997).
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Evaluation of thalassaemia control programmes:
The results of prevention programmes in various Mediterranean populations are summarized
in Fig: 1.6. The best results have been achieved in Cyprus where the incidence has declined by
almost 97%. This has been helped by a small size and population of the country, high standard
of living, high literacy rate, low birth rate, high standard of health care and helpfiul attitude of
the Church in endorsing premarital screening (Angastiniotis et al, 1986). In the UK, where the
programme is active since 1977, the birth rate of thalassaemia major has fallen to just 50% of
the expected. In the UK screening and counselling is well delivered to British Cypriots, but
very inadequately to British Asians particularly Pakistanis (Modell Ct al, 1984). An important
reason for the low acceptance rate for prenatal diagnosis amongst British Pakistanis and
Bangladeshis is that they are referred late in the second trimester and many then reftise prenatal
diagnosis. Due to the availability of first trimester diagnosis the acceptance rate of prenatal
diagnosis has improved substantially in these communities (Petrou et a!, 1990). Almost 80% of
Pakistani couples referred in the first trimester now request prenatal diagnosis (Petrou 1994).
Unfortunately, many such couples are identified late as the screening is done in antenatal
clinics.
Cost effectiveness of thalassaemia prevention:
Cost analysis of prevention versus treatment, done in many Mediterranean countries and the
UK, shows that the cost of prevention is equivalent to treating the affected new born for just
one year (Ostrowsky et al, 1985; Cao 1987). Table: 1.6 shows six possible policies for
thalassaemia (Aiwan and Model! 1997). A comparison of the cost of the six policies in a
population (Fig 1.7) shows that the policy involving best possible patient care, plus
premarital and antenata! "prospective" carrier screening and genetic counselling, with
availability of prenatal diagnosis is the most cost effective.
DNA analysis for thalassaemia:
In the mid 1970s, two revolutionary techniques became available that radically simplified the
analysis of DNA structure. The first evolved from the discovery of DNA cleaving enzymes
called restriction endonucleases which could cut a DNA molecule only at specific sequences
(Weinberg 1985). The other technical revolution came with the ability to sequence DNA
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(Sanger et al, 1977). The discovery of Polymerase Chain Reaction (PCR) in the mid 1980's
has fi.irther simplified the analysis of DNA (Mullis and Faloona 1987).
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Fig: 1.6. Fall in the birth rate of infants with thalassaemia major associated with four national
thalassaemia prevention programmes (Based on Cao 1987).
Table: 1.6. Six possible policies for thalassaemia. Policies 1-5 are currently in existence
in different countries of the Eastern Mediterranean Region (EMR) (Aiwan and Modell
1997).
Policy 1
	 A "baseline situation" in which no treatment, counselling or prevention is
available. (Until recently this was the situation throughout most of the Middle
East, but there has been rapid progression towards "policy 2" in many countries
__________ during the last 10 years.)
Policy 2	 The best possible patient care, plus "retrospective" genetic counselling after the
first affected child is diagnosed. (This is now common in many countries of the
__________ Region.)
Policy 3	 The best possible patient care, plus "retrospective" genetic counselling, plus the
option of prenatal diagnosis in subsequent pregnancies. (Available for a limited
-___________ number of families in the Region at present.)
Policy 4	 The best possible patient care including retrospective genetic counselling, plus
"prospective" (premarital) carrier screening and counselling, but no prenatal
___________ diagnosis. This is in place in some countries of the EMR.
Policy 5
	 The best possible patient care, plus premarital and antenatal "prospective"
carrier screening and genetic counselling, with availability of prenatal diagnosis.
___________ At present, the only country of the Region implementing this policy is Cyprus.
Policy 6	 The best possible patient care, plus premarital, and family- and population-based
"prospective" carrier screening, plus genetic counselling, but no prenatal
____________ diagnosis.
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Fig: 1.7 Projected evolution of total costs of treating and preventing thalassaemia over
the first 20 years, with the six different policies described in Table: 1.6 (Aiwan and
Modell 1997).
Southern blotting:
Localization of particular sequences within genomic DNA can be accomplished by the transfer
technique of Southern (1975). Genomic DNA is digested with one or more restriction
enzymes and the resulting fragments are separated according to size by electrophoresis
through an agarose gel. DNA is then denatured in situ, transferred to nitrocellulose filter or
nylon membrane and is then hybridized to radiolabelled probe. Southern hiotting has been
extensively used in the past for analysis of gene defects in thalassaemia (Boehm and Kazazian
1989).
Restriction Fragment Length Polymorphism (RFLP):
The term RFLP denotes a variation in fragment sizes when genomic DNA from different
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individuals is cleaved with the same restriction enzyme. There are several polymorphic sites
that are closely linked to the 3-globin gene (Antonarakis et al, 1985). These polymorphic sites
can be recognized by the use of restriction endonucleases (Fig: 1.8) which cleaves double
stranded DNA at a specific sequence (Varawalla et al, 1992).
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Fig: 1.8 Restriction endonuclease site polymorphisms in human non-a globin gene cluster.
The sites shown below the line have been most intensively studied and are commonly used to
define chromosomal haplotypes in genetic analyses. Polymorphisms at the sites encompassed
in brackets I and H are usually in linkage disequilibrium with one another within each
bracketed area, but random recombinations or associations occur between polymorphisms of
group I and those of group II (Bunn and Forget 1986).
Many 13-thalassaemia mutations can also be identified by restriction enzymes (Them and
Weatherall 1988). RFLP analysis can be used for prenatal diagnosis of thalassaemia by
identiFying the restriction sites closely linked to the 13-globin gene (Old et al, 1986a). A
disadvantage of the linkage based diagnosis is that a meiotic recombination between the
polymorphic site and the 3-globin gene can be a potential source of error (Old et al, 1 986b).
Requirement of a previously affected or normal child in the family or the grand parents, lack
of informativeness of the marker sites in some families (Antonarakis 1989) and the presence of
a mutation outside the J3-globin gene cluster e.g. in the locus control region (Kazazian et a!,
1990) are other disadvantages.
Genomic sequencing:
Sanger et a!, (1977) described a method of determining the sequence of unknown DNA. The
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method is based on the principle that the inhibitory activity of 2',Y-dideoxythymidine
triphosphate (ddTTP) on DNA polymerase-I is incorporated into the growing oligonucleotide
chain in the place of thymidylic acid (dT). Because the ddT contains no 3'-hydroxyl group, the
chain cannot be extended further, so that termination occurs specifically at positions where dT
should be incorporated. If a primer and template are incubated with DNA polymerase in the
presence of a mixture of ddTTP and dTTP, as well as the other three deoxyribonucleoside
triphosphates, a mixture of fragments, all having the same 5' end with ddl residue at the 3'
ends, is obtained. When this mixture is separated by electrophoresis on denaturing
polyacrylamide gels the pattern of bands shows the distribution of dTs in the newly synthesized
DNA. By using analogous terminators for the other nucleotides in separate incubation
reactions and running the samples in parallel on a gel, a pattern of bands is obtained from
which the sequence of DNA can be read.
Sequencing of DNA is an extremely useful tool in identification of an unknown gene defect.
Currently, sequencing is carried out on fragments of either double stranded or single stranded
DNA that are amplified by Polymerase Chain Reaction (Engelke et al, 1988; Rao 1994).
Polymerase chain reaction (PCR):
Polymerase Chain Reaction (PCR) is an in-vitro technique that allows amplification of a
specific DNA region (Mullis and Fallona 1987). The amplification of DNA is achieved by
using oligonucleotide primers. These are short, single stranded DNA molecules that are
complimentary to the ends of a defined sequence of the DNA template. The primers are
extended on single stranded denatured DNA (template) by heat stable DNA polymerase in
the presence of deoxynucleoside triphosphate (dNTPs) under suitable reaction conditions.
This results in the synthesis of a new DNA strand complementary to the template strand.
DNA polymerase is used to synthesize new strands of DNA in successive cycles of heat
denaturation of the template, annealing of primers by cooling the mixture and primer
extension at a temperature suitable for the enzyme. Each cycle of amplification creates
new DNA strands that become templates for the next cycles.
PCR products consist of fragment(s) of DNA of size(s) defined by the boundaries of the
PCR primers. The simplest and most commonly used method of PCR product analysis is
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its electrophoresis on agarose or polyacrylamide gels. DNA is a negatively charged
molecule and migrates towards the positive electrode when it is placed in an electrical
field. This movement is inversely proportional to the molecular weight of DNA. Once
separated by electrophoresis, DNA can be visualized by staining with ethidium bromide or
silver nitrate (Newton and Graham 1994).
PCR is an extremely sensitive technique and in about 20 cycles there will be 220 fold
amplification. Therefore the commonest source of error in PCR involves contamination at
the pre PCR step (Newton and Graham 1994). It is important to include negative controls
and reagent blanks with every batch of reactions. Other useful measures to avoid
contamination may be the physical isolation of PCR reagents and products, autoclaving
solutions, avoiding splashes, use of positive displacement pipettes and aliquoting reagents
(Kwok and Higuchi 1989).
The basic technique of PCR has been used in several approaches that identify known and
unknown gene defects. These include Amplification Refractory Mutation System
(ARMS), dot blot, reverse dot blot, Denaturing Gradient Gel Electrophoresis (DGGE),
Single Strand Conformation Polymorphism (SSCP) and chemical cleavage of mismatches
(Newton and Graham 1994).
Ampljfication refractory mutation system (ARMS):
In PCR the yield of reaction is critically dependent on a perfect match between the Y end of
the primer and the template DNA. A primer designed to match the change encountered in a
point mutation will only amplify the mutant sequence and similarly the primer for a normal
sequence will amplify only the normal sequence and not the mutant sequence (Newton et al,
1989). Kowk et al, (1989) have shown that additional mismatches at position -3 or -4 from the
3' end of the primer can further improve the specificity of the reaction. They also demonstrated
that A:G, C:C and to some extent G:G mismatches gave the best results. Studies by Old et al,
(1990) and Varawalla et al, (1991) have proven the efficacy of ARMS method in detecting 3-
thalassaemia mutations.
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Denaturing gradient gel electrophoresis (DGGE):
The method is based on the principle that electrophoretic mobility of a double stranded DNA
molecule through linearly increasing concentration of denaturing agents is retarded by its
denaturation (Myers et al, 1987). As the DNA fragment proceeds through the gradient gel, it
will reach a position where the concentration of the denaturing agent equals the melting
temperature (Tm) of its lowest melting domain. This results in marked retardation of its
electrophoretic mobility. The Tm of a melting domain is dependent on its nucleotide sequence.
Therefore, when DNA fragments, that differ by a single nucleotide change in their lowest
melting domain, are electrophoresed through denaturing gradient gels, branching and
consequent retardation of their mobility will occur at different positions along the gel. This
allows their separation. The DGGE can not resolve DNA fragments differing by base changes
located in the highest Tm domains. This problem can be overcome by attaching a G-C rich
domain (40-45 bases) into the fragment to be analyzed (Myers et al, 1985). The G-C rich
domain has a high Tm and it prevents complete denaturation of the DNA molecule. The PCR-
DGGE combination is a very useful tool for detection of single neucleotide changes in DNA
(Fodde and Losekoot 1994).
Dot blot and reverse dot blot:
The technique of dot blot involves immobilization and denaturation of PCR products to a
membrane, such as nitrocellulose or nylon, followed by hybridization with the allele
specific oligonucleotides. Using stringent conditions an oligonucleotide that is fully
complementary to one allele will hybridize to that allele only. The other allelic variants
will, similarly, be hybridized by its specific oligonucleotide probe (Amselem et al, 1988).
The reverse dot blot is similar to dot blot but the process is reversed i.e. allele specific
oligonucleotides are immobilized onto a membrane and hybridization is then carried out
using a radioactive or biotinylated PCR product. It offers the advantage of simultaneous
analysis of several mutations in a single test (Newton and Graham 1994).
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Historical background:
The people of Pakistan are made up from all those who, at various times and for various
reasons, have come to the land that today is known as Pakistan. The first urban settlements
that emerged as Indus Valley Civilization can be traced back in history to beyond 2500 B.C.
(Wolpert 1977). However, it was with the arrival of the Aryans from Eurasia between 1500-
500 B.C. that the new chapter in the story of Pakistan really begins. Subsequently, the region
saw successive invasions by Persians in 530 B.C., Greeks in 330 B.C., Bactrians, Scythians,
and Parthians between 185 B.C. and 75 B.C., Kushans in 1st century A.D., Huns in 500 A.D.,
Arabs in 700 A.D., Turks in 977 A.D., Mongols in 1221 A.D., and Mughals from Central Asia
in 1504 A.D. (Rapson 1962).
In spite of the frequent invasions and tribal migrations, mainly from the Central Asia, the vast
majority of the population, however, stems from a genetic pool that has its roots in South
Asia. The first impression of the Pakistanis likely to be gained by visitors to a big city in
Pakistan is of its amazing variety (Halliday 1990).
Population and the ethnic groups:
According to the census conducted in 1981 Pakistan's population was 84.25 million. Presently
it is estimated at 137 million and its growth rate is 2.8% (Economic survey 1995-1996).
There are four main ethnic groups (Fig 2.1) i.e. Punjabi, Pathan, Sindhi, and Baluchi who are
mainly distributed in the provinces of Punjab, North West Frontier Province (NWFP), Sindh
and Baluchistan respectively. In addition, a fifth group of people called Mohajirs, who
migrated from various parts of India at the time of creation of Pakistan in 1947, can also be
recognized. According to the census (1981) the proportion of the population in various
provinces was as follows: Punjab 56.4%, Sindh 22.5%, NWFP 15.8%, and Baluchistan 5.1%.
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Fig: 2.1. Four Provinces of Pakistan. The predominant population in each province consists of
Pathans in the North West Frontier Province (NWFP), Punjabis in Punjab, Sindhi and Mohajirs
in Sindh, and Baluchis in Baluchistan.
Punj abi:
The name Punjab is derived from "punj" meaning five, and "aab" meaning waters. Five major
rivers cross the province of Punjab. The inhabitants of Punjab are known as Punjabis.
Agriculture, because of an extensive network of rivers and canals, is the most important
industry in Punjab. Punjabis are the largest ethnic group numbering approximately 80 million.
The racial origin of Punjabis is considered to be from Aryans. However, a mixture from South
Indian civilizations is also present (Joshi and Singh 1976).
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Pathan:
In the mountainous terrain of the North West Frontier Province (NWFP) the people are mostly
Pathans, divided into clans or into families connected with certain villages or districts. The
Pathans number approximately 15-20 million. They are perhaps the world's largest tribal
society (Quddus 1987). Some of the tribes residing in Pakistan are also distributed over the
neighbouring Afghanistan. Many origins have been attributed to Pathans i.e. Aiyan, Greek,
Persian, Arab and Jewish (Bokhari 1975). What ever their origin may be, they can be
distinguished by their sharp features and fair skin.
Sindhi:
The province of Sindh derives its name from the mighty river "Sindh" or "Indus" that is also
the reason for the name "India" for the region as a whole. Geographically speaking "Sindh"
denotes the lower half of the Indus Valley. Ethnically Sindhi society has been cosmopolitan
and its origin ranges from the descendants of the ancient Aryans, Scythians, Arabs, Turks,
Persians, Rajputs, and Baluhis (Khan 1980). There are approximately 15 million Sindhis and
almost all of them are confined to the province of Sindh.
Baluchi:
Baluchis, the smallest ethnic population numbering about 5 million, are scattered over the
largest province of the country accounting for about 42% of its area. Most of Baluchistan has
more in common with Western Asia than with the Indian subcontinent. Although there is
evidence that the area was inhabited in the stone age (7000-3000 B.C.) the name Baluchistan
only came into existence with the arrival of tribes from Iran called "Baluch". There is evidence
that this tribal migration took place around 700 B.C. (Bokhari 1975).
Mohajir:
This group is not well defined. It includes mostly individuals and their descendants who
migrated from various parts of India during partition of the subcontinent in 1947. These
include predominantly Urdu speaking individuals from various parts of Northern India. In
addition, a large number of people from Gujrat and Bihar are also included in this group.
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Unofficial estimates for the number of Mohajirs are around 15 million. They mostly reside in
the province of Sindh.
Caste Biradri and Tribe:
The renmants of the traditional caste system, that took its origin in common with Hinduism in
the Aryan era, can also be seen in Pakistani culture. However, social discrimination on the
basis of caste, still widespread in India, is not prominent. The Biradri is a community whose
members are related either closely or distantly by blood or marriage so that members think of
each other as kinsmen (Kolenda 1978). It is much larger as compared to a kinship net work of
an individual's kindred in the Western Society. Biradris usually do not have any territorial
confinements. There are a number of sizeable Biradris in Pakistan that range in numbers from a
few hundred to even millions. Some of the larger Biradris are subdivided in to smaller sub-
Biradris. The equivalent of a Biradri amongst the Pathans and Baluchis is a tribe.
The rules for behaviour within the Biradri or a tribe are well defined and agreed upon. The
elders usually perform the duties of enforcing the rules, doing justice on disputes and carrying
out social planning (Punjabi 1976).
Consanguineous marriages:
A consanguineous marriage is defined as marriage between individuals who have at least
one, not too remote, common ancestor. In practice the relationships beyond 2' cousins
are taken as non-consanguineous (Bittles 1994). The offspring of a consanguineous
marriage is said to be inbred. The main genetic consequence of consanguinity is an
increase in the proportion of homozygotes. Recessive genes, that are unable to express
themselves in the heterozygous state, are thus brought to the fore (Bodmer and Cavalli-
Sforza 1976).
Marriages in Pakistani culture are usually stable and arranged by family members of the two
spouses. Consanguineous marriages are a frequent occurrence. Pakistan is a Muslim country
so a marital relationship closer than 1st cousin is prohibited (Al-Quran, Sura Al-Nisa). Studies
in the major urban cities of Punjab show that almost 50% of the marriages are between close
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relatives (Shami and Zahida 1982; Shami and Iqbal 1983; Shami and Hussain 1984; Shami and
Mlnhas 1984; Shami and Siddiqui 1984; Darr and Modell 1988; Bittles et a!, 1993). A study of
9,520 couples in the urban Punjab by Bittles (1994) showed that 50% of the marriages are
consanguineous, 34% are between unrelated but Biradri members, and only 16% are between
completely unrelated individuals (Table 2.1). Average coefficient of inbreeding, the probability
that an individual inherits two genes at a locus that are identical by descent i.e. from a common
ancestor, in Punjabis is estimated to be 0.0280 (Bittles 1994).
A study of consanguineous marriages amongst Pathans of Swat (Table 2.1) showed that it
was 31% (21d cousin or closer) in the urban areas and 37% in the rural areas (Wahab and
Ahmed 1996). Comparable data from other regions and ethnic groups are lacking.
Unpublished reports on consanguineous marriages amongst other ethnic groups are
summarized in Table: 2.1. A rural Sindhi sample of 202 couples showed that 73% marriages
were consanguineous (Dr. Rafique Memmon, personal communication). In 189 couples from
rural Baluchis 87% marriages were consanguineous (Dr. Jaleel Anwar, personal
communication). Consanguineous marriages in 120 Mohajir couples, however, were 47.5%
(Mr. Mohammad Iqbal personal communication).
Dan and Model! (1988) have shown that consanguineous marriages amongst the British
Pakistanis were more common in the present generation of couples as compared to their
previous generation. Wahab and Ahmad (1996) also observed similar trend in a study of
Pathan couples in Pakistan.
The main effect of parental consanguinity is to increase the risk of recessively inherited
disorders in the offspring. It particularly favours the manifestation of rare recessive disorders,
because the chance that one carrier will many another is low unless they are related. When the
recessive disorder is common the carrier has a relatively high risk of marrying another however
they choose their partner, and the risk is approximately doubled in a first cousin marriage
(Modell and Kuliev 1992).
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Haemoglobin disorders in Pakistan:
3-tha1assaemia trait:
Stern et al, (1968) reported a 4% carrier rate for 3-thalassaemia amongst 129 Pathans. The
incidence of thalassaemia in Pakistan remained under reported due to very limited diagnostic
facilities (Saleem 1974). The studies on carrier rate of f3-thalassaemia in Pakistani population
have widely variable results (Table 2.2). Farzana et al, (1975) reported 2.6% incidence in 610
healthy blood donors and medical staff at a hospital in Karachi. In another study of 1224 adults
from Karachi, Hashmi and Farzana (1976) found 1.4% carrier rate for 13-thalassaemia. A study
on 67 Pakistanis in Paris reported an incidence of 3.0% (Coquelete et al, 1983). Latif (1983)
found 9.6% carrier rate for -thalassaemia in a selected sample of 437 individuals from Lahore
who had hypochromic and microcytic anaemia. In another study Hameed and Chaudhry
(1984) found a carrier rate of 1.6% in 300 healthy adults from Lahore. Ihsanullah et al, (1985)
found 6.3% 13-thalassaemia carriers amongst 256 individuals in a hospital based study at
Karachi. The carrier rate amongst the British Pakistanis is around 6% (Modell and Berdoukas
1984). Dash (1985) has found 3.6% carrier rate for [3-thalassaemia in 2000 healthy blood
donors from East Punjab in India. In a more recent population based study, conducted at the
Armed Forces Institute of Pathology Rawalpindi by Khattak and Saleem (1992a), 5.4% of the
500 individuals were found to be carriers of -thalassaemia. The later study also identified that
the carrier rate in Punjabis was 3.3% and amongst Pathans it was 8.0%. A recent survey of
1000 individuals from Rawalpindi showed 3.9% carrier rate for 13-thalassaemia (Hassan et al,
1997).
Variability in results of the studies on thalassaemia carrier rate is mostly due to lack of
adequate laboratory facilities, technical difficulties in carrier detection, and inappropriate
selection of the target population (Khattak 1987). WHO (1985) has estimated that the overall
carrier rate of 13-thalassaemia in Pakistan is 5%.
a-thalassaemia:
Little is known about the prevalence of a-thalassaemia in Pakistan. Modell and Berdoukas
(1984) have anticipated that the carrier rate for a-thalassaemia (-alaa) may be as high as
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50% and about 6% of the population may be homozygous for cC-genotype (-a/-a).
Population based data on a-thalassaemia in Pakistan are very scanty (Table: 2.2). Khan and
Hayee (1986) screened 320 cord blood samples for red cell indices and Hb-Barts at a hospital
in Lahore. They found low MCV and MCH with raised level of Hb-Barts, indicating a-
thalassaemia trait, in only 3 (1%) of the new born babies. In another study of Hb-Barts in the
cord blood of 500 new born babies in a hospital at Rawalpindi 2.4% had raised level indicating
a carrier status for a-thalassaemia (Zuhur-ur-Rehman 1991). Hb-H disease is an uncommon
disorder in Pakistan. At the Armed Forces Institute of Pathology, Rawalpindi, each year
approximately 150 new cases of 13-thalassaemia major are diagnosed and during the same
period approximately 3-4 cases of Hb-H disease are also seen (Saleem 1996).
Abnormal haemoglobins:
Lehman and Ager (1961, cited by Stern et a!, 1968), were the first to describe sickle
haemoglobin in a native of Pakistan. The study of 129 Pathans by Stern et a!, (1968) also
revealed an individual having Hb-D Punjab. Saleem (1974) reported compound heterozygotes
of Hb-S/t3-thalassaemia and Hb-E/[-thalassaemia in Punjabi subjects. Hashmi and Farzana
(1976) found that 0.9% of 1224 individual from Karachi were carriers for Hb-D (0.65%), Hb-
E (0.16%), and Hb-S (0.08%). The largest study of 5000 individuals from Pakistani Armed
Forces by Sharma Ct al, (1976) showed that 39 (0.78%) had an abnormal haemoglobin
including Hb-D (0.42%), Hb-E (0.18%), and Hb-S (0.18%). A recent study of 500 healthy
individuals from the northern parts of Pakistan showed that 1.2% carried Hb-D trait, and 0.2%
were carriers of Hb-E (Khattak and Saleem I 992b).
f.-thaIassaemia major:
Raheemtoola (1960) was the first to document a case of Cooley's anaemia in Pakistan. Since
then relatively few studies have described thalassaemia major (Saleem 1974, Raheemtoola
1981, PMIRC 1982, Sa!eem Ct a!, 1985).
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Estimated number of thalassaemia major cases in Pakistan:
The number of cases of a recessive disorder in a population can be calculated from its carrier
rate by Hardy Weinberg law which states that p2 + + 2pq = 1, where p and q are the
frequencies of the two alleles under question. Hardy Weinberg equation needs a correction for
consanguineous marriages. In a population where mating is not random, the proportion of
homozygotes is increased by Fpq. Where F is the inbreeding coefficient (Bodmer and
Cavalli-Sforza 1976).
Alwan and Model (1997) have estimated that in Pakistan with a population of 115 million and
3% annual birth rate, 5% carrier rate for -thalassaemia, and 50% consanguineous marriages,
a little over 3000 3-thalassaemia homozygotes will be born each year (Fig: 2.2).
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Fig: 2.2. Annual number of infants born with a haemoglobin disorder in the Eastern
Mediterranean region (Total 18,600) (Alwan and Modell 1997).
Treatment facilities for thalassaemia:
The Government has paid very little attention to thalassaemia (Saleem 1996). Consequently,
there is a lack of awareness amongst the general public and the health professionals. Fatimid
Foundation, a charity organization working since 1982, is providing blood transfusion services
to over 6000 of its registered patients. This organization runs its centres in Karachi, Lahore,
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Multan, and Peshawar. A few other charity organizations in different parts of the country look
after an additional 1500 registered cases. Fig: 2.3 summarizes the total number of registered
cases in various cities of the country. The registered cases are less than 25% of the estimated
30,000 total in the whole of the country.
Saleem (1996) has comprehensively reviewed thalassaemia at the National level. Retrospective
analysis of over 900 cases seen at the Armed Forces Institute of Pathology (AFIP) Rawalpindi
showed that the average number of new cases diagnosed per year has steadily increased from
58 in 1984 to 173 in 1995. This is primarily due to increasing awareness amongst the local
medical practitioners who refer the cases. The mean age at presentation was 32 months. Most
of the children were severely anaemic and had developed moderate to marked hepato-spleno-
megaly. Most patients come from the rural areas or smaller cities where specialist doctors and
adequate facilities for diagnosis are not available. Therefore, a substantial delay in reaching a
specialized medical centre for treatment is not unusual.
The quality of treatment that is provided to these patients is far from ideal or even optimum.
There is no audit on the treatment protocols being followed at the transfusion centres. Pre-
transfusion haemoglobin of patients receiving regular blood transfusions at one of the
treatment centres (Fig: 2.4) showed a mean level of 6.5 g/dI with values ranging between 3.0-
9.5 g/dl (Saleem 1996). A low pre-transftision haemoglobin is due to poorly developed
transfusion services, inadequate voluntary blood donations, and the lack of awareness amongst
the treating physicians and the affected parents about the benefits of hyper-transfusion
regimen.
A survey of thalassaemic children receiving treatment at a centre in Pakistan showed that 33%
had never received iron chelation, 42% were occasionally getting one injection of desferal at
the time of transfusion, 18% were getting desferal at irregular intervals and only 1.5% were on
regular desferal therapy (Saleem 1996). The importance of screening of blood for hepatitis B
and C has just started to be realized. In a recent study by Bhatti (1995) it was shown that 60%
of the multiply transfused thalassaemics are positive for Hepatitis-C. Transmission of HIV,
fortunately, is not a significant problem at least in the northern areas of Pakistan (Tariq and
Hussain 1995).
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Fig: 2.3. The number of registered cases of f3-thalassaemia major in various cities of Pakistan
(Saleem 1996).
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Fig: 2.4. Frequency distribution of pretransftision haemoglobin in 75 patients of 3-
thalassaemia major at one of the treatment centres in Pakistan (Saleem 1996).
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Poor management of thalassaemics is reflected by an average survival of 10.5 years (Fig 2.5) in
76 deceased children getting treatment at one of the centres in Pakistan (Saleem 1996). The
average survival of 10.5 years is for patients who receive treatment, whereas at least 2/3" of
thalassaemics in Pakistan do not have an access to a treatment centre and they probably die
during very early childhood. As a result of poor survival and poor quality of life the affected
families experience tremendous psycho-social burden.
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Fig: 2.5. Age distribution at the time of death in 76 patients with thalassaemia major who
received blood transtljsions at one centre in Pakistan (Saleem 1996).
Thalassaemia and consanguineous marriage:
When a recessive disorder is common, 5% 3-thalassaemia carriers in Pakistan for example, the
carriers have a relatively high risk of marrying another carrier however they choose their
partner, and the risk is approximately doubled in a first cousin marriage (Modell and Kuliev
1992). Saleem (1996) in a retrospective analysis of 602 patients of 13-thalassaemia major
observed that the parents of 357 (59%) patients were 1g cousins, 145 (24%) had more distant
related parents, and only 100 (17%) had completely unrelated parents.
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Prevention of thalassaemia in Pakistan:
There is very little awareness about the concept of prevention of thalassaemia amongst the
health professionals and the general public in Pakistan. Genetic counselling is available to only
a fraction of the couples attending various treatment centres. Carrier screening although
available at many private laboratories is not widely used. The main reason for the under
utilization of the screening facilities is the lack of awareness amongst the health professionals
dealing with thalassaemic families and the high cost. The quality of work at the private
laboratories is also dubious. There is a general lack of counselling of the carriers. Inadequate
counselling of the affected families is also due to the non-availability of prenatal diagnostic
facilities within the country.
Alwan and Modell (1997) have calculated (Fig: 2.6) that the number of pregnancies at risk of a
clinically significant haemoglobin disorder in Pakistan is in excess of 12000 every year. These
figures are the highest for f3-thalassaemia in the Eastern Mediterranean Region. Screening of
such large number of pregnancies would require tremendous financial and administrative
resources. The first step would be to identify a pregnancy at risk. In a Pakistani setting, where
the majority of the pregnancies escape medical attention, it will be a challenging task. The next
problem would be to establish centre(s) where facilities for prenatal diagnosis are available.
This would also involve in depth studies of 3-thalassaemia mutations in all ethnic groups of
Pakistan and a cost-effective strategy for carrying out prenatal diagnosis. Varawalla et al,
(1991a; 1991b), have studied the mutations causing 13-thalassaemia in 167 subjects from the
northern region of Pakistan. They have identified seven different mutations in the study
population (Fig: 2.7).
Another important issue that would determine the success of a thalassaemia prevention
programme in Pakistan would be the attitude of the affected couples towards prenatal
diagnosis and termination of pregnancy. In the Mediterranean, extensive data now exists about
the relative acceptability of the options open to the at risk couples. The absence of equivalent
objective information for the predominantly Muslim countries of the Eastern Mediterranean
Region, including Pakistan, introduces considerable uncertainty about the success of a
prevention programme (Alwan and Modell 1997). Some information about the attitude of the
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British Pakistanis towards prenatal diagnosis and termination of pregnancy is available. The
British Pakistanis have a greater difficulty requesting prenatal diagnosis than most other ethnic
groups in the UK. However, when couples are adequately counselled, they often make use of
prenatal diagnosis, although they have particular problems with late termination of pregnancy
(Petrou 1994).
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Fig: 2.6. Annual pregnancies at risk of a haemoglobin disorder in the Eastern Mediterranean
region (Total=74,250) (Aiwan and Modell 1997).
Fr 8-9(44%)
Fig: 2.7. 3-thalassaemia mutations in 167 individuals from the Northern region of Pakistan
(Varawalla et al, 1991a and b).
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3 Materials aild methods
Sequence and the time frame of the work:
The work in this study was done at the Department of Haematology, Armed Forces Institute
of Pathology (AFIP), Rawalpindi, Pakistan and the Perinatal Centre, Department of Obstetrics
and Gynaecology, University College Medical School, London. Table 3.1 gives a summary of
the events, in a chronological order.
Haematological Methods:
Red cell indices:
The basic haematological parameters evaluated include, Haemoglobin (Hb) estimation, Total
Red Blood Cell Count (TRBC), Mean Cell Volume (MCV), and Mean Cell Haemoglobin
(MCI-I). These parameters were measured on blood collected in EDTA. An automated cell
counter Sysmex K-bOO was used. However, Coulter S880 was also available as a backup
support. Both instruments work on the principle of the electronic resistance method (Dacie
and Lewis 1991). The instruments were calibrated according to the manufacturers instructions
using the high, low and normal whole blood controls. Once calibrated, the performance of the
instruments was regularly checked after every 20 samples by running a control.
Haemoglobin electrophoresis and Hb-A2
 estimation:
Blood collected in EDTA was thrice washed in normal saline (9.0 g/L NaC1). The washed red
cells were lysed by adding two volumes of water and one volume of carbon tetrachioride
(CCL). Clear haemolysate was separated after shaking and centrifügation at 1200 g for 10-20
minutes (Dacie and Lewis 1991). In a simple alternative method haemolysate was prepared by
adding an equal volume of 1% saponin to the washed red cells. The final concentration of the
haemolysate was adjusted to around 10 g/dl.
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Table: 3.1. A chronological summary of the work carried out in the study.
Sr. No:	 Event:	 Place:	 Period:
1. Collection /extraction of DNA samples from	 AFIP, Rawalpindi. June 1992 to
the northern areas of Pakistan.	 _______________ July 1993.
2. Gene analysis of the DNA samples by ARMS Perinatal Centre, 	 July 1993 to
method.	 UCL London.	 1994.
3. Establishment of facilities for gene analysis 	 AFIP, Rawalpindi.	 February 1994.
______ by PCR at AFIP Rawalpindi. 	 _____________ __________
4. Collection/extraction of DNA samples from	 AFIP, Rawalpindi. February 1994
southern areas of Pakistan and their mutation	 to May 1994.
________ analysis by ARMS.
5. Start of prenatal diagnostic service for 	 AFIP, Rawalpindi. 	 May 1994.
thaiassacmia in Pakistan.
6. Thalassaemia Carrier screening in Punjabis 	 AFIP, Rawalpindi. 	 May 1994 to
and Pathans. 	 August 1994.
7. Thalassacmia carrier screening m pregnant
	 AFIP, Rawalpindi. 	 August 1994 to
females.	 September
1994.
8. Thalassaemia carrier screening and collection AFIP, Rawalpindi.
	 October 1994 to
of DNA samples in two large thalassaemic
	 December 1994.
families.
9. Gene analysis by DGGE.
	 Perinatal Centre,
	 July 1995.
______	 UCL London.
10. Genomic sequencing of uncharactenzed
	 Perinatal Centre,	 August 1995 to
alleles.	 UCL London.	 September
_________	 1995.
11. Short Tandem Repeat (STR) analysis on
	 Perinatal Centre, 	 October 1995 to
DNA samples from the two families and
	 UCL London. 	 December 1995.
controls.
12. Thalassaemia carrier screening on the
	 AFIP, Rawalpindi. January 1995 to
extended families. 	 February 1995
13. Thalassacmia carrier screening in Baluchi,
	 AFIP, Rawalpindi. March 1995
Sindhi and Mohajirs.
	 ___________
14. Gene analysis for a-thalassaemia.	 AFIP, Rawalpindi. 	 April 1995
15. Assessment of the response of thalassaemic
	 Fatimid	 May 1995
families to the availability of prenatal
	 Thalassacmia
diagnosis.	 Centre, Lahore.
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Haemoglobin electrophoresis was carried out on cellulose acetate membranes at alkaline pH
(Dacie and Lewis 1991). At alkaline pH haemoglobin is a negatively charged protein and in an
electrical field moves towards the anode (+). Most structural forms of haemoglobin can be
separated due to a difference in the amount of charge on their surface.
The electrophoresis was carried out in a buffer containing Tris/EDTA!borate at pH 8.5. The
cellulose acetate strips (Shandon UK) were allowed to soak in the buffer for at least 10
minutes. The haemolysate was applied to the cathode end of the strip. Electrophoresis was
carried out at 200 V for 30 minutes or until adequate separation was achieved. The strips were
stained in Ponceau-S and were subsequently dried at 37°C for 30 minutes. With each batch of
samples haemolysates prepared from cord blood and known cases of -thalassaemia trait were
included as controls.
Hb-A2
 was separated electrophoretically on cellulose acetate at pH 8.9 after applying 5-1 0j.tl
of the haemolysate. The bands of Hb-A and Hb-A2
 were carefully cut and placed in 15 ml and
1.5 ml respectively of the buffer. Elution of the bands was allowed for 20-3 0 minutes.
Absorbance of each fraction was measured at 413 nm against the buffer as blank. Percentage
of Fib-A2 was calculated as follows:
A413 Fib-A2
%Hb-A2 =
	
	
X 100
(10 X A413 Hb-A) + A413 Hb-A2
Microcolunm chromatography kits (Bio-rad, USA) were used on some samples to crosscheck
the results of Fib-A2. Commercial controls of Fib-A2
 (Bio-rad, USA) were used to check the
quality control.
Strategy for carrier screening:
fi- thalassaemia:
Haematological parameters including Hb, TRBC, MCV and MCH were recorded. Fib-A2
estimation was done on all those who had MCV ^75 fi or MCH ^25pg (Modell and
Berdoukas 1984). I-lb-A2 ^3.5% confirmed the diagnosis of t3-thalassaemia trait
(Steinberg and Adams III 1991). In subjects who had Fib-A 2
 in the borderline range (3-
69
3.4%) or who had Hb <9gldl and Hb-A 2 in the normal range, multiplex ARMS PCR was
carried out to screen for the thalassaemia mutations (Cao et a!, 1994).
Abnormal haemoglobins:
Screening for abnormal haemoglobins by electrophoresis was possible only in cases that had
MCV ^75 fi or MCH ^25pg.
a-lhalassaemia:
ct-thalassaemia screening was done by the PCR based detection of -a 37 and -a42 deletions
(Baysal and Huisman 1994).
Gene analysis:
DNA extraction:
For gene analysis 5m1 of blood was collected in EDTA. The red cells were lysed by 1%
solution of triton X-100 and the white cells were lysed by 0.5 ml of 2% SDS solution
containing 50 mM Tris and 20 mM Na 2EDTA (pH 8.0). Protein digestion was done with 250
p.g Proteinase-K (Sigma, USA) at 37°C overnight or at 56°C for 2 hours. DNA extraction was
done by phenol chloroform method (Maniatis 1989). The extraction was done in 1.5 ml
Eppendorf tube by adding 250j.il each of buffered phenol containing 0.1% 8-hydroxyquinolone
(pH 8.0) and chloroform. Phenol chloroform extraction was done twice and was then followed
by one wash in chloroform. Final precipitation of DNA was carried out in 70% ethanol. The
extracted DNA was dried and re-dissolved in water to yield a final concentration of
approximately 500ngItl. The DNA samples were stored at -20°C until analysis.
Mutation analysis:
Strategy for mutation analysis:
The samples were first screened by the Amplification Refractory Mutation System
(ARMS) for 15 13-thalassaemia mutations previously reported in Pakistani and Indian
subjects (Varawalla et al, 1991a and 1991b). Those who were not positive for these
mutations were screened by Denaturing Gradient Gel Electrophoresis (DGGE) as this
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identifies the region of the gene where the mutation may be present (Cai and Kan 1990).
The region of 3-g1obin gene that was found by DGGE to have a mutation was sequenced
by the di-deoxy chain termination method (Sanger et al, 1977). In samples where a
mutation was not found by ARMS or an abnormal fragment by DGGE, had the entire -
globin gene sequenced with its immediate 5' and 3' flanking sequences.
Amphfication Refractory Mutation System (ARMS):
The 3-globin mutations screened for, and the sequence of the ARMS primers used is
presented in Table: 3.2. The primers were in use for prenatal diagnosis of 3-thalassaemia
at the Perinatal Centre, UCH, London. Most of the primers were used in combination
with an upstream (5') primer (No 3 in Table: 3.2). However, for Cd 15 (G-A) and Cap+1
(A-C) a downstream (3') primer (No 4 in Table: 3.2) was used. Another set of primers
(No 1 and 2 in Table: 3.2) was used to amplify an 861 bp fragment of the distal part of the
13-globin gene, to serve as an internal control for the PCR. The same set of primers was
also used to screen for the 619 bp deletion, which when present results in amplification of
a 242 bp fragment instead of the usual 861 bp fragment. Patients with homozygous 13-
thalassaemia who were positive for a mutation were then tested for the presence of the
normal allele to test if they were homozygous for the mutation or not. Primers for the
normal sequence (Table: 3.3) were used to identify the normal allele. Subjects with the
normal allele were then tested for the presence of other mutations.
PCR conditions for ARtt'IS:
The PCR for ARMS was carried out in a 25tI reaction mixture containing 5 pM of each
primer, 0.5 units of Taq polymerase (Advanced Biotechnologies, UK), 30 j.t M of each dNTP
(Advanced Biotechnologies, UK), 10 mM Tris HCI (pH 8.3), 50 mM KCL, 1.5 mM MgCl2,
100 mg/mI gelatin (Sigma, UK), and 0.3-0.5 ig of genomic DNA. Primers were synthesized
by Oswell UK, and Pharmacia Biotech, UK. Thermal cycling was carried out in an automated
DNA thermal cycler (TC-480) from Perkin Elmer, USA. The regimen consisted of 25 cycles
each consisting of denaturation at 94°C for 1 minute, primer annealing at 65°C for I minute,
and DNA extension at 72°C for 1 '/2 minutes. In the final cycle, the extension reaction was
prolonged for another 3 minutes.
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Table: 3.2. The mutations screened for and the sequence of the ARMS primers used.
Mutation
IVSI-5 (0-C)
Fr 8-9 (+G)
IVSI-1 (G-T)
Fr 41-42 (-UCT)
Del 619 bp
Cd 15(0-A)
Cd 5 (-CT)
Cd 30 (0-C)
Cd 30 (0-A)
Fr 16 (-C)
IVSII-1 (0-A)
Cd 26 (G-TXHb-E)
Cap +1 (A-C)
Fr 47-48 (+ATCT)
1VS1-25 (25b del)
Hb-S
1. CONTROL
2. CONTROL
3. COMMON
4. COMMON
Primer	 Used with
CTCCTTAAACCTGTC UG TAA CCT TOT TAG 3
CCI TOC CCC ACA 00(3 CAG TAA COG CAC ACC 3
UA AAC CTG TCT TOT AAC CiT OAT ACG AAA 3
GAG TOG ACA OAT CCC CAA AGO ACT CAA CCT 3
CAA TOT ATC ATG CCT CU TOC ACC 2
TGA OGA OAA GTC TGC COT TAC TOC CCA OTA 4
ACA 0(3(3 CAG TAA COG CAG ACT TCT CCG CGA 3
TAAACC TGTCUGTAACC UGATACCTACG 3
TAA ACC TGT CTT GTA ACC iTO ATA CCT ACT 3
TCA CCA CCA ACT TCA TCC ACG TTC ACG UC 3
AAG AAA ACA TCA AGO OTC CCA TAO ACT OAT 3
TAA CCT TGA TAC CAA CCT 0CC CAO OGC OU 3
ATA AOT CAO OGC AGA 0CC ATC TAT TOG UC 4
ATA ACA OCA TCA GGA OTO GAC AGA TAO ATC 3
CTC TOG OTC CAA GGG TAG ACC ACC AGC ATA 3
CCC ACA 0(3(3 CÁO TAA COG CÁO ACT TCT GCA 3
CAA TOT ATC ATO CCT CU TGC ACC
GAG TCA AGG CTO AOA OAT GCA OGA
ACC TCA CCC TOT GGA 0CC AC
CCC CU CCT ATO ACA TOA ACT TAA
Size
285
215
281
439
242
500
205
280
280
238
634
278
567
467
354
207
Table: 3.3. Primers used for identifying the normal alleles of the respective mutations.
Allele:	 Primer for the normal sequence:	 Used with:	 Frag Size:
IVSI-5	 CTC CiT AAA CCT GTC iTO TAA CCT TOT TAC
	 3	 285
Fr 8-9	 CCT TGC CCC ACA 00(3 CÁO TAA COG CAC ACT
	 3	 214
IVSI-1	 OAT GAA OU GOT OGT GAO 0CC CTG GGT AGO
	 4	 450
Fr41-42	 GAGTOGACAGATCCCCAAAGGACTCAAAOA
	 3	 443
Cd 15	 TGA GGA GAA GTC TOC COT TAC TGC CCA OTG
	 4	 500
Cd 5
	 ACA 06(3 CÁO TAA COG CÁO ACT TCT CCO CAG
	 3	 207
Cd 30	 TAA ACC TOT CU OTA ACC iTO ATA CCT ACC
	 3	 280
IVSII-1	 AAG AAA ACA TCA AGO GTC CCA TAG ACT GAC
	 3	 634
Fr 16	 TCA CCA CCA ACT TCA TCC ACO 1TC ACO iTO
	 3	 238
1. CONTROL CAA TOT ATC ATO CCT CU TGC ACC
2. CONTROL GAG TCA AGO CTG AGA GAT GCA GGA
3. COMMON ACC TCA CCC TOT OGA 0CC AC
4. COMMON CCC CU CCT ATG ACA TOA ACT TAA
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Electrophoresis ofARl'ISproducts.
At the end of PCR 20p.l of the amplified product was mixed with 5l of the loading dye
(0.25% bromophenol blue in 40% sucrose). Electrophoresis was carried out in 4% NuSieve
Agarose gel (FMC Corporation, USA) at 150 V for 1 hour. The gels were stained in ethidium
bromide (250p.gIlOOml) for 30 minutes and were visualized and photographed under 302 m
UV light.
Multiplex ARMS PCR:
A multiplex PCR for ARMS (Newton and Graham 1994) was carried out under the
standard PCR conditions but instead of using one ARMS primer specific for one
mutation, several primers were mixed. The combination of ARMS primers used for
screening in multiplex PCR is presented in Table: 3.4. The three multiplex primers, AD-i,
AD-2 and AD-3, were prepared as stock solutions containing 5pmollpi each of all the
primers for the mutant alleles. In addition, the two control primers and the respective
common primer were also added to the stock mixture. In each ARMS reaction 1 p.1 of the
stock primers was used.
The amplified products of all mutations were sufficiently different for resolution by
polyacrylamide gel electrophoresis. However, the size of the fragments generated by
IVSI-i and IVSI-5 differed by 5 bp and therefore was difficult to resolve. Similarly there
was no difference between the fragments of Cd30 G-C and G-A and IVSI-1. The problem
of differentiating IVSI- 1 and IVSI-5 was overcome by adding IVSI- i primer to AD-i and
AD-2 groups. IVSI-5 resulted in amplification with AD-i, but IVSI-1 caused
amplification with AD-i and AD-2. Amplification with AD-2 but not AD-i indicated
Cd30. The difference between the two mutations in Cd30 was only of academic interest
because the same normal primer was required to differentiate between the homozygotes
and heterozygotes. AD-3 primer combination included CdiS and Cap+1 as their common
primer was different from the one used with other mutations (Table 3.2).
An allelic ladder for the respective mutations was prepared by pooling together the PCR
products of separately amplified reactions for various mutations. Each fragment was
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amplified in 50tl reaction mixture under standard ARMS conditions. The individually
amplified products were pooled and were kept frozen in aliquots. 5p.l of the pooled
product was used in all polyacrylamide gel electrophoresis runs.
Table: 3.4. Combination of various mutations screened by multiplex ARMS PCR.
Primer ID:	 Mutations pooled:	 Amplified product size:
AD-i	 Fr 8-9 (+G)
	
215bp
IVSI-5 (G-C)
	
285 bp
Fr 4 1-42 (-TTCT)	 439 bp
IVSI-1 (G-T)	 280 bp
Del 619bp	 242bp
AD-2	 Cd 5 (-CT)	 205 bp
Fr 16 (-C)
	 238 bp
IVSI-i (G-T)	 280 bp
Cd 30 (G-C)	 280bp
Cd 30 (G-A)	 280bp
IVSII-1 (G-A)	 634 bp
AD-3	 Cd iS (G-A)	 500 bp
Cap+i (A-C)
	 567 bp
Electrophoresis of multiplex ARIvISproducts.
The multiplex ARMS amplified products were resolved by non-denaturing polyacrylamide
gel electrophoresis on Mini-Protean electrophoresis apparatus (Bio-rad, USA). 2 p1 of the
amplified product was loaded on 6% non-denaturing polyacrylamide gels measuring 1mm
X 10cm X 10cm. Electrophoresis was carried out at 150V for 40 minutes. The gels were
stained by silver nitrate. The details of gel preparation and silver staining are described in
the subsequent sections.
Denaturing Gradient Gel Electrophoresis (DGGE):
-globin gene was amplified in several overlapping fragments as shown in Fig: 3.1. Table:
3.5 shows the sequence of the primers used for amplification of various fragments of the
J3-gene. The primers were in use at the Perinatal Centre, UCH, London.
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I3(.),SIVS- I	 .,SIVS- II
_______	 /
DG7
Fragment-I	
DG6 
FragmentlVDG2
_______/ _____
DG3	 Fragment-Il	 DG4	 /0GB Fragment-V 0G9
/DG1 Fragment-Ill	 0G5
/
DG1O Fragment-VI DG11
Fig: 3.1. Fragments of 3-globin gene that were amplified for DGGE.
PCR conditions for DGGE:
PCR for DGGE was carried out in a 5Oj.tl reaction mixture containing 10 pM of each primer,
1.0 unit of Taq polymerase (Perkin Elmer, UK), 200 iM of each dNTP (Boehringer
Manheim), 10 mM Tris HC1 (pH 8.3), 50 mM KC1, 1.5 mM MgC1 2, 100 mg/mI gelatin and
0.3-0.5 j.tg of genomic DNA. Thermal cycling consisted of initial denaturation for 5 minutes at
95°C and then 40 cycles each of denaturation at 94°C for 30 seconds, primer annealing at 55°C
for 30 seconds, and DNA extension at 70°C for 1 minute. In the final cycle the extension was
prolonged to 3 minutes. lOp.l of the amplified product was run on 2% agarose gel to determine
the quality of amplification.
Preparation of denaturing gels.
The following stock solutions were prepared:
1
	
40% acrylamide (Molecular Biology grade. BDH, UK) and 1.07% bisacrylamide
(Sigma Chemicals, UK).
2
	
20 X gel running buffer (TAE pH 7.4) containing 800 mM Tris base, 400 mM
Sodium acetate, and 20 mM EDTA (BDH, UK).
3
	
80% denaturant stock solution containing 7% acrylamide, 32% formamide (BDH,
UK), 5.6 M Urea (BDF1, UK) and I X TAE buffer (pH 7.4).
4
	
0% denaturant stock solution containing 7% acrylamide, and 1 X TAE buffer (pH
7.4).
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Formamide was deionized before use by gently stirring with Dowex AG5OW (20-40) mesh
Mixed bed resin (Bio-rad, UK). The stock solutions of 0% and 80% denaturent were used to
prepare the gradients of varying strengths. Gels measuring 20 X 16 cm and 1.5 mm in
thickness were poured by using a gradient mixer (Hoefer Scientific, USA). Ammonium
persulphate (1 00tl of 10% stock solution) and I 0tl of TEMED (Sigma Chemical, UK) were
used as gel polymerization catalysts.
Formamide urea gradient varied for different fragments of the 3-globin gene. The optimal
gradient was determined by trial and error. The fragments-I, II and III were run on a
denaturant gradient of 42% and 72%. The fragment-IV and V were run on 50%-80%
gradient and the fragment-VI was run on 25%-50% gradient.
Table: 3.5. DGGE primers for amplification of various fragments of f3-globin gene.
Frag-	 ID	 Location:	 Sequence:	 Size:
ment:
I:
11°
rn
Iv
V:
DGI	 -123to-104
DG2	 Exon-I Cd 24-17
DG3	 -129to-104
DG4	 Exon-I Cd 24-17
DG1	 -123 to-104
DG5	 IVSI-ll9to 101
DG6	 IVSI-29 to 48
DG7	 IVSII-30 to 11
D08	 IVSI-101 to 120
DG9	 IVSII-30 to 11
5' 40[GC] CTG TCA TCA CU AGA CCT CA
5' CAA CU CAT CCA CGT TCA CC
5' GTA CGG CTG TCA TCA CU AGA CCT CA
5' 45[GC] CAA CU CAT CCA COT TCA CC
5' 40[GC] CTG TCA TCA CU AGA CCT CA
5' AAAATAGAC CAA TAG GCAG
5' AAG GAG ACC AAT AGA AAC TG
5' 45[GC] AGA AAA CAT CAA GQG TCC CA
5' 40[GC] CTG CCT AU GQT CTA UT TC
5' AGA AAA CAT CAA GGG TCC CA
286 bp
297bp
424 bp
409 bp
321 bp
VI:	 DG1O IVSII 588 to 607
	 5' ATG ATA CAA TGT ATC ATG CC
	 339 bp
DG1 I Exon-ifi Cd 132-125
	 5' 45[GC] TCT GAT AGO CAG CCT GCA CT
GC Clamp
45[GC] GCGGGCGGGGCGGGGGCACGG000GCGCGQCGGGCGGGGCGGQQG
40[GC] GCGGGCGGGGCGGOGGCACGGGGQGCGCGQCGGGCGGGGC
Running conditionr for DGGE:
Electrophoresis was carried out on SE600 vertical polyacrylamide gel running system (Hoefer
Scientific, USA). The original buffer bath was replaced by a specially designed acrylic
container designed to hold the gel assembly as well as the heating and the buffer circulation
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device. Once the gradient gel had polymerized, the comb was careflully removed and the wells
were washed with 1 X gel running buffer. Each well was loaded with 7p1 of amplified product
mixed with 6jtl of loading dye. The quantity of amplified product was increased to 8-1 Ojil
depending on the quality of amplification. Once loaded, the gel was removed from the casting
assembly and the upper buffer reservoir of the system was secured in place. The Hoefer SE600
accommodates two gels at a time. The whole assembly was placed in the main buffer
compartment and the heating and buffer circulating device was turned on.
Electrophoresis was carried out at 50V for 16 hours. Throughout the procedure buffer
temperature was maintained at 60°C. The gels were then removed and the glass plates
carefully separated. The gel was stained in ethidium bromide (250tg/1 00 ml) solution for 30
minutes. It was photographed at 302 nm UV light.
Genomic sequencing:
The primers used for amplifjing the J3-globin gene and the internal sequencing primers are
shown in Table: 3.6.
PCR amplification for seguencing.
The whole of -globin gene (-308 bp from the Cap site to +475 bp from the termination site)
was amplified by a set of primers in which the 5' primer was biotinylated (Table: 3.6). PCR
was carried out in 100 t1 reaction mixture containing 20 pM each of the two primers and 2
units of Taq polymerase (Perkin Elmer, UK). The thermal cycling consisted of 1St cycle of
denaturation at 94°C for 4 minutes, primer annealing at 56°C for 3 minutes and extension at
72°C for 2 minutes. In the subsequent 35 cycles the timing of denaturation and primer
annealing were reduced to 1 minute and 2 minutes respectively. In the last cycle the extension
reaction was prolonged to 8 minutes. The quality of amplification was checked by running
101tl of the product on 2% agarose gel.
Preperation of single stranded template DNA:
DNA amplified with biotinylated primer was used for preparation of single-stranded template.
Streptavidin coated Dynabeads (M-280, Dynal UK) and a magnetic particle concentrator
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(MPC-E, Dynal UK) was used to separate and concentrate the single stranded DNA (Huitman
et a!, 1989; Them and Hinton 1991). The dynabeads were washed in TES (10 mM Tris-HC1, 1
mM EDTA, and 100 mM NaCI at pH 8.0). Approximately 80il of the amplified product was
mixed (without vortexing) with 50.tl of dynabeads. It was left on the bench for 5 minutes
followed by denaturation with freshly prepared 0.15 M NaOH. The denatured single stranded
template was washed in TES and concentrated to yield a final volume of 2Opi.
Preparation of double stranded template DNA.•
For the majority of the sequencing reactions double stranded DNA template was used. The
amplified double stranded DNA contains excess of unused amplification primers, dNTPS and
some extraneous single stranded DNA produced by PCR. Two hydrolytic enzymes i.e. Shrimp
alkaline phosphatase, and Exonuclease-I can remove the unwanted accompaniments. The two
enzymes are available in a kit (United States Biochemical, USA). In the protocol, 5p.1 of the
amplified product was treated with 2 units of Shrimp alkaline phosphatase and 10 units of
Exonuclease-I. The reaction mixture was incubated at 37°C for 15 minutes in a thermal cycler
followed by an additional 15 minutes at 80°C to inactivate of the two enzymes.
Labelling reaction.
The labelling reaction was done by the Sequenase version 2.0 sequencing kit (United States
Biochemical, USA). The method described by Tabor and Richardson (1990), based on di-
deoxy chain termination method was used. The enzyme treated PCR product was mixed with
5 pM of internal sequencing primer (Table: 3.6) and water to yield a final volume of I Opi. It
was denatured at 100°C in a thermal cycler for 2-3 minutes. It was then cooled as quickly as
possible by directly submerging the reaction vial in crushed ice for 5 minutes.
The following were added to the ice cold denatured DNA: 1 p1 of 0.1 M dithiothreitol (DTT),
2p1 of 1:5 diluted labelling mix, 0. 5pi of 355 dATP (5 mCi) (Arnersham UK), 2pi reaction
buffer, and 2pi of diluted Sequenase DNA polymerase. The reaction mixture was incubated at
room temperature for 5 minutes. In the mean while four tubes containing 2.5 p1 termination
analogues (G, A, T and C) were warmed at 37°C for 1 minute. 3.5pi of the labelling reaction
was added to the side of each of the four termination analogue tubes avoiding direct contact
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between the two. The reaction tubes were quickly centrifuged for a few seconds to allow
mixing of the labelling reaction and the termination analogues. The tubes were incubated for 5-
10 minutes at 37°C. The reaction was stopped by adding 4tl of stop solution (95%
formamide, 0.05% Xylene Cyanol and 0.05% Bromophenol blue). The reaction tubes were
frozen until electrophoresis.
Table: 3.6. The primers and their sequence used in sequencing the J3-globin gene.
Primers used for amplification of j3-globin gene:
5'(Biotinylated) -307 from Cap site: 5' CGA TCT TCA ATA TGC TFA CCA AG
3' +475 from termination site: 	 5' GAG TCA AGG CTG AGA GAT GCA GGA
Internal sequencing primers:
ID:	 Location:
SE 1
	
Cd 16
SE2
	
Cd 33
SE3
	
IVSII-24
SE4
	
IVSII-142
SE5
	
IVSII-332
SE6
	
IVSII-742
5E7
	
Cd 142
5E8	 +196 from term site
Sequence:
5' CCC ACA GGG CAG TAA CGG CAG ACT TCT CCT
5' ACC AGC AGC CTA AGG GTG GGA AAA TAG ACC
5' ACA TCA AGG GTC CCA TAG AC
5' GAT CCT GAG ACT TCC ACA CT
5' ATG TAC TAG GCA GAC TGT GT
5' GGA TG TAG CTG CTA TrA GC
5' CCAGGGCATTAGCCACACCA
5' AAT GCA CTG ACC TCC CAC AU CC
Preparation of sequencing gels.
The sequencing gels were prepared at 6% polyacrylamide concentration (Acrylamide and Bis-
acrylamide ratio 19:1). Both the reagents used were of molecular biology grade (BDH and
Sigma Chemicals, UK). Molecular biology grade urea (BDH, UK) at 7M concentration was
used as a denaturant. The glass plates were thoroughly washed with light detergent and de-
ionized water. The plates were dried and cleaned with ethanol. One of the plates, usually the
same plate for all gels, was siliconized with Sigmacoat (Sigma Chemicals, UK). The gel
thickness was kept at 0.4 mm. All sequencing gels were run on an apparatus from Bio-rad,
USA. This can accommodate gels measuring 20cm X 50cm. Ammonium persuiphate (400pi)
and TEMED (40il) were used as polymerization catalysts. The gels were poured using a 50m1
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syringe and keeping the plates inclined at an angle of about 45°. Any bubbles were removed by
gently tapping the plates. Shark-tooth combs were used for creating the sample wells.
Running the sequencing gels.
The gels were run in TBE buffer (Tris 10.8g, Borate 5.5g and Na 2EDTA 0.93g at pH 8.3).
The sample wells were thoroughly washed with gel running buffer to remove any urea that
constantly flows out of the gel. The labelled samples were denatured at 95°C for 2-3 minutes
and kept on ice until loading. Each well was loaded with 2.5-3.OpJ of reaction mixture from
each tube and electrophoresis was carried out at a constant power of 50W for 2-3 hours.
During the run the gel temperature remained at 5 0°C. At the end of the run the plates were
carefully separated and the gel was fixed for 20 minutes with freshly prepared fixative
containing 10% methanol and 10% acetic acid. The fixed gel was transferred to a piece of
Whatman filter paper cut to a size slightly larger than the glass plates. The gel was covered
with cling film and placed on a gel dryer at 80°C for 1 hour. The gel was then exposed to X-
ray film (Kodak, USA) for 2-3 days.
Restriction Fragment Length Polynwrphism (RFLP) analysis:
The polymorphic sites linked to the 13-globin gene were analysed by first amplifijing the
fragment of DNA containing the site, followed by its digestion with a restriction enzyme.
Table: 3.7 gives details of the polymorphic sites, the primer used for amplification and the
restriction enzyme used. All of the primers were in use at the Perinatal centre, UCL, London.
The general conditions for PCR were the same as ARMS except that the annealing
temperatures of the primers for Ay, 5".j'13 , 3'j43, Rsa-I 13 and Hinf-I 13 was 56°C and 60°C for
Gy. The number of cycles was also increased to 30. Cleavage was carried out by overnight
incubation of 201.11 of the amplified product at 37°C with 10 units of the restriction enzyme
(Gibco BRL, UK). The digested fragments were separated on 4% NuSieve Agarose gel.
Xmn-I Polymorphism:
Xmn-I can recognize the C-T polymorphism at position -158 from the cap site of the Gy-
globin gene (Them et al, 1988). In order to demonstrate this polymorphism, a 641bp fragment
of DNA flanking the polymorphism was amplified using the following primers:
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5'-GAA CTT AAG AGA TAA TGG CCT AA
5'-ATG ACC CAT G€C GTC TGG ACT AG
PCR conditions were the same as for the RFLP protocol except that the annealing temperature
was increased to 60°C. The amplified fragment was digested with 10 units of Xmn-I
(B oehringer, Mannheim) and the results were read after electrophoresis on 4% Nusieve
Agarose gel.
Table: 3.7. Polymorphic sites linked to the -globin gene, the restriction enzymes used for
their recognition and the sequence of the primers used for amplification of the respective
fragments.
Site:	 Enzyme used:	 Primer sequence:
Gy-gene	 Hind-ill	 5'-AGT GCT GCA AGA ACA ACT ACC
____________ _____________ 
5'-CTC TGC ATC ATG GGC AGT GAG CTC
Ay-gene	 Hind-ill	 5'-GAC TAG TGC UG AAG GGG AAC AAC
____________ _____________ 
5'-CCT CTG CTG AU CAT UC UA CAC
5'4-gene	 Hind-il	 5'-TCC TAT CCA UA CTG UC CU GAA
___________ _____________ 5'-ATF GTC UA TFC TAG AGA CGA 1TF
3'.43-gene	 Hind-Il	 5'-GTA CTC ATA CTFTAA GTC CTA ACT
____________ _____________ 5'-TAA GCA AGA TFA 1TI' CTG GTC TCT
p-gene	 Hinf-I	 5'-TGG AU CTG CCT AAT AAA A
____________ _____________ 5'-GGG CCT ATG ATA GGG TAA T
3-gene	 Rsa-I	 5'-AGA CAT AAT UA UA GCA TGC ATG
____________ ______________ 5'-ACA TCA AGG GTC CCA TAG AC
Gene analysis for a-thalassaemia:
Most cx-thalassaemias are caused by large gene deletions. In the past these deletions were
detected by laborious and expensive restriction enzyme mapping of the gene. However, the
introduction of PCR has simplified the detection of gene defects in ct-thalassaemia. The
common a-thalassaemia-1 and 2 determinants can now be detected by PCR (Bowden et al,
1992; Dode et al, 1992; Baysal and Huisman 1994). The PCR primers are used to amplify
appropriate segments of the chromosome with the deletion and the normal chromosome under
identical experimental conditions. On a normal chromosome the PCR primers are far apart and
therefore are unable to amplify whereas the presence of an ct-thalassaemia deletion brings the
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two primers sufficiently close for the amplification to take place. The amplified products can be
separated by agarose gel electrophoresis.
PCR conditions for -a37 and-a42 detection:
The PCR buffer contained 67 mM Tris-HC1, pFI 8.8; 16.6 mM ammonium sulphate, 0.10
mg/ml Bovine Serum Albumin, 10 mM J3-Mercaptoethanol, 4.0 mM MgCl 2, 10% DMSO, 200
mM dNTPs, and 2.0 units of Taq polymerase (Perkin Elmer, UK). The primers and their
sequences are presented in Table: 3.8. The strategy for detection is described in Fig: 3.2
(Baysal and Huisman 1994). Normally the primers A+B are far apart and can not amplify.
Whereas the presence of -a37 deletion brings the two primers sufficiently close for
amplification to take place. In the absence of the -a 37 deletion primers A+C amplify the normal
sequence. A similar approach was used for -a42, where primers D+E amplify the abnormal
fragment if present, and D+F amplify the normal sequence.
A
	
	
B
C
F
D	 E
Fig: 3.2. Strategy for the amplification of segments of DNA from chromosomes with the two
types of a-thalassaemia-2 deletions. The functional a2 and al and 41a1 genes are shown as
open boxes. The solid boxes indicate the extent of the deletions. Primers A and C amplified a
control fragment whereas primers A and B amplified only when 3.7kb deletion was present.
Similarly, primers D and F amplified a control fragment while primers D and E amplified a
fragment only when 4.2kb deletion was present (Baysal and Huisman 1994).
The PCR for detection of normal and mutant allele for -a37 was carried out in two different
tubes because the amplified product under both conditions is of the same size, and therefore,
cannot be separated on agarose gel electrophoresis. For the 
-a42 both the reactions were done
in the same tube, as the amplified products considerably differ in size. The PCR was carried
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out with the "Hot start" method where Taq polymerase was added when reaction mixture was
above 80°C. The thermal cycling consisted of 25 cycles each of denaturation at 94°C for 1
minute, primer annealing at 60°C for 1 minute and extension reaction at 72°C for 3 minutes.
The extension in the last cycle was prolonged to 8 minutes. At the end of the PCR the
amplified products were separated on 2% agarose gel.
Table: 3.8. Primers used for detection of a thaiassaemia deletions (Baysal and Huisman
1994).
Primer ID:	 Sequence:	 Concentration:
CYITTCCCTACCCAGAGCCAGGTF	 25 pmollreaction
CCC ATG CTG GCA CGT TFC TGA GG
	
25 pmollreaction
CCA TFG TFG GCA CAT TCC GGG ACA
	
25 pmollreaction
CCT TCC TCT CAC TFG GCC CTG AG
	
20 pmollreaction
CCC TGG GTG TCC AGG AGC AAG CC
	
15 pmol/reaction
CGC CTC CCT GGA CAA G1T 	 15 pmollreaction
Analysis of Short Tandem Repeats (STR):
A bulk of intergenic DNA in the human genome consists of tandemly repeating sequences
whose length varies between individuals in the same population. The polymorphisms
created by such elements are termed variable number of tandem repeats (VNTR) for the
larger repeats and short tandem repeats (STR) for 1-6 base pair repeats (Krawczak and
Schmidtke 1994). VNTRs and STRs can be analyzed by PCR (Horn et al, 1989; Urquhart
et al, 1994).
STR alleles at D2 1 SI I locus were amplified by the following pair of flanking primers (Sharma
and Lit 1992):
D2IS1 1-F
	
5'-GTG AGT CAA TTC CCC AAG-3'
D2 1S11 -R 5'-GTT GTA TTA GTC AAT GTT CTC C-3'
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The PCR was carried out in a 25pJ reaction mixture under the same conditions as for the
ARMS except that a hot start strategy was used. The thermal cycling comprised of 30 cycles
each of denaturation at 93°C for 48 seconds, primer annealing at 60°C for 48 seconds and
extension reaction at 72°C for 1 minute.
Allele szing of D2JSIJ.
In order to carry out precise allele sizing for the D2 iS 11 locus 30 samples were run on an
automated gene scanning system called ALF (Pharmacia Biotech, USA). The DNA amplified
with a fluorescent labelled primer is electrophoresed on a denaturing sequencing gel. An
internal lane standard is also loaded along with the test sample. The internal lane standard as
well as the amplified DNA is read by the flourescent detection system comprising of a laser
source. It generates a signal that is recorded as a peak and is stored in a computer.
The samples analyzed on ALF were amplified with primers in which the forward primer was
labelled with flourescene. The samples were loaded on a 6% polyacrylamide gel containing 8M
urea. Two internal lane standards of 100 and 300 bp (Pharmacia Biotech, UK) were also
loaded with each sample. The gel was run at 1900 Volts at 42°C until the equipment had
recorded the samples and the lane standards.
Once the allele sizes of several samples had been accurately determined on the ALF, suitable
samples that represented most of the common alleles were chosen as controls for manual allele
sizing. Each amplified sample was run on two different types of polyacrylamide gels. The
samples were first run on 6% denaturing polyacrylamide gels measuring 16 X 20 cm X 1.0
mm on a Protean-Il apparatus (Biorad, UK). 7pJ of the amplified product and 5j.tl of loading
dye was loaded and overnight electrophoresis was carried out at 100 volts. The gels were
stained in ethidium bromide for 30 minutes and were photographed under 302 nm UV light.
The samples were also run on 6% denaturing polyacrylamide sequencing gels. The protocol
for preparing the gels was the same as for sequencing, except that larger sample wells were
created by using widely spaced combs. This was essential to accommodate 5tl of the sample
and the loading dye. The gels were run at 500 Volts overnight.
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Silver staining ofpolvacrvlamide gels:
The glass plates were carefully separated, and the gel that usually sticks to one of the plates
was fixed in 30-50 ml of freshly prepared fixing solution, containing 10% ethanol and 5%
glacial acetic acid. Wrinides in the gel, if any, were removed by gently blowing the fixative on
the wrinides with the help of a pasture pipette. The gel was then evenly covered with 0.1%
silver nitrate for 20 minutes. The stain was poured off and the reaction developed by adding
freshly prepared solution of 1.5% NaOH and 0.15% formaldehyde. Within 10-15 minutes the
bands of DNA could be seen clearly. The gel was then washed with tap water and transferred
to a clean sheet of filter paper. It was covered by cling film and left between layers of filter
paper to dry.
Variable Number of Tandem Repeat (VNTR) analysis:
The VNTR sequences in the Apolipoprotein-B gene were amplified by PCR (Deka et a!,
1992). The general conditions of PCR were the same as for ARMS PCR except that the
annealing temperature was reduced to 55°C and the number of cycles was increased to 30. The
following primers were used to amplify the VNTR sequences (Deka et al, 1992):
ApoB-F:	 5'-ATG GAA ACG GAG AAA TTA TG
ApoB-R:	 5'-CCT TCT CAC TTG GCA AAT AC
Electrophoresis of the amplified fragments was carried out on 2% agarose gels at 40V
overnight. The gels were stained in ethidium bromide and were photographed at 302nm.
Statistical analysis:
Means, ranges, and standard deviations were calculated for the continuous variables that
had normal distribution. Confidence intervals and hypothesis testing for the data that were
normally distributed and for the data that were not normally distributed were calculated
by parametric and non-parametric tests respectively (Altman 1991). A computer package
"SPSS version 6.1.3" was used for most of the statistical analysis.
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4 Epidemiology of haemoglobin disorders
Introduction:
Haemoglobin disorders are the commonest inherited disorders in Pakistan. Analysis of the
situation is essential before a large scale community based prevention programme for these
disorders can be initiated (Alwan and Model! 1997). The results of several studies on
haemoglobin disorders in Pakistan are available (Stern et a!, 1968; Hashmi and Farzana 1976;
Sharma et a!, 1976; Latif 1983; Saleem Ct a!, 1985). But many of these surveys have
limitations regarding the methods used, and the selection of the subjects (Khattak 1987). This
chapter aims at studying the epidemiology of haemoglobin disorders in the major ethnic groups
of Pakistan. The information is used to provide a basis for calculating the number of affected
children born each year.
Subjects:
In this study 1345 adult males from the five major ethnic groups of Pakistan were
screened for 3-thalassaemia. Due to resource constraints haemoglobin electrophoresis
was done only in those cases where Hb-A 2
 estimation was required i.e. the cases that had
MCV ^75 fi or MCH ^ 25pg. The subjects included, 290 (2 1.6%) Punjabi, 307 (22.8%)
Pathan, 223 (16.6%) Sindhi, 300 (22.3%) Baluchi, and 225 (16.7%) Mohajirs. The
subjects were sampled at several different places and the staff was provided by the local
military hospitals. The samples from Punjabis were collected from an infantry battalion
stationed at Rawalpindi. The samples from Sindhis and Baluchis were collected at the
regimental centres in Hyderabad and Quetta respectively. The samples from Pathans were
collected from the students of Khyber Medical College, Peshawar by a team of two
volunteer doctors. The samples from Mohajirs were collected at Karachi by a mobile team
of two volunteers who went from door to door for collection of samples. These samples
were transported to AFIP, Rawalpindi within 12 hours of collection.
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a-thalassaemia screening was carried out in one hundred randomly selected patients with
3-thalassaemia major. These included 67 Punjabis and 43 Pathans. In addition, red cell
indices from 264 cases of heterozygous 3-thalassaemia, diagnosed by PCR, were
investigated for any co-incidental a-thalassaemia. The later group of subjects comprised
of the couples who requested prenatal diagnosis for thalassaemia and they all had at least
one affected thalassaemic child.
Results:
13-thalassaemia:
The haematological values of 1345 adult males from the five ethnic groups are presented
in Table: 4.1. The mean Hb for each ethnic group varied from 13.7 to 15.0 gldl. Baluchis
had the highest mean Hb (15.0 SD ±1.5). The number of individuals who had Hb <13.5
g/dl, varied from, 94/290 (32.4%) in Punjabis, 102/307 (33.2%) in Pathans, 98/223
(43.9%) in Sindhis, 41/300 (13.7%) in Baluchis, to 77/225 (34.2%) in Mohajirs. There
were 164/1345 (12.2%) subjects who had MCV ^75 fi or MCH ^25 pg and required Mb-
A2
 estimation (Table 4.2). Raised Hb-A2 was found in 71/164 (43.3%) cases selected by
low red cell indices. Molecular genetic analysis by multiplex PCR was done in 15 out of
the remaining 96 cases because these subjects in addition to low red cell indices (MCH
25 pg or MCV < 75 fi) also had I-lb <9.0 g/dl. This analysis did not find any carriers.
The results of carrier screening in the ethnic groups are summarized in table 4.2. There
were 71/1345 (5.3%) carriers of 13-thalassaemia in all ethnic groups (95% confidence limit
4.1-6.5%). The proportion of 13-thalassaemia carriers out of the individuals who had
hypochromic microcytic red cell indices ranged from 39% in Punjabis, 53% in Pathans,
14% in Sindhis, 42% in Baluchis, and 52% in Mohajirs. The carrier rate in the ethnic
groups was as follows: Punjabis 4.5%, Pathans, 5.2%, Sindhis 1.3%, Baluchis 9%, and
Mohajirs 5.2%.
Abnormal haemoglobins:
Since haemoglobin electrophoresis was done only in cases that had MCV ^75 fl or MCH
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^25 pg, many cases of abnormal haemoglobins could not be identified. Out of the 57
Baluchi subjects, in whom electrophoresis was done, 5 (8.7%) were found to have
heterozygous Hb-S. Similarly, 2/30 (6.6%) Pathans, in whom electrophoresis was done,
had heterozygous Hb-S. No other abnormal haemoglobin was detected in any of the
ethnic groups.
a-thalassaemia:
Heterozygous -a37 (-a/aa) deletion was found in 5/100 (5%) cases. One case with
homozygous -a? 7 (-cd-a) deletion was also seen. No case of-a 42 deletion was observed.
The red cell indices of 264 J3-thalassaemia carriers confirmed by ARMS PCR showed that
259/264 (98%) had MCH ^ 25 pg while 256/264 (97%) had MCV ^ 75 fi (Fig: 4.1). In
the cases with MCV >75 fi or MCH> 25 pg, 5/264 (1.9%) had Cap+1 (A-C) mutation
and 4/264 (1.5%) had a severe 13-thalassaemia mutation. The subjects with the Cap+1
mutation had normal Hb-A2
 whereas the level in the other 4 subjects was ?3.5%. The
later four cases were suspected to have coincidental a-thalassaemia trait.
M CH
M CV
ig: 4.1 Histogram of MCV and MCH in 264 cases of j3-thalassaemia trait proven by PCR.
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Discussion:
This study is a population based survey of thalassaemia in the ethnic groups in Pakistan. Its
main strengths are appropriate sample selection, representation by the major ethnic groups,
and reliable methodology. However, its limitations include a relatively small sample size and
the inability to screen for the abnormal haemoglobins.
Screening for thalassaemia:
-thalassaemia trait can be suspected when MCV and/or MCH are low. Its main differential
diagnosis includes iron deficiency and a-thalassaemia trait. There is a considerable overlap in
the haematological picture of the three conditions. 13-thalassaemia trait in most situations can
be confirmed by raised Hb-A2 and iron deficiency can be confirmed by serum femtin
(Steinberg and Adams III 1991). Identification of a-thalassaemia trait, however, requires
either globin chain synthesis ratios or DNA analysis (Higgs et al, 1989). The distinction
between the three conditions is important not only for treatment but also for identification and
subsequent counselling of carriers. Iron deficiency is by far the commonest cause of low MCV
and MCH in Pakistanis. This impression, unfortunately, has cast a shadow on the importance
of low MCV and MCH caused by thalassaemia.
In this study 12% of the individuals were found to have MCV <75 fi and/or MCH 25 pg and
43% of the later population had 3-thalassaemia trait. It shows that -thalassaemia, at least in
the adult healthy males, is a significant cause for low MCV and MCH. The frequency of low
MCV and MCI-I was similar amongst all ethnic groups except in Sindhis where although 9%
had this abnormality only 1.3% had 13-thalassaemia trait. This may be due to concomitant a-
thalassaemia in Sindhis that can mask the red cell indices in 3-thalassaemia carriers (Kanavakis
et al, 1982). Study of red cell indices in the British Pakistanis shows that about 11% of the
adult males have MCH <23 pg, of whom about half have J3-thalassaemia trait (Modell and
Berdoukas 1984). MCH data from the adult male population of this study also confirm this
observation (Fig: 4.2). Modell and Berdoukas (1984) have suspected that most Pakistanis who
have low MCH but do not have 13-thalassaemia trait may have a-thalassaemia trait. The results
of low red cell indices in this study are in agreement with those of Modell and Berdoukas
(1984). However, it is questionable whether all individuals with low MCV or MCH who are
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not 13-thalassaemia carriers have a-thalassaemia because many of them might also be iron
deficient. Screening for the common a-thalassaemia determinants in 100 individuals
investigated in this study showed that 6% carried -a37 deletion (-czlaa:5 and -al-a: 1). The
study of a-thalassaemia although very small indicates that the majority of the individuals who
have low MCV or MCH and are not 13-thalassaemia carriers may have iron deficiency.
Population-based data on a-thalassaemia in Pakistan are very scanty. The only two studies by
Khan and Hayee (1986) and Zahur-ur-Rehman et al, (1991) show carrier rates of 0.94% and
2.4% respectively. These studies also support that cx-thalassaemia is not a significant factor in
causing low MCV or MCH in the Pakistanis.
The carrier rate for deletional a-thalassaemia-2 was found to be 6%. At this rate one would
expect 0.4% of the population to be homozygous for a-thalassaemia-2. However, red cell
indices in 264 13-thalassaemia carriers (confirmed by PCR) showed that 97% had MCV75fi
and 98% had MCH 25pg. In the 3% with red cell indices in the normal range half had Cap+1
mutation. This suggests that interference due to co-inheritance of a-thalassaemia (-al-a) may
be present in only 1.5% of the cases. If the deletional forms of a-thalassaemia is seen in 0.4%
then the remaining 1% must be non-deletional in type. The combined incidence of deletional as
well as non-deletional forms of a-thalassaemia in Pakistan may be around 12%, a rate at which
about 1.5% of the population may be homozygous for ct-thalassaemia trait (deletional or non-
deletional).
In populations where a-thalassaemia is common it can cause significant problems in
identification of [3-thalassaemia carriers (Kanavakis et al, 1982). Another diagnostic problem
may be caused by silent mutations (Cao et al, 1994). The results of this study indicate that both
a-thalassaemia and silent mutations may not be very significant problem in Pakistani
population. However, in working out a strategy for detection of at risk couples it may be
useflul to investigate by DNA methods all those individuals whose partners are known carriers
of f3-thalassaemia.
Modell and Berdoukas (1984) suggested that for all practical purposes the finding of MCH
?25 pg should exclude 13-thalassaemia trait in Pakistanis. The same cut off limit for MCH was
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used in this study for identifying individuals requiring Hb-A2 estimation. This approach,
although cost effective, might have missed about 3% of 13-thalassaemia carriers who either had
concomitant a-thalassaemia or silent mutations. However, in an epidemiological survey this
would not make a significant difference.
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Fig: 4.2. A comparison of MCH values from the normal adult male Pakistanis (this study)
and a similar English population (Modell and berdoukas 1984). The Pakistanis have a
long tail in the low MCH region. The solid area in the histogram represents the proportion
of 3-thalassaemia carriers.
13-thalassaemia carrier rates in the ethnic groups:
The study by Khattak and Saleem (1 992a) gave an indication that the 3-thalassaemia carrier
rate is different in Punjabis (3.3%) and Pathans (8.0%) (Table: 4.1). Apart from the later study
no information is available on the carrier rate in any of the ethnic groups in Pakistan. It is
important to investigate the carrier rate in each group because f3-thalassaemia genes may be
unevenly distributed amongst the ethnic groups. Moreover, the frequency of consanguineous
marriage is also different between the ethnic groups (Bittles 1994; Wahab and Ahmad 1996).
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This could affect the calculation of annual birth rate of thalassaemia major in each group. The
overall 3-thalassaemia carrier rate of 5.3% (95% confidence limits: 4.1-6.5%) found in this
study is in agreement with the generally accepted figures (WHO 1985). The carrier rate in the
ethnic groups varied considerably. The rate was lowest in Sindhis (1.3%) and highest in
Baluchis (9%). The carrier rate in Sindhis may be spuriously low due to coincident a-
thalassaemia. This issue, however, remains open for flirther investigations. Baluchis are a well-
defined group who are mostly descendants of a few tribes that originally migrated from Iran to
their present location in 700 B.C. (Bokhari 1975). It is likely that the high gene frequency for
thalassaemia in Baluchis is due to a founder effect (Bodmer and Cavalli-Sforza 1976).
Abnormal haemoglobins:
A major limitation of this study is the inability to screen for abnormal haemoglobins. However,
other published reports indicate that abnormal haemoglobins are not a significant problem as
compared to J3-thalassaemia. Hashmi and Farzana (1976) found the following carrier rates in
1224 individuals from Karachi: Hb-D 0.65%, Hb-E 0.16%, and Hb-S 0.08%. The largest
study of 5000 Pakistani Armed Forces personnel by Sharma et al, (1976) showed that 39
(0.7 8%) had an abnormal haemoglobin including Hb-D (0.42%), Hb-E (0.18%), and Hb-S
(0.18%). A study of 500 individuals from the northern parts of Pakistan showed that 1.2%
carry heterozygous Hb-D, and 0.2% were carriers of Hb-E (Khattak and Saleem 1992b).
Calculation of the number of annual births of thalassaemia major:
Carrier frequency of thalassaemia can be used to calculate the annual number of births of
affected children. This information is essential prerequisite in planning a national programme
for control and prevention of the disorder (Alwan and Modell 1997).
Theoretical considerations:
The annual birth rate for thalassaemia major can be calculated by the Hardy Weinberg analysis
of the carrier rate (Bodmer and Cavalli-Sforza 1976). According to the Hardy Weinberg law,
the number of heterozygotes and the homozygotes for a trait in a randomly mating population
is: p2 + + 2pq = 1. Where p and q are the frequencies of the two alleles under study. Ifp and
q are the frequencies for the normal and f3-thalassaemia genes in a population then p2. q2 and
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2pq will represent the proportion of normals, homozygotes and heterozygotes respectively. In
a population where mating is not random, the proportion of heterozygotes is reduced in
comparison to Hardy-Weinberg proportions by an amount 2Fpq, while that of
homozygotes is increased by Fpq where F is the inbreeding coefficient. The actual number
of homozygotes will be equal to q 2 + Fpq (Bodmer and Cavalli-Sforza 1976).
Taking the carrier rate for 3-thalassaemia as 5% (0.05) its gene frequency (p) will be
0.025 (1/2 of the carrier rate because each carrier has one normal and one f3-thalassaemia
gene) and the frequency of normal gene (q) will be I-p (0.975). The number of 13
-thalassaemia homozygotes (p2) per thousand will be 0.625. This figure would require a
correction for the frequency of consanguineous marriages. The average inbreeding
coefficient (F) of the Pakistani population is 0.028 (Bittles 1994). The actual number of
J3-thalassaemia homozygotes will be equal top2 + Fpq i.e. 0.625 + 0.683 = 1.308 per
thousand.
Calculations based on the aiready published work:
Several studies have focused attention on carrier rate of 13-thalassaemia in Pakistan. Table 2.2
gives a summary of the studies so far carried out on Pakistanis. Stern et al, (1968) were the
first to report a 4% carrier rate for J3-thalassaemia amongst 129 Pathans. The studies
conducted thereafter have reported carrier rates ranging from 1.4-9.6%. Variability in the
results is mostly due to lack of adequate laboratory facilities, technical difficulties in carrier
detection, and inappropriate selection of the target population (Khattak 1987). WHO (1985)
have reported an overall 13-thalassaemia carrier rate of 5%.
The estimated number of annual thalassaemia major births in Pakistan, based on 5% carrier
rate in 137 million population with annual birth rate of 2.8% (Economic survey 1995-1996)
and a coefficient of inbreeding of 0.028 (Bittles 1994) will be 5014. This estimate is based on
the assumption that the carrier rate and the frequency of consanguineous marriage in all ethnic
groups is similar.
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Revised calculations based on the results of this study:
This study shows that the carrier rates amongst the ethnic groups are different. The
coefficient of inbreeding also varies considerably between the groups (Table: 2.1). It is
therefore expected that estimates of the annual birth rate for thalassaemia major would
also be different in each ethnic group. Table: 4.3 gives a detailed picture of the calculation
of number of annual births of thalassaemia major in each ethnic group. The population of
Pakistan is estimated at 137 million and the annual birth rate is 2.8% (Economic Survey
1995-1996). The last census was carried out in 1981. The latest information on the
population of ethnic groups is not available. For the purpose of calculation the population
of each group has been taken in the same proportion as these were found in the 1981
census.
The revised calculations show 4550 annual new births of thalassaemia major (1.2/1000) in
Pakistan (Table 4.3). The maximum number of births is expected in Punjabis (1.124/1000)
which also is the largest ethnic group (80 million). The highest birth rate is expected in
Baluchis (4.3/1000) due to a high carrier rate and high frequency of consanguineous
marriages. The birth rate amongst Sindhis (0.324/1000) is low because of a very low
carrier frequency (1.3%) found in this group. As discussed earlier the carrier rate in
Sindhis might be spuriously low because of possible coincidental ct-thalassaemia.
Unpublished data from the Fatimid thalassaemia centre in Karachi, that looks after the
majority of Sindhi patients, suggests that the number of Sindhi patients with thalassaemia
are not less than the patients from other ethnic groups.
Consanguineous marriage and thalassaemia:
Consanguineous marriage increase the frequency of recessive disorders. The increase,
however, is most marked in disorders that are rare (Model and Kulievl992). Table: 4.3 gives
an estimate of the number of thalassaemia births with and without correction for the
consanguineous marriage. It is clear that the number of births in the absence of
consanguineous marriage is lower (2442) than in their presence (4550). It is apparent that even
in the complete absence of consanguineous marriage there would still be approximately 2500
annual births of thalassaemia major.
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Calculation of the number of patients with abnormal haemoglobins:
Since abnormal haemoglobins were not studied, their calculations are based on the already
published data. The largest study of abnormal haemoglobins in Pakistanis is that of Sharma et
al, (1976) which reported an incidence of 0.18% each for Hb-S and Hb-E. According to these
figures it is estimated that only three new homozygotes each of Hb-S and Hb-E will be born
every year if there was no consanguineous marriage. However, the expected number of
homozygotes in the presence of consanguineous marriage is estimated at 99 each for Hb-S and
Hb-E. The number of new births of compound heterozygotes of abnormal haemoglobins
and/or thalassaemia per year is estimated at 368 (Hb-S/J3-thaiassaemia: 181, Hb-E/3-
thalassaemia: 181, and Hb-E/Hb-S: 6). The correction for consanguineous marriages on the
birth rate of compound heterozygotes is more difficult to apply. In fact, it is expected that
consanguineous marriage would reduce their incidence. The total number of new cases of a
clinically significant abnormal haemoglobins, including compound heterozygotes with
thalassaemia, is expected to be 560.
The effect of consanguineous marriage on the birth rate of Hb-S and Hb-E is marked because
both are rare in Pakistan. Only three homozygous SS or EE births per year are expected
without any correction for consanguineous marriage as compared to 99 per year when the
correction is applied. This highlights the importance of consanguineous marriages in affecting
the birth rate of rare recessive disorders.
Estimated total number of patients and pregnancies at risk:
The number of births of a clinically significant haemoglobin disorder per year in Pakistan
is estimated at 5110 (thalassaemia: 4550 and abnormal haemoglobins 560). This
corresponds to an annual birth rate of 1.3 5/1000 new births. Thalassaemia major
represents the bulk of the problem (Fig: 4.3). The estimated number of pregnancies at risk
would be around 20440.
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HbS/Tha1 (3.5%)
Hb-S/S (2%)
1'. Major (89°7o)	 / Hb4/Tha1 (3.5%)
FIb-E'E (2%)
Hb-SIE 0.1%
Fig: 4.3 The estimated annual births of a clinically significant haemoglobin disorder in
Pakistan.
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5 Screening for haemoglobin disorders
Introduction:
Initiating a community based carrier screening programme for f3-thalassaemia in Pakistan
is handicapped by resource constraints, low rate of literacy and lack of organization of the
health care system. In order to evaluate the feasibility of a carrier screening strategy, a
pilot study of two approaches was carried out i.e. screening in pregnancy and testing of
extended family members when a patient with thalassaemia major was identified. This
chapter describes the results, advantages and disadvantages of the two approaches.
Subjects:
Screening in pregnancy:
A total of 350 pregnant women, who reported at the antenatal clinic of Holy Family
Hospital, Rawalpindi, were included in the study. The husbands of the women found to be
carriers of f3-thalassaemia were also screened at a subsequent stage.
Targeted screening:
A total of 16 families with a haemoglobin disorder were offered carrier screening. The
screening service was offered at the homes of family members. The selection criteria,
other than voluntary participation, were the ease of availability of the maximum number of
family members.
Eight families without an apparent history of a haemoglobin disorder were also offered
screening for inclusion as controls. The only selection criterion was the ease of availability
of the maximum number of family members. The control families belonged to the
members of the laboratory staff working at A.FIP who were aware of the implications of
screening for haemoglobin disorders.
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Methods:
Sampling procedures:
Antenatal screening:
A volunteer lady doctor did the screening in the antenatal clinic at Holy Family Hospital,
Rawalpindi. At the time of screening a note was made about the ethnic group,
consanguinity (husband and wife) and the number of weeks of gestation.
Screening in the families:
The samples for screening in the families were collected by a team comprising of two
other assistants and myself The two assistants were male laboratory technicians whose
basic education was FA (equivalent to A levels). They were briefed about drawing
pedigrees. They also agreed to collect samples from their own families as controls.
A box containing about 100 disposable plastic syringes (5 ml), approximately 100 blood
collection tubes, spirit swabs, tourniquet, sample racks for holding about 100 tubes, a
sketch book and pencil for drawing the pedigree were always kept ready for a field trip.
At each visit the presence of at least two members of the team was considered essential.
After selecting a family for sampling a meeting with one of the family member was
arranged. In the subject families the key person was either the father, mother or a
grandparent of the affected child. In the control families the person who was first offered
screening acted as the resource person. The importance of carrier screening was frilly
explained to the key person(s) and a sketch of the pedigree was drawn. Later the sketch
was transferred to a computer with the help of a pedigree drawing software "Cyrillic
Version 2.0". A suitable time and date for sampling was arranged by mutual agreement
with the family members.
Genetic counselling:
Genetic counselling was carried out according to the internationally accepted guidelines
(Harper 1993). It was non-directive, and was aimed at providing information to the
individual or the couple so that they could make an informed choice. Particular care was
taken to maintain confidentiality.
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The results of antenatal screening were communicated to the women and the importance
of screening their husbands was explained. The results of screening in the families were
given either to the carriers themselves or to the parents of very young subjects.
Counselling of the very young individuals was done through the parents. The significance
of being a carrier and the possibility of planning marriages in the future were verbally
explained. An easy to understand booklet in Urdu was provided to those who could read.
Results:
Screening in pregnancy:
A total of 350 pregnant women were screened. This included 284 (81%) Punjabi, 40
(11.5%) Mohajir and 26 (7.5%) Pathan women. Fig: 5.1 shows the number of weeks of
gestation of the women at the time of screening. Only 18% of the women were in the l
trimester.
A summary of the haematological parameters of the women screened is presented in
Table: 5.1. The frequency distribution of MCV and MCH shown in Figs: 5.2 and 5.3.
There were 66/3 50 (19%) women who had MCV ^75 fi or MCH ^25 pg and required
Hb-A2 estimation. I-lb-A2
 above normal (>3.5%) was found in 15 women. In 12 out of the
remaining 51 women who either had Hb-A2 in the borderline rage (3.0-3.4%) or their Hb
was <9.0 g!dl DNA analysis by multiplex ARMS was carried out to establish the
diagnosis. As a result of DNA analysis two more women were diagnosed as 13 -
thalassaemia trait. One had Hb 9.9 g/dl, MCV 63.5 fi and MCH 21.7 pg and the other had
Hb 9.7 g/dl, MCV 58.1 fi MCH 19 pg. There were 17/350 (4.9%) 13-thalassaemia carriers
and only 2/17 carriers were in the first trimester of pregnancy. The remaining 49 women
were not investigated further. It is expected that 12% of them would have cx-thalassaemia
and the remaining would have iron deficiency.
Both carrier or non-carrier women with low MCV and/or MCH had no difference in the
level of Hb (Table: 5.1). However, microcytosis (low MCV) and hypochromia (low
MCH) was more marked in the carrier women than in the non-carriers. Similarly, TRBC
values were also higher in the carrier women than the non-carriers.
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Fig: 5.1. Number of weeks of gestation at the time of screening in 350 women.
Fig: 5.2. Frequency distribution of MCV in 350 pregnant women screened for
thalassaemia in an antenatal clinic.
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Fig: 5.3. Frequency distribution of MCH in 350 pregnant women screened for
thalassaemia in an antenatal clinic.
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The husbands of 17 3-thalassaemia carrier women were also screened and none was
found to be a carrier. The husbands of 5/17 (29%) were first cousins, 5/17 (29%) were
more distantly related while 7/17 (42%) were unrelated.
Targeted carrier screening:
Families with a known history of haemoglobin disorder (subjects):
Six out of the 16 selected families with a history of a haemoglobin disorder refused testing
for the following reasons:
1. It will be very difficult to get every one together.
2. Other people say that we are all right why should we get tested?.
3. I will decide after consulting the elder brother.
4. Other relatives do not understand this and it will be difficult to get them together.
5. We will not allow you to come to our village.
6. It is very difficult to ask every one to give blood for testing.
7. We may have problems in arranging marriages of our children especially daughters.
8. We would like to be tested but some of our relatives think that it is not good
because other people might think this family has some problem for which a "team
of doctors" is coming from Rawalpindi to test them.
Families without history of haemoglobin disorder (controls):
Out of the eight individuals who were offered screening of their families, five agreed. The
remaining three found it difficult to collect samples from the other family members. All
three felt it was difficult to ask every one else in the family to give blood for no obvious
reason.
Description of the families:
Subj ect families:
Table 5.2 summarizes the family condition, location, ethnic group, Biradri/Tribe, number
of family members, and the number of individuals tested in the 10 subject families. Seven
105
families were targeted because at least one child with thalassaemia major was present, one
family was targeted because of thalassaemia trait in a family member, and two families had
children with sickle cell disease. Eight subject families were Punjabis and two were
Pathans. Three families were from urban localities while seven were from rural areas.
There were 846 alive members in the 10 families. On an average there were 85 living
members per family. Out of 846 members 591 (70%) were tested.
Control families:
The five control families had no previous history of a haemoglobin disorder in the family
(Table: 5.3). These included two Punjabi and three Pathan families. All five were from the
rural areas. In the five control families there were 609 living individuals and the average
number of individuals per family was 122. In the five families 3 97/609 (65%) individuals
were screened. On an average there were 97 individuals per family in the 10 subject and 5
control families.
Pedigrees:
Pedigrees of the subject and the control families are shown in Fig: 9.4 to 9.17 (Chapter 9).
Time taken in sampling:
The sampling time of a complete family varied from one day to one month depending on
the size and location of the family, distance from AFIP (place where testing was done),
and the distribution of the family members. The two families (No: 1 and 2), resident in the
urban areas, were particularly difficult to sample. It took 4-5 visits each to collect their
samples. The main cause of delay was the adult males and school going children who
were often busy in their daily routine. The best time to sample such families was late
evening hours when most members were available. The sampling was easiest in the rural
areas where it usually took a few hours to sample the whole family. The people in small
villages were more co-operative and welcoming than in the urban areas.
In all families the role of one key member, usually a parent or a grandparent of the
affected child, was found to be very important. The sampling was greatly facilitated when
an assertive or influential person was available. In fact, some of the families who refused
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screening, did so due to the lack of a key member who could convince his relatives to
have screening.
Haematological parameters:
Haematological parameters were evaluated in 480 individuals from the eight subject
families and 397 individuals from the five control families. The samples from 111
individuals of the two subject families with sickle cell disorders (No: 9 & 10) haemolysed
due to extreme hot weather and lack of refrigeration facilities in the area of collection.
These samples therefore could not have red cell indices done. However, it was possible to
prepare haemolysates for electrophoresis on their samples.
Table: 5.4 presents a comparison of the haematological parameters (Hb, TRBC, MCV,
and MCH) between the individuals of the subject and the control families. The Hb level of
adults as well as children from the subject and the control families were not different.
TRBC of adult males and children from the subject families was significantly higher than
the controls (no overlap in 95% CI). The difference for the adult females was not
significant. Similarly, MCV and MCH in the adults as well as the children from the subject
families were significantly lower than the controls. Fig: 5.4 & 5.5 show a comparison
between the frequency distribution of MCH in adult males, adult females and children 15
years from the subject and the control families.
Table: 5.5 presents a summary of the haematological parameters in the individuals from
the subjects and the control families grouped according to age, sex and 13-thalassaemia
carrier status. Hb levels in all groups were lower in f3-thalassaemia carriers than the non-
carriers. Similarly, TRBC was higher and MCV and MCH were lower in 13-thalassaemia
carriers than the non-carriers. Amongst the 3-thalassaemia carriers the adult females as
well as the children had significantly lower Hb as compared to the adult males. The
children with 3-thalassaemia trait had lower MCV and MCH than the adult carriers.
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Fig: 5.4. Comparison between the MCH of adult males and females from the subject and
the control families. A large number of individuals from the subject families have low
MCH. However, many adult females from the control group also have low MCH.
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Fig: 5.5. Comparison between the MCH of children 1 5 years from the subject and the
control families. A large number of children from the subject families have low MCH.
However, many children in the control group also have low MCH.
Confirmation of f-thaIassaemia trait:
Hb-A2
 estimation was required in 245/480 (51%) individuals in the subject families and in
24/245 (9.8%) individuals Hb-A2
 was either in the borderline range (3.0-3.4%) or their
Hb-A2
 was normal but Hb was < 9 gIdl (Table: 5.6). In these individuals multiplex ARMS
PCR was done to check for 3-thalassaemia trait. PCR found seven new carriers (all
severe mutations) that included four children less than 3 years of age and 3 adult females
(Table: 5.7). They all had MCV and MCH below normal.
Number of carriers and affected children for a haemoglobin disorder:
There were 183/59 1 (31%) carriers for 13-thalassaemia or Hb-S in the 10 subject families.
The proportion of carriers in each family ranged from 20-70% (Table 5.8. and Fig: 5.6).
There were 97 (29%) carriers out of 339 unmarried individuals tested in the 10 subject
families (Table: 5.8). On an average there were 18 carriers per family and out of this 10
were unmarried. In addition to the carriers, there were 28 dead or alive affected children
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in these families. Average number of affected children per family was 2.8 (Table 5.8). In
the control families 144/3 97 (3 6%) required Hb-A 2 estimation but no carrier of 13 -
thalassaemia or other abnormal haemoglobin was identified (Table: 5.9).
Couples at risk of a haemoglobin disorder:
Table 5.10 shows the total number of couples, their consanguinity and the number of at
risk couples in the ten subject and five control families. On an average there were 22.5
couples per family. The ratio of consanguineous to non-consanguineous couples in the
subjects (93/121) and the controls (56/68) did not differ significantly (pO.O9). In the ten
subject families 17 couples were at risk of a haemoglobin disorder. No at risk couple was
seen in the family where the index person was a thalassaemia carrier. On an average there
were 1.7 at risk couples per family.
Prospective detection of at risk couples:
In the ten subject families eight at risk couples were found prospectively (Table: 5.10). In
Family No: 1 three couples, in addition to the index couple, had thalassaemic children.
However, only one was consanguineous (Pt cousins). As a result of screening in this
family some distant family members became interested and asked for testing. One such
couple was found to be at risk. The couple had two children who were found to be
carriers. The couple was interested in using prenatal diagnosis in future pregnancies. In
Family No: 2 one couple, in addition to the index couple, was found to be at risk. This
couple had one apparently normal child and the mother was six months pregnant. The
father was educated and listened to the advice about the risk for his children. However,
the couple declined the offer of prenatal diagnosis as the pregnancy was at an advanced
stage. The child when tested after birth was found to be a carrier. The couple would be
requesting prenatal diagnosis in future pregnancies. In addition to the index couples, one
additional couple in Family No:5 and two additional couples in Family No: 7 had
thalassaemic children. Similarly, in Family No: 10 one elderly couple, in addition to the
index couple, who had grand children was found to be at risk, although they did not have
an affected child. The couple was not available for detailed discussion on the deaths of
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any children during early childhood. In the remaining families no other at risk couple was
found.
Table: 5.6. The number of individuals who had MCV ^75 fi or MCH ^25 pg and
required Hb-A2 estimation or PCR for establishing the diagnosis of J3-thalassaemia in the
eight subject families.
Family ID:
	 MCV ^75 fi or	 -thalassaemia trait diagnosis by:
MCH ^25 pg	 _____________ ____________ ______________
_________ ______________ Hb-A2 :	 PCR:	 Total:
No: 1
	 55/138 (39.9%)	 36/55 (65.5%)	 0/3	 36/138 (26.1%)
No: 2
	 46/85 (54.1%)	 23/46 (50.0%)	 3/6	 26/85 (30.6%)
No: 3
	 27/51 (52.9%)	 12/27(44.4%)	 2/5	 14/51 (27.6%)
No: 4
	 21/41 (51.2%)	 16/21 (76.2%)	 1/3	 17/41 (41.5%)
No: 5	 27/45 (60.0%)	 17/27 (63.0%)	 0/3	 17/45 (37.8%)
No: 6
	 25/42 (59.5%)	 18/25 (72.0%)	 1/2	 19/42 (45.2%)
No: 7
	 17/20 (85.0%)	 14/17 (82.4%)	 0/0	 14/20 (70.0%)
No: 8
	 27/58 (46.6%)	 12/27 (44.4%)	 0/2	 12/58 (20.7%)
Total:	 245/480 (5 1.0%)	 148/245 (60.4%) 7/24 (29.2%)
	 155/480(32.3%)
Table: 5.7. Haematological features of seven cases of t3-thalassaemia that required DNA
analysis for confirmation of diagnosis.
Case: Age: Sex: Hb:
	 TRBC:	 MCV: MCH: Hb-A2 : Mutation:
_______ (yrs) ______ (g/dl) (X10 9/L)	 (fi)	 (pg)	 (%)	 _______________
1. 3	 F	 3.5	 3.23	 50.8	 10.8	 2.0	 IVSI-5 (G-C)
2. 21	 F	 8.2	 5.99	 48.6	 13.7	 2.4	 Fr 8-9 (+G)
3. 2	 M	 8.5	 4.81	 64.2	 17.7	 2.1	 Fr8-9(+G)
4. 20	 F	 8.4	 4.61	 58.6	 18.2	 3.0	 IVSI-5 (G-C)
5. 16	 F	 9.3	 3.80	 73.7	 24.5	 3.1	 IVSI-5 (G-C)
6. 2	 M	 8.5	 5.29	 49.5	 16.1	 3.2	 IVSI-5 (G-C)
7. 1	 M	 9.2	 5.30	 58.1	 17.4	 3.0	 IVSI-5 (G-C)
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Table: 5.9. The number of individuals who had MCV ^75 fi or MCH ^25 pg and
required Hb-A2 estimation in the five control families.
Family ID: MCV ^75 fi or	 -thalassaemia	 f3-thalassaemia
MCH ^25 pg
	
trait by Hb-A2 :	 trait by PCR:
No: 11	 8/48 (16.7%)	 None	 Not done
No: 12	 17/57 (29.8%)	 None	 Not done
No: 13	 18/111 (16.2%)	 None	 Not done
No: 14	 73/13 1 (55.7%)	 None	 Not done
No: 15	 28/50 (56.0%)	 None	 Not done
Total:	 144/397 (36.2%)	 None	 Not done
1OY/o
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5cp/o
3cy%
C.) LUYO
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1oJ/o
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Fig: 5.6. Carrier rate for -thalassaemia and Hb-S disorder in the 10 subject families.
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Genefic counselling:
The families were approached approximately one year from the time of screening to
assess their response to counselling. No contact could be established with Families No: 9
and 10 as they were residing in a very remote area. In Family No: 1 three marriages took
place since the completion of screening. All three were planned in the light of the results
of screening. The first was between a carrier female and her normal l' cousin. The second
was between a normal male and his first cousin who was not tested and the third marriage
was between a carrier female and her normal 1 1/2 cousin. The members of the family had
become very conscious about thalassaemia. In family No: 2, one marriage took place
which was arranged between a male carrier and his 2"' cousin who was not tested. The
reason given by the elder sister of the gentleman, who had an affected child, was that the
engagement of her brother had broken three times in the past and it was with a great
difficulty that they had arranged this marriage. Therefore it was not possible for them to
disclose this problem. In Family No: 4 one engagement took place between two Pt
cousins and it was planned in accordance with the results of screening. The boy was
normal and the girl was a carrier. In Family No: 7 premarital screening was requested by
two individuals who had not been screened earlier. The feedback from Family No: 3, 4, 5,
and 6 was encouraging and they appeared to have become conscious of the importance of
thalassaemia screening.
Discussion:
Carrier detection methods:
Screening parameters:
The results of this study suggest that screening for 13-thalassaemia in most cases is
straightforward. It is important to define the baseline haematological values at which
thalassaemia should be suspected. The threshold values should also not miss any cases.
Setting a high threshold for suspicion to include all cases, however, can be cost
ineffective. The level of Hb can not be used for suspecting thalassaemia because a large
proportion of women and children have low Hb due to nutritional causes. Red cell
indices, on the other hand, can be extremely useful as a first line screening procedure. The
cut off limit for MCV ^75 fi and MCH ^25 pg (Modell and Berdoukas 1984) were found
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useful. Analysis of MCV and MCH in 264 13-thalassaemia carriers diagnosed by PCR
(Chapter: 4) showed that only 9/264 (3.4%) cases did not fall within the defined limits.
Five out of the nine such cases had Cap+1 that is a silent 13-thalassaemia mutation (Cao et
al, 1994). All of the Cap+l individuals had completely normal haematology. In the
remaining 4/264 (1.5%) a co-incident a-thalassaemia was suspected. Raising the
threshold for MCV and MCH to any level will not identify Cap+1 carriers. It is expected
that 3.4% of the carriers might be missed with the proposed cut off limit. Lowering the
cut off limits for red cell indices will increase the number of Hb-A2
 estimations and the
benefit gained would be only an inclusion of a small number of carriers.
Another pitfall in the proposed cut-off limit is the possibility of missing abnormal
haemoglobins especially Hb-S that has normal red cell indices. The carrier rate of Hb-S in
Pakistanis is 0.18% (Sharma et al, 1976). Its frequency may be higher in Pathans (Khattak
and Saleem 1992b) and Baluchis (this study, chapter: 4). It may be useful to include the
sickling test as a screening procedure in the high-risk ethnic groups. Hb-E is usually
associated with low or borderline red cell indices (Yeo et al, 1994). Therefore it should
not be missed by the proposed policy.
One tube osmotic fragility can be a simple and cost effective alternative for red cell indices
as a screening method (Kattamis et al, 1981; Silvestroni and Bianco 1983). The efficacy
of this procedure could not be evaluated in this study. However, a pilot study on the
correlation between microcytosis and osmotic lysis of red cells in 0.36% saline in 100
unselected samples including some with low MCV showed there were 12 false positives
and 4 false negatives. The false negatives were encountered in individuals who had MCV
between 70-75 fi. However, the results in 50 cases of 13-thalassaemia trait showed no false
negative (unpublished observations).
Confirmatory tests:
Raised Hb-A2
 provides a confirmatory test for J3-thalassaemia trait (Steinberg and Adams
III 1991). Hb-A2
 estimation by column chromatography is technically superior than the
cellulose acetate elution method (International Committee for Standardization in
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Haematology 1978). In this study Hb-A2 was measured by elution of the fraction
separated by cellulose acetate electrophoresis. The method is technically easy. A study
from AFIP on a comparison between indigenously prepared DEAE cellulose
chromatography columns and cellulose acetate elution for Hb-A 2
 estimation showed close
correlation of the results (Anwar et a!, 1995). The cellulose acetate method is more
suitable for a Pakistani setting because it is easy to carry out and is more cost effective.
Most of the 3-thalassaemia carriers in this study had clearly raised level of Hb-A2.
However, out of 172 carriers (155 in the families and 17 in pregnant women) only 9
(5.2%) had Hb-A2
 in the normal or borderline range. This included 4 children less than 3
years of age and 5 adult females (Table: 5.7). Their DNA analysis showed severe 1 3
-thalassaemia mutations. Co-incident c-thalassaemia is unlikely in these cases because such
individuals commonly have normalized red cell indices and their Hb-A2
 remains in a higher
range (Kanavakis et a!, 1982; Rosatelli et al, 1984). In very small children Hb-A 2
 level
may not reach the heights seen in an adult (Steinberg and Adams III 1991). Whether such
an effect can persist for three years of age is questionable. Most if not all of the nine cases
may be due to concomitant iron deficiency therefore lowering the Hb-A 2 levels. Iron
deficiency in a normal individual can result in a reduction of Hb-A2
 (Steinberg and Adams
III 1991) and it may coexist with 13-thalassaemia (Earley et al, 1990; Hinchliffe and
Lilleyman 1995), a situation that is not uncommon in Pakistani women and children
(Qureshi et a!, 1995). Modell and Berdoukas (1984) doubt whether iron deficiency can
reduce the level of Hb-A2
 to the normal range in 13-thalassaemia trait.
A practical difficulty in the diagnosis of 13-thalassaemia trait is caused by coincidental a-
tha!assaemia. This can cause considerable diagnostic difficulties in populations where the
a-thalassaemia gene frequency is high (Cao et al, 1994). However, masking of 13-
thalassaemia trait by a-thalassaemia is not a significant problem in Pakistan (Chapter: 4).
Another diagnostic difficulty may be caused by "silent" or "mild" 13-thalassaemia alleles.
In this study three such alleles were identified (Table: 6.3). These include Cap+1, -88, and
Hb-E. Of the three, Cap+1 is the most difficult to detect as it is associated with normal
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red cell indices and I-lb-A2 level (Cao et al, 1994). Hb-E is usually associated with
borderline red cell indices (Yeo Ct al, 1994) but can be identified by its electrophoretic
mobility (Dacie and Lewis 1991). In this study only one case with -88 was encountered
which had borderline red cell indices. Identification of mild thalassaemia alleles is
important because when co-inherited with a severe allele can cause a syndrome of
thalassaemia intermedia of variable severity (Meloni et al, 1992). A useful strategy to
avoid missing "silent" or "mild" f3-thalassaemia alleles in the Pakistanis would be to carry
out molecular genetic analysis on those who have borderline red cell indices, particularly
if their spouses are known carriers of 3-thalassaemia.
A protocol for carrier detection:
Fig: 5.7 shows a suggested flow diagram for identifying J3-thalassaemia carriers in
Pakistanis. This is likely to identify most carriers except those with mild mutations. Stress
is laid on complete analysis of individuals whose spouses are known carriers. Some
unmarried or married carriers whose spouse is not available for testing might be
mislabelled as normal when they may in fact be carrying a thalassaemia mutation.
The first line screening procedure may be the single tube osmotic fragility test or red cell
indices. If the osmotic fragility or the red cell indices are in the normal range the
individual may not require further investigations. If however, the spouse of a
haematologically normal person is a carrier then the "normal" individuals would be
investigated further. If the osmotic fragility test is positive or MCV ^75 fi or MCH ^25
pg, Hb-A2 would be estimated. Hb-A2 levels >3.5% would confirm the diagnosis of -
thalassaemia trait and the individual would be counselled. If Hb-A 2 is in the borderline
range (3.0-3.5%) or is <3.0% and Hb is <9 gIdl multiplex ARMS PCR for the known 13
-thalassaemia mutations would be done.
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This protocol is likely to miss abnormal haemoglobins as electrophoresis would be done
only in selected cases. Since clinically significant abnormal haemoglobins are rare in
Pakistan (Sharma et a!, 1976), omission of electrophoresis is unlikely to have significant
effects. It may be advisable to do a sickling test or electrophoresis, in the high-risk
groups. In a family screening it may be advantageous to first identify the family condition
by electrophoresis or DNA analysis and then screen the members accordingly.
Identification of at risk couples:
Antenatal screening:
Surprisingly, screening in 350 pregnant women in this study did not identify any at risk
couple. This is probably due to a relatively small number of individuals investigated.
Theoretically it is expected that at a 5% carrier rate, 1 in 400 couples would be at risk and
the risk may be doubled if the spouse is a first cousin (Chapter: 9).
There are also technical difficulties in screening during pregnancy e.g. a large number of
women with low MCV or MCH due to iron deficiency would require I-lb-A2
 measurement
in a comparatively large number of cases. Screening difficulties may also be due to an
increase in MCV in pregnant 3-thalassaemia carrier women by about 2% (Lewis et a!,
1982; Yeo et a!, 1994). Therefore the cut off limit for doing Hb-A2
 estimation will have to
be increased which could increase the number of Hb-A2
 measurements required in
pregnant women.
A major limitation of antenatal screening in Pakistan is that the vast majority of the
pregnancies, especially in the rural areas, can not be screened as the women do not report
to an antenatal clinic. Trained personnel attend only 26% of pregnant women in Pakistan
(Burney 1993). Therefore it is unlikely for antenatal screening to be practically feasible.
Also the late discovery of risk in pregnancy is unlikely to lead to the abortion even if the
fetus is affected. In this study only 18% of the women were seen in the first trimester, the
remaining were in an advanced stage of pregnancy for prenatal diagnosis to be accepted.
Another important factor that could not be assessed in this study, is the response of at risk
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couples identified through antenatal screening. It is also expected that counselling would
be difficult because couples who do not have an affected child may find it difficult to
accept prenatal diagnosis.
Screening in the index families:
The results of screening in the index families suggest that nearly 2I3 of the families may be
willing to undergo screening. The response may be improved by more intensive efforts to
pursue families. A major advantage of screening in the index families, apart from prospective
detection of at risk couples, is the identification of the carriers early enough for marriage
choices to be affected. The results of follow-up for one year after screening in the study
families showed that there was some effect on the marriage choices. Long-term follow-up of
these families, however, would be required to draw firm conclusions.
In addition to identifying a large number of carriers in a family, there are several other
advantages of the targeted approach for thalassaemia screening. The process of screening
can be initiated by counselling of one or a few individuals in a family. The counselling
itself may be easy and effective because most family members have some knowledge of a
child's illness in the family. This is a significant advantage for a community where the
literacy rate is very low. There are also some technical advantages in a family screening. It
can be started from the eldest available members. Their children may be screened only if
one or both parents are found to be carriers. However, a practical problem may arise
because in a field trip to a rural area it may be difficult to screen the elders first and then
sample the children at a later stage. The one tube osmotic fragility test (Kattamis et al,
1981) could be useful for this purpose as it can indicate on the spot the members to be
included or excluded from screening. The actual number of individuals that may require
screening can be reduced to almost 50% or less.
Distribution of the thalassaemia gene in the community:
Autosomal recessive disorders are likely to have a uniform distribution in a randomly
mating population and a clustered distribution in a population where consanguineous
marriages are common (Modell and Kuliev 1992). The observations in this study also
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support this hypothesis. Several families, that had a history of a haemoglobin disorder,
were found to have clustering of the carriers and the homozygotes. Interestingly, there
was not a single -thalassaemia carrier in 397 individuals from the five control families.
Screening in a similar number of people from the general population would have identified
approximately 20 carriers. In Pakistan where consanguineous marriage is customary the
autosomal recessive genes may be "trapped" in a relatively few selected families. This
ftirther supports the concept that targeting index families for screening a recessive
disorder can be the most suitable and cost effective choice for screening in a Pakistani
setting.
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6 Characterization of -tha1assaemia mutations
Introduction:
This chapter describes study of 13-thalassaemia mutations in all ethnic groups in Pakistan. In
addition, data on the molecular pathology of thalassaemia intermedia is also presented.
Subjects:
A total of 712 unrelated individuals were studied. These included 184 f3-thalassaemia
heterozygotes, 519 3-thalassaemia homozygotes and 9 cases of Hb-S/-thalassaemia who
were also receiving transfusions. The heterozygotes were identified from individuals referred
to the department of haematology, Armed Forces Institute of Pathology (AFIP), Rawalpindi,
for screening of 13-thalassaemia. Their diagnosis was made by red cell indices and HbA2
estimation. The patients with f3-thalassaemia major and Hb-S/13-thalassaemia included in the
study were receiving treatment at Fatimid Foundation Thalassaemia Treatment Centres,
Karachi, Lahore, and Peshawar, Hussaini Blood Bank, Karachi and Pakistan Thalassaemia
Welfare Society Thalassaemia Treatment Centre, Rawalpindi. The patients were diagnosed at
various government and private laboratories.
At the time of sampling each individual or his/her parents were interviewed. Information
including age, ethnic group, parental consanguinity and transfusion history was recorded.
From each individual 3-5 ml of blood was collected in EDTA and kept refrigerated until DNA
was extracted.
Thalassaemia intermedia:
Patients of 3-thalassaemia who had a mild phenotype, characterized by late start or infrequent
requirement of transfusions, were further investigated for the type of J3-thalassaemia mutation,
Xmn-I polymorphism and coincidence of a-thalassaemia (-a 37 and -a42). Xmn-I
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polymorphism was also investigated in 39 randomly selected patients of severe 13-thalassaemia
major and 58 apparently normal individuals (Controls).
Results:
Distribution of ethnic groups:
The subject's diagnosis and ethnic group is shown in Table: 6.1.
Table: 6.1. Distribution of the subjects according to ethnic group and diagnosis.
Ethnic	 Thalassaemia Thalassaemia Hb-S/ 	 Total	 Total mutant
Group:	 trait:	 major:	 Thalassaemia: Subjects:
	 chromosomes:
Punjabi:	 117	 139	 -	 256	 395
Pathan:	 57	 78	 4	 139	 221
Sindhi:	 3	 129	 1	 133	 263
Baluchi:	 6	 83	 1	 90	 174
Mohajirs:	 1	 90	 3	 94	 187
TOTAL:	 184	 519	 9	 712	 1240
Age distribution:
Subjects with 13-thalassaemia major ranged in age from 3 months to 35 years (Fig: 6.1). Their
distribution according to age was as follows: <1 year 6%, 1-2 years 9%, 2-5 years 33%, 5-10
years 34%, and >15 years 18%. The ages of patients with Hb-S/13-thalassaemia ranged from 4-
17 years (Mean 9 years).
Fig: 6.1. Age distribution of 519 patients of thalassaemia major in whom mutation analysis
was done.
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Mutation analysis:
Each heterozygote of f3-thalassaemia represented one mutant allele and homozygotes
represented two alleles. In 184 heterozygotes, 519 cases of 3-thalassaemia major and 9 cases
of Hb-S/3-thalassaemia 1240 mutant alleles were identified.
Screening by ARMS.
The ARPVIS method identified 1218/1240 (98.2 %) alleles. Bright and clear bands showed a
positive result (Fig: 6.2a). For most of the mutations negatives were clear negative but a faint
false positive band was seen in some (Fig: 6.2b).
1	 2	 3	 4	 5	 6	 7	 8
Fig: 6.2a. Ethidium bromide stained agarose gel electrophoresis of ARMS amplified products.
All lanes show 861bp control bands. Lane 1 and 4 show bands of IVSI-5, lane 3 is Cd5, lane 5
and 7 are Fr 4 1-42, lane 8 is IVSII-1 and lane 9 is Fr 8-9.
False positive bands were always seen with Hb-E mutant and Cd 15 (G-A) normal primers.
Similarly, faint positive bands, although of much less intensity, were also given by Fr 8-9 (+G)
mutant, Cap+1 (A-C) mutant, and IVSI-1 (G-T) normal primers. The false positive bands
could be made less intense by (a) reducing the amount of Taq polymerase from Advanced
Biotechnologies, UK (b) using Taq from Perkin Elmer UK, (c) increasing the annealing
temperature to 67° C instead of the 65° C (d) comparing the intensity of 861 bp control band
and the mutant/normal band: the presence of a brighter control band (861 bp) suggested a
false positive result. Comparing the bands for known positive or negative samples also helped
to identify false positive bands. The false positive band shown by Hb-E mutant primer was
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made even fainter by redesigning the primer with a (GIG) mismatch instead of the (GIA)
mismatch at position -3 relative to the 3' end of the primer (Table: 6.3).
1	 2	 3	 4	 5	 6	 7	 8
Fig: 6.2b. Agarose gel electrophoresis of ARMS amplified products for Cd15 (lanes 1 and 3)
and Cap+1 (lanes 6 and 8). False positive bands for the same mutations can be seen in the
lanes 2, 4, 5 and 7. 861 bp control fragments are visible in all lanes.
Twenty two alleles were not characterized by the ARMS method. Subsequent investigations
(DGQE and sequencing) suggested that 8 of these were false negatives and analysis of the
records showed that the negative result was a consequence of human errors. In five cases
testing by ARMS had been omitted due to a clerical error and in 3 the absence of 861 bp
control band, indicating failure of PCR, had been overlooked. These eight samples gave a clear
positive result when subsequently tested by the respective ARMS primers i.e. Cd 15 (G-A): 3,
Fr 16 (-C): 2, Cap+1 (A-C): 2, and Cd 30 (G-A): 1). This left 14/1240 (1.1%) uncharacterized
mutations.
Denaturing Gradient Gel Electrophoresis (DGGE):
The 13-globin gene was tested by DGGE in overlapping regions (Fig 3.1). The primers used
covered the gene except the major portion of IVSII (IVSII-30 to IVSII-588), the last 14
codons, the termination site and the polyadenylation site.
Fragments I and II:
This region contains most of the promoter region sequences and the first few codons of Exon-
1. The majority of mutations including the C-T polymorphism in the 2nd codon were identified
by DGGE of this region (Fig: 6.3). The fast moving bands in a particular lane represented
homoduplexes containing the mutation while the slower bands resulted from heteroduplex
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formation between the mutant and the normal sequences. Single bands were seen when the
test sample was homozygous for either the mutation/polymorphism or the normal sequence.
1	 2	 3	 4	 5	 6	 7	 8
Fig: 6.3. DOGE of the amplified fragment-I after ethidium bromide staining. Lane 1 and 7
show heterozygous polymorphism and lane 8 is homozygous polymorphism at Cd2, lane 2 is
heterozygous Cd 15, lane 3 and 5 are homozygous Fr16, lane 4 is heterozygous Cd5 and lane 6
is heterozygous Fr 8-9.
DGGE of fragment-I revealed seven mutant alleles. Some samples were also homozygous or
heterozygous for the polymorphism at the Cd2. Careful analysis of the patterns produced by
the polymorphism was required to distinguish it from a mutation. The problem was overcome
by including known samples with or without Cd2 polymorphism. The fragment-Il was
amplified by a set of primers in which the GC clamp was shifted to the downstream primer as
compared to the GC clamp used with the upstream primer that amplified the fragment-I. This
resulted in identification of three mutantions, all shown by subsequent sequencing to have the -
88 (C-T) mutation. In fact, close proximity of -88 (C-T) to the GC clamp in fragment-I
prevents identification by using this fragment.
Fragment-Ill:
Fragment-Ill was large (424bp) and encompassed promoter sequences, Exon-I and most of
the IVS-I. It was found to be useful for identification of mutations located in the splice
junction of Exon-I and the IVS-I. DGGE of this fragment resulted in identification of two
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mutations. Subsequent sequencing revealed them to be Cd 30 (G-A), and IVSI-1 (G-A).
Fragments IV and V:
Fragments IV and V were useful for identifying mutations in Exon-Il. DGGE of this fragment
identified one mutation which on subsequent sequencing showed Cd 39 (C-T) which is a
Mediterranean mutation.
Fragment VI:
This fragment spans the terminal part of IVSII and the major portion of Exon-Ill. This region
contains several thalassaemia mutations and a C-T polymorphism at position IVSII-666
(Ghanem et al, 1992). DGGE of this fragment did not reveal any mutant allele. However, the
polymorphism was seen on 7 out of 22 chromosomes.
Genomic sequencing:
Genomic sequencing elucidated the precise nature of the mutations identified by DGQE. The
results of sequencing on single stranded as well as the double stranded templates were
comparable but the double stranded protocol had the advantage of being quicker.
The results are summarised in Table: 6.2. New mutations identified by sequencing include Cd
39 (C-T), IVSI-1 (G-A) and -88 (C-T). A Pathan patient with severe transfusion dependent
thalassaemia was found to be homozygous for a novel mutation in the Exon-Ill of 3-globin
gene, namely a 17 bp deletion (-TGC/AGG/CTG/CCT/ATC/AG) involving codons 126 to 131
(Fig: 6.4). The deletion was located between two copies of a CAG sequence present in Cd
125/126 and Cd 131. It was not possible to ascertain whether the breakpoint was before or
following the CAG sequence in Cd 125/126. However, the Cd 125 was left intact. The
deletion caused a frame-shift leading to a premature stop signal (TAA) at the new Cd 133.
This deletion was not detected by DGGE because the sample had failed to amplify with the
primers for the fragment VI as the downstream primer for this fragment is complementary to
Cd 125-132 (Primer DG1 1 in Table: 3.5), deleted in this sample.
In four subjects with thalassaemia major and two with thalassaemia intermedia only one 13 -
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thalassaemia allele was identified by ARMS and DGGE. Sequencing of the entire -globin
gene including 110 bases upstream to the Cap site and 10 bases beyond the poly-A site in all
six samples could not identify the second mutant allele.
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Fig: 6.4. DNA sequencing gel showing the non coding strand of exon-Ill containing the 1 7bp
deletion. Sequence of the normal DNA is also shown.
Table: 6.2. Mutations characterized by genomic sequencing.
Mutations:	 Number of alleles:
	 Mutations:	 Number of alleles:
Cd 15 (G-A)	 3	 IVSI-1 (G-A)	 2
Fr 16 (-C)
	
2	 Cd 39 (C-T)	 I
Cd30(G-A)	 I	 Fr125-131(-l7bp) 2
-88 (C-T)	 3	 Cap+I (A-C)
	
2
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Spectrum of 13-thalassaemia mutations:
A total of 1225 3-thalassaemia alleles were characterized, 19 different 3-thaIassaemia
mutations being identified (Table: 6.3). In addition, 9 alleles of Hb-S in combination with
different f3-thalassaemia mutations were identified. The five most frequent mutations were
called common mutations. The mutations that were not common but had a frequency of 1% or
more were called uncommon and those with less than 1% frequency were called rare
mutations. The common mutations, IVSI-5 (G-C) (37%), Fr 8-9 (+G) (25.6%), Del 619bp
(7%), Fr 41-42 (-TTCT) (6.6%), and IVSI-1 (G-T) (5%) accounted for 81% of the alleles
(Table: 6.3). Six uncommon mutations formed 15% of the total and another nine (4%) were
categorized as rare mutations. Six subjects with transfusion dependent anaemia had only one
J3-thalassaemia mutation and the other allele remained unknown. Three of these had IVSI-5
(G-C), two had Fr 8-9 (+G), and one had Fr 4 1-42 (-TTCT).
Punjabi.
The total of 393 alleles from Punjabi subjects included 16 different mutations (Table: 6.3). The
common mutations Fr 8-9 (+G), IVSI-5 (G-C), Fr 41-42 (-TTCT), IVSI-1 (G-T) and Cd 30
(G-C) constituted 82% of the alleles. Cd 30 (G-C) replaced del 619 in the common group of
mutations. The uncommon mutations formed 15.3% and rare mutations were 2.5% of the
total.
Pathan:
Fr 8-9 (+G) comprised 48% of the alleles identified. The other common mutations were IVSI-
5 (G-C), Fr 41-42 (-TTCT), Cd 5 (-CT), and Cd 15 (G-A) (Table: 6.3). Cd 5 (-CT) and Cd 15
(G-A) replaced IVSI-1 (G-T) and Del 619 in the common group. Two 1 3 mutations Cap+1
(A-C) and -88 (C-T) comprised 4.5% of the alleles. Compound heterozygotes of Hb-S and 3-
thalassaemia formed 4/82 (5%) of the subjects with transfusion dependent haemoglobin
disorder in Pathans. A novel I 7bp deletion that involved Cd 126-131 was found in a
transfusion dependent Pathan child with consanguineous parents. In twoPathan patients with
apparent thalassaemia major only one j3-thalassaemia allele was identified.
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Sin dhi:
The common mutations including IVSI-5 (G-C), del 619, IVSI-1 (G-T), Fr 8-9 (+G) and Cd
30 (G-C) comprised 88% of the alleles (Table: 6.3). Del 619 was found at a frequency of
13.6% and only one allele of IVSI minus 25 was seen. In two Sindhi patients with apparent
transftision dependent thalassaemia only one 13-thalassaemia allele was identified.
Baluchi.
The mutation pattern amongst Baluchis was comparatively less heterogenous. IVSI-5 (G-C)
accounted for 75% of the alleles (Table: 6.3). The other common mutations included Fr 8-9
(+G), Cd 15 (G-A) and Fr 16 (-C). There was one unidentified allele in a patient with apparent
f3-thalassaemia major.
Mohajir:
The pattern of mutations in Mohajirs was fairly heterogeneous (Table: 6.3). The common
mutations including IVSI-5 (G-C), del 619bp, Fr 8-9 (+G), Fr 4 1-42 (-TTCT) and Hb-E
accounted for 80% of the alleles. There were 10 (10.8%) compound heterozygotes with Hb-
E/3-thalassaemia and 3 (3.2%) with Hb-S/13-thalassaemia.
Parental consanguinity and inheritance of mutations:
Both 13-thalassaemia alleles were identified in 513 homozygotes. The relationship between
parental consanguinity and inheritance of mutations in these patients is summarized in Table:
6.4. On the whole 315 (61.4%) were offspring of first cousin marriages, 89 (17.3%) had more
distant related parents (relationship not beyond second cousin) and 109 (21.2%) had totally
unrelated parents. Forty three percent of subjects whose parents were unrelated had inherited
the same mutation from both the parents. It increased to 58.4% for those with more more
distantly related parents, and to 88.3% for the subjects whose parents were first cousins. The
pattern was generally similar in all ethnic groups (Table: 6.4). However, amongst the Baluchis,
where IVSI-5 (G-C) was found at a frequency of 75%, there was no difference in the
frequency of inheriting the same mutation whether the parents were consanguineous or not. In
9 Hb-S/13-thalassaemia patients 5 had unrelated parents and 4 had consanguineous parents (Pt
cousins).
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Table: 6.3. 13-thalassaemia mutations and Hb-S disorder in the ethnic groups of Pakistan.
Allethnic groups: 	 ______________________________
Common mutations:	 Uncommon mutations:	 Rare mutations:
IVSI-5 (G-C)
	
457(36.9%)	 Cd 15 (G-A)	 51(4.1%)	 Cd 30 (G-A)	 11(0.9%)
Fr 8-9 (+G)
	
317 (25.6%)	 Cd 30 (G-C)	 43 (3.5%)	 IVSII-1 (G-A)	 10 (0.8%)
Del 619	 85 (6.9%)	 Cd 5 (-CT)	 31(2.5%)	 Hb-S	 9 (0.7%)
Fr 4 1-42 (-TTCT)	 82 (6.6%)	 Fr 16 (-C)	 29 (2.3%)	 -88 (C-T)	 3 (0.3%)
IVSI-1 (G-T)
	
65 (5.2%)	 Cap +1 (A-C)	 20 (1.6%)	 IVSI-1 (G-A)	 2 (0.2%)
1-Ib-E	 13 (1.1%)	 Fr 47-48 (+ATCT) 2 (0.2%)
Fr126-131 (-l7bp) 2 (0.2%)
Cd39(C-T)	 1(0.1%)
IVSI minus 25	 1 (0.1%)
Unknown	 6 (0.5%)
Total 1240 (100%) 1006 (81.1%) 	 187 (15.1%)	 47 (3.8%)
Punjabi:
Common mutations: 	 Uncommon mutations: 	 Rare mutations:
Fr 8-9 (+G)	 146 (37.2%)	 Del 619	 14 (3.6%)	 Cd 30 (G-A)	 3 (0.8%)
IVSI-5 (G-C)
	
107 (27.2%)	 Cd 15 (G-A)	 14 (3.6%)	 Hb-E	 3(0.8%)
Fr 41-42 (-TTCT)	 36 (9.2%)	 Cd 5 (-CT)	 11(2.8%)	 Fr 47-48 (+ATCT) 2 (0.5%)
IVSI-1 (G-T)
	 19 (4.8%)	 Cap +1 (A-C)	 9 (2.3%)	 IVSI-1 (G-A)	 1 (0.3%)
Cd 30 (G-C)
	
15 (3.8%)	 Fr 16 (-C)
	
6 (1.5%)	 -88 (C-T)	 1(0.3%)
IVSII-1 (G-A) 6 (1.5%)
Total 393 (100%)
	 323 (82.2%)	 60 (15.3%)	 10 (2.5%)
Pathan:
Common mutations:	 Uncommon mutations: 	 Rare mutations:
Fr 8-9 (+G)	 105 (47.7%)	 Fr 16 (-C)
	
8 (3.6%)	 Cd 30 (G-A)	 2 (0.9%)
IVSI-5 (G-C)
	
27 (12.3%)	 Cap +1 (A-C)
	 8 (3.6%)	 Fr126-13 1 (-17 bp) 2 (0.9%)
Fr 41-42 (-TTCT)
	 18(8.2%)	 IVSI-1 (G-T)
	 4(1.8%)	 -88 (C-T)	 2(0.9%)
Cd 5 (-CT)	 17 (7.7%)	 Del 619
	 4 (1.8%)	 IVSII-1 (G-A)	 1(0.5%)
Cd 15 (G-A)	 14 (6.4%)	 Hb-S	 4 (1.8%)	 Cd 30 (G-C)	 1(0.5%)
Cd 39 (C-T)	 1(0.5%)
Unknown	 2 (0.9%)
Total 220 (100%)
	 181 (82.3%)	 28 (12.7%)	 11(5.0%)
Continued on next page.
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Table: 6.3 3-tha1assaemia mutations and Hb-S disorder in the ethnic groups of Pakistan.
(Continued from previous page).
Sindhi:
Common mutations: 	 Uncommon mutations:	 Rare mutations:
IVSI-5 (G-C)
	
114 (43.2%) Fr41-42	 16(6.1%)	 Hb-S	 1(0.4%)
(-TTCT)
Del 619	 36 (13.6%)	 Fr 16 (-C)	 6 (2.3%)	 IVSI minus 25	 1(0.4%)
IVSI-1 (G-T)	 33 (12.5%)	 Cd 15 (G-A)	 5 (1.9%)	 IVSI-1 (G-A)	 1(0.4%)
Fr 8-9 (+0)	 29 (11.0%)	 Unknown:	 2 (0.8%)
Cd 30 (G-C)	 20 (7.6%)
Total 264 (100%)
	
232 (87.8%)	 27 (10.2%)	 5 (1.9%)
J3aluchi:
Common mutations: 	 Uncommon mutations:	 Rare mutations:
IVSI-5 (G-C)
	
132 (75.4%) Fr 16 (-C)
	
6(3.4%)	 Fr 41-42 (-TTCT) 1(0.6%)
Fr 8-9 (+G)	 14 (8.0%)	 Cd 30 (G-C)	 3 (1.7%)	 Cd 5 (-CT)	 1(0.6%)
Cd 15 (G-A)	 9 (5.1%)	 Cd 30 (G-A)	 2 (1.1%)	 IVSII-1 (0-A)	 1(0.6%)
Del 619	 2(1.1%)	 Hb-S	 1(0.6%)
IVSI-1 (G-T)	 2(1.1%)	 Unknown	 1(0.6%)
Total 175 (100%)
	 155 (88.6%)	 15 (8.6%)	 5 (2.9%)
Mohajir:
Common mutations: 	 Uncommon mutations:	 Rare mutations:
IVSI-5 (G-C)
	 77 (41.0%)	 Cd 15 (0-A)	 9 (4.8%)	 Unknown	 1(0.5%)
Del 619	 29 (15.4%)	 IVSI-1 (0-1)	 7 (3.7%)
Fr 8-9 (+G)	 23 (12.2%)	 Cd 30 (0-C)
	
4 (2.1%)
Fr 41-42 (-TTCT)
	 U (5.9%)	 Cd 30 (0-A)	 4(2.1%)
llb-E	 10 (5.3%)	 Fr 16 (-C)
	
3 (1.6%)
Cap +1 (A-C)	 3 (1.6%)
Hb-S	 3 (1.6%)
Cd 5 (-CT)	 2 (1.6%)
IVSII-1 (0-A)
	 2 (1.1%)
Total 188 (100%)	 150 (79.8%)	 37 (19.7%)	 1(0.5%)
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Table: 6.4. Relationship between parental consanguinity and inheritance of thalassaemia
mutations in patients where both of the 3-thalassaemia genes were identified.
Ethnic	 1st cousins	 Related but not	 Unrelated
Groups (n):	 1st cousins
Same	 Different	 Total Same	 Different	 Total Same	 Different	 Total
mutation	 mutations	 mutation	 mutations	 mutation	 mutations
Punjabi (137)	 81 (83.5%)	 16(16.5%) 97	 15(71.4%) 6 (28.6%) 21	 10(52.6%) 9(47.40%) 19
Pathan(75)	 42 (93.3%)	 3 (6.7%)	 45	 4 (30.8%) 9 (69.2%) 13	 7 (41.2%)	 10(58.8%) 17
Sindhi (128)	 77 (90.6%)	 8 (9.4%)	 85	 10 (55.6%) 8 (44.4%) 18	 7 (28.0%) 18(72.0%) 25
Baluchi(83)	 54 (87.1%)	 8(12.9%)	 62	 11(84.6%) 2 (15.4%)	 13	 7 (87.5%)	 1 (12.5%) 8
Mohajir (90)	 24 (92.3%)	 2 (7.7%)	 26	 12(50.0%) 12 (50.0%) 24	 16(40.0%) 24(60.0%) 40
All groups (513) 278(88.3%) 37(11.7%) 315	 52(58.4%) 37(41.6%) 89	 47(43.1%) 62(56.9%)
	 109
Thalassaemia Intermedia (TI):
In the 519 patients of j3-thalassaemia on transfusions 39 (7.5%) had a mild phenotype
characterised by a late start and less frequent requirement of blood transfusions. The Xmn-I
polymorphism, type of mutations, and coincidence of ct-thalassaemia are presented in Table:
6.5. In 24/39 (61.5%) patients a definite cause for mildness of the disease was identified.
Xmn-I +1+ genotype was found in 14 patients, 13 k
-mutations with or without coincident a-
thalassaemia were found in 12 patients, and coincident cx-thalassaemia was found in 2 patients.
Two patients had unidentified mutations in combination with IVSI-5. In 14 patients Xmn-I 
-1+
genotype was found. However, two such patients had Cap+1 and a suspected unknown
mutation outside the 3-globin gene. In the remaining 12 patients Xmn-I 
-/+ alone or a
suspected coincidental a-thalassaemia was the likely cause of thalassaemia intermedia.
Age distribution:
The ages of TI patients ranged from 3-35 years with mean age of 12 years (Fig: 6.5). The
average age at first transfusion ranged from 3-26 years (mean 7 years) (Fig: 6.6). Mean age at
first transfusion when examined in relation to the underlying cause of thalassaemia intermedia
(Table: 6.6), it was a maximum of 10 years in patients who either had confirmed coincidence
of ct-thalassaemia or in whom it was suspected. It was 6 years in patients with Xmn-I +1+
genotype and 3 years in patients with a ft-mutation.
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Table: 6.5. Molecular basis of Thalassaemia Intermedia in the ethnic groups of Pakistan.
Sr. Age:	 First	 13-thaiassaemia	 Xmn-I	 a-Thai	 Probable cause of
No &rs)	 Trans# Mutations	 genotype genotype* Thaiassaemia Intermedia
jabi :	 _______ ____________________ ________ _________ ______________________
1	 3 yrs	 None	 IVSI-5 (G-C)J IVSI-5 (G-C)	 +7+	 aa/aa	 Xmn-I +1+
2. 5 yrs	 3 yrs	 IVSI-5 (0-C)! IVSI-5 (G-C)	 +7+	 aalaa	 Xmn-I +1+
3. 12 yrs	 4% yrs	 IVSI-5 (G-Cy IVSI-5 (G-C)	 +1+	 aalcxa	 Xmn-I +1+
4. 12 yrs	 3% yrs	 IVSI-1 (G-T)! IVSI-1 (G-T)	 +7+	 aa/aa	 Xmn-I +1+
5. 5'/ yrs	 3 yrs	 IVSI-1 (G-Ty IVSI-1 (G-T)	 +1+	 acilaa	 Xmn-I +1+
6. 7 yrs	 5'/2 yrs	 IVSI-1 (G-T)/ IVSI-i (G-T)	 +1+	 actlaa	 Xmn-I +7+
7. 6 yrs	 5 yrs	 IVSII-1 (G-A)!IVSII-1 (G-A)	 +7+	 aulaa	 Xmn-I +7+
8. 8 yrs	 5 yrs	 IVSII-1 (G-A)IIVSII-1 (G-A)	 +7+	 aa'aa	 Xmn-I +1+
9. 8 yrs	 4'/2 yrs	 Cd 30 (G-C)!Cd 30 (G-C) 	 +7+	 cxa/aa	 Xmn-I +1+
10. 13 yrs	 3'/2 yrs	 IVSI-5 (G-C)/Cap+1 (A-C)	 -I-	 aa/aa	 p thai mutation
11. 5'/ yrs	 2 yrs	 IVSI-5 (G-C)/Cap-I- 1 (A-C) 	 -I-	 aa/a.a	 thai mutation
12	 6 yrs	 3 yrs	 IVSI-5 (G-C)!Cap+ 1 (A-C)	 ___________	 thai mutation
13. 13 yrs	 5 yrs	 Fr 8-9 (+G)/Cap+ 1 (A-C) 	 -I-	 -a37aiaa	 I3 thai mutation & -a37
14. 10 yrs	 None	 Fr 8-9 (+G)/ IVSII-1 (G-A)	 -1+	 ?	 Xmn-I -7+, Coincident a-thai??
15. 7 yrs	 3 yrs	 IVSI-5 (G-C)IFr 8-9 (+G)	 -I-	 -a3 7a1-a37a	 Coincident a-thaiassaemia
16. 20 yrs	 15 yrs	 Fr 47-48 (-ATCT)IFr 47-48	 -I-	 -a37a1-a37a	 Coincident a-thalassaemia
Pathan:	 _______ _____________________ ________ _________ _______________________
17. 35 yrs	 24 yrs	 IVSI-1 (G-T)/IVSI-1 (G-T)	 +7+	 act/aa	 Xmn-I +7+ & a-thai (nd ??)
18. 5 yrs	 2% yrs	 IVSI-5 (G-C)/Cap+ 1 (A-C) 	 -7+	 aa/aa	 Xmn-I -1+, 3 thai mutation
19. 15 yrs	 3 yrs	 IVSI-5 (G-C)/Cap+ 1 (A-C) 	 -I-	 aa'aa	 p thai mutation
20. 5 yrs	 2% yrs	 Cd 5 (-CT)/Cap+ 1 (A-C)	 -I-	 aolaa	 p thai mutation
21. 23 yrs	 17 yrs	 Fr 8-9 (+G)!-88 (C-T)
	
-I-	 aciiaa	 p thai & a-thai (nd ??)S
Sindhi:	 _______ ______________________ _________ __________ ________________________
22. 18 yrs	 3'/2 yrs	 IVSI-5 (G-CYCd 30 (G-C)	 +7+	 ?	 Xmn-I +7+
23. 13 yrs	 5 yrs	 IVSI-1 (G-T)/dei 619 bp
	
-1+	 ?	 Xmn-I -/+,Coincident a-thaia??
24. 15 yrs	 5 yrs	 IVSI-5 (G-C)ICd 30 (G-C)	 -7+	 ?	 Xmn-I -/+,Coincident a-thala??
25. 16 yrs	 9 yrs	 IVSI-5 (G-C)/IVSI-5 (G-C)
	
-I-	 ?	 Coincident a-thaia??
26. 15 yrs	 12 yrs	 IVSI-5 (G-C)!IVSi-5 (G-C) 	 -7+	 ?	 Xmn-I -/+,Coincident a-thala??
Baiuchi:
27. 16 yrs	 7 yrs	 IVSI-5 (G-C)!IVSII-i (G-A)
	 -1+	 ?	 Xmn-I -/+,Coincident a-thaia??
28. 11 yrs	 10 yrs	 IVSI-5 (G-C)/?	 -/+	 ?	 Unknown mutation??
Mohajir:	 ________ _________________________ __________ ___________ ___________________________
29	 9 yrs	 5 yrs	 IVSI-5 (G-C)/IVSi-5 (G-C)
	
+1-1-	 ?_________ Xmn-I +1+
3	 30 yrs	 9 yrs	 IVSI-5 (G-C)!IVSi-5 (0-C)
	 +1+	 9	 Xmn-I +7+
31. 17 yrs	 6 yrs	 IVSII-1 (G-A)/IVSII-i (0-A)
	
+7+	 9	 Xmn-I +1+
32. 26 yrs	 12 yrs	 IVSI-5 (G-CyHb-E	 -7+	 9	 Xmn-I -7+, ptmut & a-thai??
33. 21 yrs	 18 yrs	 IVSI-5 (G-C)/Hb-E	 -7+	 9	 Xmn-I -7+, pFmut & a-thai??
34. 15 yrs	 9 yrs	 IVSI-5 (G-C)IHb-E	 -7+	 9	 Xmn-I -7+, I3-mut & a-thai??
35. 7 yrs	 None	 Cd 15 (G-A)!Cap+ 1 (A-C)
	 -I-	 9	 )(mn-I -7+, 3-mut & a-thai??
36. 21 yrs	 5 yrs	 IVSI-5 (G-C)/dei 619 bp
	 -1+	 9	 Xmn-I -7+, Coincident a-thai??
37. 31 yrs	 26 yrs	 IVSI-5 (G-CyIVSI-5 (0-C)
	 -7+	 9	 Xmn-I -7+, Coincident a-thai??
38. 6 yrs	 5Y2 yrs	 IVSI-5 (G-C)!IVSi-5 (0-C)
	
-7+	 9	 Xmn-I -7+, Coincident a-thai??
39	 14 yrs	 5 yrs	 IVSI-5 (G-C)/?	 -7+	 9	 Unknown mutation??
Age at first transfusion; * a-thalassaemia screenin g included -a37 and -a42 kb deletions: 5a-thai (nd'i: non-
deletional a-thalassaemia.
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Fig: 6.5. Age distribution of 39 patients of thalassaemia Intermedia.
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Fig: 6.6. Age distribution of 39 thalassaemia intermedia patients at the start of transfusion.
Table: 6.6. Average age at Pt transfusion and the time of examination in relation to the
underlying cause of thalassaemia intermedia.
Cause of Thalassaemia Intermedia:
	 n: Mean age:	 _________________
_________________________________________ 	 At 1st transfusion:	 At examination:
Xmn-I +1+ genotype	 14 6 years	 13 years
ptmutation	 6	 3 years	 8 years
-mutation and suspected coincident a-thai
	
6	 11 '/4 years	 18 years
Unidentified thalassaemia mutation 	 2	 7 '/2 years	 12 '/2 years
Confirmed coincident a-thalassaemia
	 2	 9 '/2 years	 13 '/2 years
Suspected coincident a-thalassaemia	 9	 9 '/2 years	 16 years
Total	 39	 7 years	 14 years
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Xmn-I genotype:
Xmn-I +1+ genotype accounted for thalassaemia intermedia in 14/3 9 (3 6%) patients. It was
also the commonest cause for the mild phenotype in Punjabi patients where 9/16 (5 6%) had
+/+ genotype. Xmn-I +1+ genotype was relatively uncommon in the other ethnic groups. A
comparison of the Xmn-I +1+ genotype between patients of thalassaemia intermedia, severe 13-
thalassaemia major and normal individuals showed significant differences (Table: 6.7). There
was a marked difference between thalassaemia intermedia and thalassaemia major (p=O.0005).
The difference was less marked between thalassaemia intermedia and normal individuals
(p=O.O46) and between normal individuals and thalassaemia major (p—O.O24). Xmn-I -/+
genotype was observed in 13/3 9 (33.3%) patients of thalassaemia intermedia. However, 9/39
(23%) patients of thalassaemia major also had Xmn-I -/+ genotype (Table: 6.8).
Correlation between the mutations and the Xmn-I genotypes in patients of thalassaemia
intermedia (Table: 6.5) and thalassaemia major (Table: 6.8) showed that association between
some mutations and the '+' site was present (Table: 6.9). IVSI-5 (G-C), for example, was
definitely associated with '+' site in 12/3 3 alleles in thalassaemia intermedia and 1/25 alleles in
thalassaemia major. Its association was suspected in 9/33 alleles in thalassaemia intermedia and
3/25 alleles in thalassaemia major patients. IVSI-1 (G-T), IVSII-1 (G-A) and Cd 30 (G-C)
were other mutations that showed association with the "+" site.
Table: 6.7. A comparison of the Xmn-I genotypes in patients of thalassaemia intermedia,
thalassaemia major and normal individuals.
Xmn-I genotype: 	 Thai Intermedia:	 Thai Major:	 Normal:
-I-	 12(30.8%)	 30(76.9%)	 30(51.7%)
-1+	 13 (33.3%)	 9(23.1%)	 20(34.5%)
+1+	 14(35.9%)	 None	 8(13.8%)
Total:	 39(100%)	 39(100%)	 58(100%)
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Table: 6.8. 13-thalassaemia and Xmn-lgenotypes in patients of thalassaemia major.
Mutation:	 Xmn-1	 Mutation:	 Xmn-1	 Mutation:	 Xmn-1
_________________ genotype: _________________ genotype: _________________ genotype:
IVSI-5/IVSI-5	 -I-	 IVSI-5/Fr 8-9	 -I-	 Fr 8-9/I VSII-1	 -1+
Fr 41-42/Fr 41-42	 -I-	 Fr 8-9fHb-E	 -I-	 IVSI-5fHb-E	 -1+
Fr 41-42/Fr 41-42	 -I-	 Fr 8-9/Fr 8-9	 -I-	 IVSI-5/IVSII-1	 -1+
IVSI-5/IVSI-5	 -I-	 Fr 8-9/Fr 8-9	 -I-	 IVSI-5/Cap+1	 -I-
Fr 41-42/Cd 5	 -I-	 Fr 8-9/IVSI-5	 -I-	 IVSI-1/del 619	 -1+
IVSI-5/IVSI-5	 -I-	 Cd 15/Cd15	 -I-	 Cd 5/Cap+1	 -I-
Del 619/Cd 5	 -I-	 IVSI-5/IVSI-5	 -I-	 Fr 8-9/Cap+1	 -/-
Fr 41-42/Fr 41-42	 -/-	 IVSI-5/IVSI-5	 -I-	 Fr 8-9/Fr 8-9	 -/-
IVSI-5/IVSI-5	 -/+	 IVSI-5/Cd 15	 -1+	 IVSI-5/Cap+1	 ___________
Fr 8-9/Fr 8-9	 -/-	 IVSI-5/IVSI-5	 -I-	 Cd 15/Cd 15	 -/+
Fr 8-9/Fr 8-9	 -/-	 Fr 8-9/Fr 41-42	 -1+	 Fr 41-42/Fr 41-42	 -/-
Fr 41-42/Cd 15	 -/+	 IVSI-5/TVSI-5	 -I-	 Fr 8-9/Fr 41-42	 -/-
Fr 8-9/Fr 8-9	 -/-	 Fr 8-9/Fr 8-9	 -I-	 IVSI-5/IVSI-5	 -/-
Table: 6.9. Association between Xmn-I "+" site and 13-thalassaemia mutations in patients of
thalassaemia major and thalassaemia intermedia.
Mutation:	 Thalassaemia_major:	 Thalassaemia_Intermedia:
-	 +	 +?* Total:	 -	 +	 +?* Total:
IVSI-5 (G-C)
	 21	 1	 3	 25	 12	 12	 9	 33
Fr 8-9 (+G)
	 20	 -	 1	 21	 3	 -	 1	 4
Fr 4 1-42 (-TTCT)	 10	 -	 2	 12	 -	 -	 -	 -
IVSI-1 (G-T)
	 -	 -	 1	 1	 -	 8	 1	 9
IVSII-1 (G-A)	 -	 -	 2	 2	 -	 6	 2	 8
Cd 15 (G-A)	 3	 1	 2	 6	 1	 -	 -	 I
Cd30(G-C)	 -	 -	 -	 -	
-	 3	 1	 4
Cap +1 (A-C)	 4	 -	 -	 4	 7	 -	 1	 8
Cd5(-CT)	 3	 -	 -	 3	 1	 -	 -	 1
Hb-E	 1	 -	 1	 2	 -	 -	 3	 3
De1619	 1	 -	 1	 2	 1	 -	 1	 2
Others	 -	 -	 -	
-	 3	 -	 2	 5
Total:	 63	 2	 13	 78	 28	 29	 21	 78
Suspected ••+
Type of /3-thalassaemia mutations:
Table: 6.10 gives a comparison between the frequency of mutations in thalassaemia major and
thalassaemia intermedia patients. Significant differences in the frequency of Fr 8-9, IVSI-1 (G-
T), Cap+1 and IVSII-1 were observed between the two groups. Similarly, differences in the
frequency of Fr 8-9, Del 619, IVSI-1 (G-T) and Cd 5 were also observed between the younger
(<3 years) and the older (?3 years) patients of thalassaemia major.
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There were 12/39 (31%) patients who had mild 13-thalassaemia mutations in combination with
another 130 or 13 k-mutation. These included Cap+1 (8), Hb-E (3) and -88 (1). Out of 519 cases
of homozygous 3-thalassaemia 17 had Cap+1 mutation in combination with another severe 13-
thalassaemia mutation. However, their transfusion dependency was variable. Nine patients
started transfusions during the first year of life while 3 received their first transfusion at or
around three years of age and five received the first transfusion at an average age of 10 years.
In the later group of five patients one had a coincident a-thalassaemia (-a 37a/cxa ) while in the
other four although a-thalassaemia could not be shown due to technical reasons, it was
suspected because no apparent cause for the mild phenotype was seen.
There were 10/519 (1.9%) patients who had Hb-E in combination with a 13-thalassaemia
mutation. Three of these patients had thalassaemia intermedia (mean age at first transfusion 13
years) while all others had severe thalassaemia phenotype (mean age at first transfusion 1½
years). In the former three patients coincident a-thalassaemia was suspected.
In two patients with thalassaemia intermedia only one 13-thalassaemia allele (IVSI-5) was
identified and the other allele could not be found in the 13-globin gene.
Co-incident a-thalassaemia:
Effect of ct-thalassaemia could not be investigated in samples where DNA was extracted
without the use of Proteinase-K, as the quality of DNA was not good for PCR based
determination of c-thalassaemia. In 22 patients, in whom it was possible to test for a-
thalassaemia deletions, 2 had -cL37cLI -a 7a genotype. One patient of thalassaemia intermedia,
who also had the Cap+1 (mild 13k-mutation), had -a37a/aa genotype. The phenotype of this
patient was less severe as compared to the other patients with the Cap+1 mutation.
Screening for a-thalassaemia in 100 randomly selected patients of thalassaemia major found
five patients with -ct37a/cta genotype (Chapter 4). All five had severe 13-thalassaemia
mutations but none had an intermedia phenotype. In 13 patients coincident a-thalassaemia
(deletional or non-deletional) was suspected.
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Discussion:
This study provides a basis for characterizing 3-tha1assaemia mutations in Pakistan. In the
subsequent sections the choice of method and the screening strategy for mutation detection
will be discussed.
Choice of method for mutation analysis:
Three different methods were used: ARMS, DGGE and genomic sequencing. Most alleles
were identified by the ARMS method, which is quick, sensitive and specific for identifying
known 3-thalassaemia mutations. False positive results may be overcome by modifying the
procedure e.g. redesigning primers, and reducing the amount of Taq polymerase. Comparison
with known positive or negative samples and careful comparison of the amplification of
control and mutant/normal sequences can further reduce the risk of error. In ARMS PCR the
mutant/normal sequences are smaller and are preferentially amplified relative to the 861bp
control fragment so a true positive band is always brighter than the control and a false positive
band is less bright.
Carry-over from one sample to another leading to false positive results is avoided by careful
procedures: using separate pipettes for pre and post amplification steps, avoiding splashes, and
using positive displacement pipettes (Kwok and Higuchi 1989). Use of uracil DNA
glycosylase to control carry over contamination in PCR can also be useful (Longo et al, 1990).
Occasionally, extraneous DNA may contaminate PCR reagents whose presence can be
excluded by using reagent blanks i.e. PCR run without adding DNA.
Denaturing Gradient Gel Electrophoresis (DGGE) provides information about the presence of
a mutation but it gives little information about its nature (Myers et al, 1987). DGGE is
extremely useful as the first line investigation for locating unknown sequence changes in the
genome (Ghanem et al, 1992). To use DGGE alone for characterizing mutations requires each
batch of samples to include appropriate controls for all the mutations and polymorphisms
being investigated (Cai and Kan 1990). However, DGGE is labour intensive and less sensitive
than ARMS, is unable to identify mutations very close to the primer with the GC clamp and
polymorphisms can cause difficulty in interpreting results. The polymorphism present in the
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second codon is particularly important, as many -thalassaemia mutations are located in its
vicinity and the same mutation gives different results in the presence or absence of this
polymorphism.
Direct sequencing on PCR-amplified DNA is the standard method for identifying unknown
sequences (Engelke et al, 1988; Rao 1994). A single stranded DNA template is used in most
conventional sequencing protocols. The template may be prepared by asymmetric PCR
(Varawalla et al, 1991b) or by magnetic particle separators (Huitman et al, 1989; Them and
Hinton 1994), but this is time consuming. In this study sequencing of double stranded and
single stranded DNA templates gave comparable results. The later has the advantage of being
simple and quick.
Spectrum of thalassaemia mutations:
Most studies of molecular genetics of thalassaemia on the Indian Subcontinent have been done
on selected individuals settled in the Western countries (Kazazian et al 1990; Varawalla et al,
1991). These studies are inadequate because of the lack of representation of the ethnic groups.
The present study of over 1200 mutant alleles provides a comprehensive picture of 13-
thalassaemia mutations in Pakistan.
The overall spectrum of mutations in Pakistan is fairly heterogenous and 19 different
mutations were identified. The five common mutations, IVSI-5 (G-C) (3 7%), Fr 8-9 (+G)
(25%), del 619bp (7%), Fr 4 1-42 (-TTCT) (7%), and IVSI-I (G-T) (5%) account for 81% of
the alleles. In each ethnic group four or five common mutations account for over 80% of the
alleles. The spectrum of mutations is heterogenous in all of the ethnic groups except in
Baluchis where IVSI-5 alone comprises 75% of the alleles.
Geographical and ethnic differences in the prevalence of mutations:
The spectrum of mutations in almost all ethnic groups in this study is fairly heterogenous.
However, the spectrum in particular is more heterogenous in the Punjabis and the Pathans that
mainly reside in the northern parts of the country. Several factors e.g. time since appearance of
a mutation, population migrations, and random genetic drift might have contributed to the
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genetic heterogeneity (Bodmer and Cavalli-Sforza 1976).
The effect of lime since appearance of a mutation:
IVSI-5 (G-C) and Fr 8-9 (+G) are consistently the most common mutations through out
Pakistan. Several studies have shown that IVSI-5 (G-C) is the most prevalent mutation on the
Indian subcontinent (Varawalla et al, 1991a), Burma (Brown et al, 1992), Iran and the UAE
(Quaife et al, 1994). The wide distribution of IVSI-5 (G-C) indicates that it is probably the
oldest and the first mutation to appear in this region. IVSI-5 (G-C) is also associated with
several haplotypes as compared to other mutations (Varawalla et al, 1992). This suggests that
sufficient time has elapsed since its first appearance to allow several meiotic recombination
events creating more than one haplotype. Alternatively, IVSI-5 (G-C), like Cd39 (C-T) in the
Mediterranean (Pirastu et al, 1987), might have arisen at more than one occasion, each time on
a new haplotype. Fr 8-9 (+G) is also widely distributed in the northern region of Pakistan and
could have been one of the first mutations to appear in this region. It appears that once the
most common mutations had established themselves in a state of balanced polymorphism,
widespread propagation of the subsequently developing or arriving mutations was prevented
by the already "established" gene frequencies of the common mutations (Modell and
Berdoukas 1984).
Effect ofpopulation migration:
New mutations may be brought in to an area through migration of populations. It is likely that
three typical Mediterranean mutations (Cd39 (C-T), IVSI-I (G-A), and IVSII-1 (G-A)
observed in some subjects from the northern Pakistan arrived through population migrations
as invaders from Central Asia, Iran, Turkey and Greece have all had their influence on this
area (Halliday 1994). Hb-E amongst the Mohajirs, many of whom migrated to Pakistan from
the province of Bihar in the eastern part of India, is also the result of population migration.
Previous studies found the 619 bp deletion in over 50% of 13-thalassaemia alleles in Sindhis
(Them et al, 1984, Varawalla et al, 1991a), but in this study it accounted for only 14% of the
alleles in Sindhis. The higher prevalence in previous reports was probably due to selected
sampling. Del 619 was also seen quite frequently in Mohajirs who also include people of
Gujrati descent among whom the 619bp deletion is common (Varawalla et al, 1991a).
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In this study Baluchis were found to have the least heterogeneous pattern of mutations and
IVSI-5 (G-C) accounted for 75% of the alleles. The history of the Baluchis dates back to 700
BC when a tribe called Baluch migrated from Iran to the present Baluchistan (Bokhari 1975).
The high frequency of IVSI-5 in Baluchis may be due to (a) founder effect (b) relative
isolation (c) relatively small numbers and (d) few marriages outside the tribe preventing entry
of new mutations.
Novel f-thalassaemia mutation:
Most 3-thalassaemia mutations are well characterized and the chance of finding new mutation
appears small. In this study only one out of 712 individuals (1240 13-thalassaemia
chromosomes) investigated showed a new mutation. The l7bp deletion in Exon-Ill of 13
-globin gene was located between two copies of a CAG sequence present in Cd 125/126 and
Cd 131. Sequence characteristics like a reiterated nucleotide sequence of two to eight base
pairs (CAG in this case) separated by a few nucleotides appear to be involved in causation of
nearly all small deletions (Bunn and Forget 1986).
Uncharacterized thalassaemia mutations:
In this study six subjects with apparent transfusion dependent thalassaemia were found to have
only one mutation in the 13-globin gene. All of these patients were heterozygous for a typical
13-thalassaemia mutation, the second mutation could not be identified in the j3-globin gene. In
these patients there may be an unidentified mutation in another gene located elsewhere in the
genome which is important in 3-globin gene expression (Kazazian et a!, 1990) or the mutation
could be in the Locus Control Region (LCR) of the 13-gene cluster (Cao et al, 1994). Co-
inheritance of triplicate ct-globin gene can also be a cause for transfusion dependency in these
patients (Garewal et al, 1984). Lastly, these patients might have some other haematological
abnormality e.g. congenital dyserythropoietic anaemia, pure red cell aplasia, or congenital
sideroblastic anaemia which caused transfusion dependency and heterozygous 13-thalassaemia
could just be an incidental finding.
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Screening strategy for prenatal diagnosis:
The objective of studying thalassaemia mutations is to carryout its prenatal diagnosis.
Knowledge of the frequency of mutations in the target population is necessary for identifying
the mutation(s) in at risk couples rapidly and efficiently. This study provides a comprehensive
picture of the common, uncommon and rare 13-thalassaemia mutations in the major ethnic
groups of Pakistan. There is considerable heterogeneity within each ethnic group and the
frequency of various mutations varies considerably between ethnic groups. However, in all
groups up to five mutations account for over 80% of the alleles. Therefore the appropriate
strategy is to first screen for the five commonest mutations in the ethnic group of the couple.
The vast majority will be assigned a mutation at this stage. In the second round, if required,
uncommon mutations may be sought and the rare mutations examined at the end.
The results of this study show that 79% of thalassaemia major patients had consanguineous
parents and 88% of couples who were first cousins had identical mutations. This frequency
declined to 58% for the more distantly related parents and to 43% for the unrelated parents.
This can be very helpful for rapid identification of mutations in the consanguineous at risk
couples.
ARMS is the ideal method for mutation analysis in a Pakistani setting. It is quick, efficient and
there are minimum chances of a false positive or negative result provided necessary
precautions are taken. DGGE can be used when an unknown mutation is encountered. In a
very small proportion of couples who might have uncharacterized mutations Restriction
Fragment Length Polymorphism (RFLP) can be used as a backup support for prenatal
diagnosis (Varawalla et al, 1992).
Thalassaemia Intermedia:
Thalassaemia intermedia is a form of homozygous thalassaemia in which affected children can
survive without transfusions or with only intermittent transfusions at least in the first few years
of life (Lukens 1993). The main phenotypic determinant in a typical case of 3-thaIassaemia
major is the degree of globin chain imbalance (Weatherall et at, 1989). Any factor that tends to
ameliorate the chain imbalance would also influence the clinical outcome. At least three well
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defined molecular mechanisms including mild 13-thalassaemia mutations (Huisman 1990;
Meloni et al, 1992), coincidence of cx-thalassaemia (Wainscoat et al, 1983), and enhanced
production of y-globin chains (Them et al, 1987) can lead to a thalassaemia intermedia
phenotype. The modifying factors may be present independently or in combination in one
patient (Ratip et a!, 1997). Coincident ct-thalassaemia reduces the chain imbalance by lowering
the a-chain output, 13k-mutations act by minimally reducing the output of 3-globin gene, and
increased production of y-chains results in improvement of the imbalance between a and non-
a chains (Cao et al, 1994).
Diagnosis of thalassaemia intermedia is mostly retrospective. However knowledge about its
molecular basis can help in prospective diagnosis at an early stage (Cao et al, 1994). The
information about thalassaemia intermedia in subjects from the Indian subcontinent is scanty
(Them Ct al, 1988). This study initiates an analysis of the molecular basis of thalassaemia
intermedia in Pakistani patients. The results indicate that the clinical outcome may be
determined by the underlying molecular basis. The least severe clinical picture was associated
with coincident a-thalassaemia (-a37a1-a37a). Coincidence of single gene deletion (-
a37riiaa) had no effect on the phenotype unless it was associated with a mild mutation
(Gringras et al, 1994). f3-mutations alone had minimal effect on the phenotype and Xmn-I +1+
genotype caused phenotypic effects that were in between the other two mechanisms. The
results also suggest that the molecular basis of thalassaemia intermedia and therefore the
clinical picture also vary considerably in the ethnic groups. In Punjabis, for example, Xmn-I
+1+ genotype and in Pathans mild f3-thalassaemia mutations like Cap+1 are important causes.
In Sindhis, Baluchis and Mohajirs, coincident a-thalassaemia may be an important factor.
Studies in Sickle cell disease (SS) and 13-thalassaemia heterozygotes have shown that A-T
polymorphism at position -158 relative to G Cap site (recognized by Xmn-I) is associated with 3-
11 fold increase in production per Gyglobjn gene (Gilman and Huisman 1985). The Xmn-I +1+
genotype acts by increasing the output of Gy..globjn gene in patients of homozygous f3-
tha!assaemia. The beneficial effect of Xmn-I -1+ genotype, however, is not well defined.
Winichagoon et al, (1993) have shown that 
-1+ genotype does not affect the phenotype.
Whereas a study from Azerbaijan suggests that even Xmn-I 
-1+ genotype may alter the
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phenotype (Dr. M. Petrou personal communication). The patients of homozygous 13
-thalassaemia with Xmn-I +1+ genotype usually have a thalassaeniia intermedia phenotype because
excessive y-chains combine with free a-chains and results in increased production of Hb-F and
lessening of dyserythropoiesis. The prevalence of Xmn-I polymorphism appears to vary between
different populations. In the Mediterranean. for example, a +1+ geneotype is very uncommon
(Gringras et a!, 1994, Ratip et at, 1997). On the contrary it is quite frequent in the Asian Indians
(Them et a!, 1987; present study) and the Southeast Asians (Winichagoon et a!, 1993).
The study of associaüonbetween Xmn-I "+" site and 13-thalassaemia mutations is not large enough to
draw firm conclusions. But the results give some indication that at least four mutations i.e. IVSI-5
(G-C), IVSI- 1 (G-T), IVSIT- I (G-A) and Cd 30 (G-C) are more frequently associated with a
site than the other mutations. f3-thalassaemia mutations are thought to have arisen in a relatively
recent past on globin gene frameworks that are common in each population. The frequent finding
of the same mutation linked to a "-" as well as a "+" site may be explained by recurrent mutations
on different backgrounds, or multiple meiotic recombination events (Antonarakis et at, 1985).
Multiple origin for JVSI-5 (G-C) is also supported by frequent finding of this mutation on several
different globin gene haplotypes (Varawalla et al, 1992).
The frequency of 13-thalassaemia mutations in patients of thalassaemia intermedia were different
from thalassaemia major. In the former group milder mutations were over represented. There are
also differences in the frequency of mutations between younger and older patients of thalassaemia
major. Severe 13-thatassaemia mutations are likely to' associated with more sever disease and
therefore eliminated in the early years of life. Converse is true for the mild mutations. This
highlights the difficulty in obtaining the true population frequencies of thalassaemia mutations.
Representation form all age groups can minimize the selection bias due to age.
151
I7 
Prenatal diagnosis of thalassaemia
Introduction:
At present a regular service for prenatal diagnosis of thalassaemia does not exist in any
Muslim country. Consequently, the response of a Muslim community to the availability of
prenatal diagnosis is largely unknown. A service for prenatal diagnosis was introduced for
the first time in Pakistan in May 1994. This chapter describes the process of introducing
the service and the response of the affected families to the availability of this facility in
Pakistan. The study period extended from May 1994 to July 1996.
Methods:
Initial preparation:
The service for prenatal diagnosis of thalassaemia was introduced after initial preparation
of training and establishment of DNA laboratory facilities, training of an obstetrician in
fetal sampling, and consultation with the religious scholars on termination of pregnancy
for a genetic disorder. After initial preparation the facility was advertised for the at risk
couples.
Training and establishment of laboratory facilities:
I was trained at the Perinatal Centre, Department of Obstetrics and Gynaecology,
University College Hospital, London. The training involved analysis of DNA samples
from thalassaemia patients collected in Pakistan. At the end of six months training from
July to December 1993 information on the pattern of mutations in the ethnic groups of
Pakistan was also available.
The necessary hardware and consumables for PCR based analysis of thalassaemia
mutations were procured from the UK. On my return back to Pakistan, in January 1994, I
established a DNA laboratory at the Department of Haematology, Armed Forces Institute
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of Pathology (AFIP) Rawalpindi. The laboratory was completely ftinctional by March
1994.
Training of obstetrician:
In April 1994 I came to know that Dr. Yasmeen Raashid, a female consultant obstetrician
at Lady Wellington Hospital Lahore, had training in Chorionic Villus Sampling (CVS).
Dr. Raashid had worked under the supervision of Dr. Gerald Mason, Fetomaternal
Consultant, Leeds General Infirmary. She could do CVS by the transabdominal placental
aspiration technique. Due to the availability of the obstetrician it became possible to offer
prenatal diagnostic service. At the same time an experienced female obstetrician (Dr.
Nadra Sultana) from the Military Hospital, Rawalpindi was also sent for training in CVS
to the Department of Obstetrics and Gynaecology, University College Hospital, London.
She had training for three months under the supervision of Prof. C. H. Rodeck and on her
return to Pakistan in August 1994 she started doing CVSs at AFIP. Dr. Sultana was
trained in using CVS biopsy forceps by the transabdominal route.
Consultation with religious scholars:
During the initial preparation I had personal communications with two of the renowned
religious scholars regarding Islam's view point on termination of pregnancy for a serious
genetic abnormality. A persona! meeting with Dr. Malik Ghulam Murtaza was arranged at
Lahore. Dr. Murtaza was of the opinion that termination of pregnancy is permissible for
thalassaemia if carried out before 120 days of gestation. The other scholar, Mohammad
Taqi Othmani, was approached through a letter. The reply by Mr. Othmani (Appendix-A)
stated that Islam permits termination of pregnancy for a genetic disorder provided (1) the
diagnosis is made by an honest person (2) severe nature of the disorder is confirmed (3)
termination of pregnancy is carried out before 120 days of gestation. He clearly prohibited
termination after 120 days even if the fetus is affected by a serious genetic abnormality.
He considered termination after 120 days like killing an affected child.
Advertisement:
After establishing the laboratory facilities, completing arrangements for CVS and
obtaining the opinion of religious scholars on termination of pregnancy, the service was
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advertised. Most of the thalassaemics in Pakistan are treated at Fatimid Foundation
thalassaemia centres, in Karachi, Multan, Lahore and Peshawar. Another NGO has its
treatment centre in Rawalpindi. This provides an easy way of communicating with the
affected families. The administration and the medical staff of the two charity organizations
were informed about the availability of prenatal diagnosis. They in turn started
communicating the information to the affected families. Instruction booklets written in
"Urdu" the local language, were also provided for distribution to the affected families.
The service was also advertised in the newspapers. A few programmes about the
significance of prenatal diagnosis were also broadcasted on Pakistan Television Network.
Booking a couple for prenatal diagnosis:
The couples from Lahore and its surrounding areas reported at the obstetrics out patient
clinic of Lady Wellington Hospital, Lahore and those from Rawalpindi and its
surroundings reported at the Department of Haematology, Armed Forces Institute of
Pathology, Rawalpindi. At the time of booking, the complete procedure of prenatal
diagnosis its associated risks and the chances of error in diagnosis were fully explained.
The chances of having an affected or unaffected child and the possibility of termination of
pregnancy was also discussed. The ethnic group, parental consanguinity and the source
from where the couple came to know about prenatal diagnosis was noted. The gestation
of the pregnancy and the position of placenta were ascertained by ultrasound examination
and the date of CVS was booked. Information about the socio-economic status,
educational status, number of children, psychosocial burden and financial burden of
thalassaemia was also recorded on a pre-designed questionnaire (Appendix-B). This was
done with a view of identifying the type of couples who requested prenatal diagnosis.
Blood samples (3-5 nil) from the parents and an affected child, if available, were collected
in EDTA containers. The couples examined at Lahore were mostly sampled at the time of
CVS and the samples were despatched to AFIP for further analysis. In 7/158 (4.4%)
couples the husband's sample could not be obtained because of their non-availability (5)
or lack of interest (2).
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Chorionic Villus Sampling:
Dr. Yasmeen Raashid did sampling at Lady Wellington Hospital, Lahore by a free hand
transabdominal ultrasound guided aspiration technique (Brambati et al, 1988). Dr. Nadra
Sultana did CVSs at AFIP, Rawalpindi by transabdominal biopsy forceps (Rodeck and
Nicolini 1989). Most of the CVSs done at Lahore were collected in culture medium
(RPMI- 1640) and were transported to AFIP in ice within 24 hours. The samples were
usually transported by the father or a close relative of the couple. When a person was not
available to carry the samples or when the CVS was done before a closed holiday, a delay
of up to 36 hours was encountered. Due to a short supply of RPMI-1640, ten CVSs
performed at Lahore were collected and transported in normal saline. The samples
obtained at AFIP were collected in normal saline and were processed without delay.
Mutation analysis of the parents:
Haematological diagnosis was available in only a few couples who requested prenatal
diagnosis. Therefore prior to mutation analysis red cell indices were routinely done in all
couples. Low MCV and MCH suggested thalassaemia trait whereas normal indices
indicated either incorrect diagnosis or a silent 3-tha1assaemia mutation (Cap+1).
In the first round of mutation analysis the five most common mutations found in the ethnic
group of the couple were tested. If the first round did not identify a mutation the second
round of ARMS was done to screen for the uncommon mutations. The rare mutations
were screened when the first two rounds failed to identify the mutation. In the last ten
couples of the study, a multiplex ARMS PCR was also done. Three multiplex primer
combinations were used to test each couple.
Where the father's DNA was not available, DNA from the affected child was used to
characterize the father's mutation. The child's sample was tested in the usual way and
when a mutation was found its normal allele was checked. The absence of a normal allele
indicated that the father and the mother had the same mutation. If the affected child
showed the normal allele the sample was further tested for other mutations.
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Fetal diagnosis:
CVS is often contaminated with maternal decidua. Careful dissection under a microscope
is essential to remove the maternal tissue (Cao and Rosatelli 1993). A stereo zoom
microscope was used to clean the CVS. Branched and highly vascular villus structures
were easily identified as compared to the more solid looking and much less vascular
pieces of maternal decidua.
Mutation analysis:
Fetal diagnosis was accomplished by putting up ten ARMS reactions i.e. one for each
parent, CVS in duplicate for the parent's mutation, one negative control for the parent's
mutation, CVS in duplicate for the normal allele of the parent's mutation, negative and
positive controls for the normal allele of the parent's mutations, and a reagent blank.
Linkage analysis:
When one or both mutations in the couple could not be identified by ARMS, diagnosis
was done by linkage analysis. Six polymorphic sites closely linked to the 3-globin gene
were used as linkage markers.
Assessment of maternal contamination:
Maternal contamination was assessed in the first 10 CVSs by carrying out Apo-B VNTR
analysis of the parents and the fetus (Rosatelli et al, I 992a). Although it would be
preferable to do this on all samples to rule out maternal contamination as well as non-
paternity, the cost must also be taken into account when applying this to a country such as
Pakistan. Therefore in order to cut down the cost, this practice was discontinued and
\NTR analysis was done only when difficulty was encountered in separating the maternal
and the fetal tissues.
Follow-up:
The record of termination of pregnancy, complications of pregnancy, and postnatal out
come following prenatal diagnosis was maintained in as many cases as was possible.
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Response of the affected families to prenatal diagnosis:
At the end of the study, randomly selected 141 couples who visited Fatimid Thalassaemia
Centre, Lahore for treatment of their children were interviewed to find out their response
to the availability of prenatal diagnosis. The couples served as control for comparison
with those who requested prenatal diagnosis. The response of the couples was recorded
on a pre-designed questionnaire (Appendix-B) that included knowledge about the
availability of prenatal diagnosis, any pregnancy after the availability of prenatal diagnosis,
request for prenatal diagnosis in pregnancy (if any), request for prenatal diagnosis in
future pregnancies and attitude towards termination of pregnancy.
Results:
Within 2-3 weeks from the announcement of the service the first couple came forward
with a request for prenatal diagnosis. Several other couples who were avoiding a
pregnancy came for counselling and information about the test. Thereafter the couples
appeared at regular intervals and a steady increase in the number of requests for prenatal
diagnosis was observed. During the two years of the study a total of 158 couples
requested prenatal diagnosis. This included 118 (74.7%) Punjabi, 30 (19%) Pathan, 4
(2.5%) Baluchi, 4 (2.5%) Mohajir and 2 (1.3%) Sindhi couples. Fig: 7.1 shows the
number of couples who requested prenatal diagnosis in each quarter of the year. The
distribution of the couples according to the place of origin is presented in Fig: 7.2.
Almost all of the couples were informed about prenatal diagnosis by their doctors. Table:
7.1 gives a summary of the medium of information for the couples who requested prenatal
diagnosis. A significant proportion (2 1%) was inspired by the experience of other couples
who already had used prenatal diagnosis and many of whom had normal children due to
the test. In 31% of the couples one member, usually the mother, had watched a
programme on television. The information booklets had either not been delivered to all
couples or many were not able to read because of illiteracy. Only two couples came with a
request for prenatal diagnosis after having read the information booklet alone.
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Table: 7.1. The medium of information for the couples who requested prenatal
diagnosis.
Informed by:	 Number:	 Percent:
Treating doctor	 153/158	 96.8%
Television	 45	 28.5%
Other parents who had used prenatal diagnosis 	 33	 20.9%
Information booklet 	 2	 1.3%
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Fig: 7.1. The number of CVSs done for prenatal diagnosis of thalassaemia in the two
study years.
Characteristics of the couples who requested prenatal diagnosis:
The characteristics of couples who requested prenatal diagnosis (cases) were compared
with the randomly interviewed couples (controls) and the comparison was as follows:
Socio-economic status:
There were significantly more couples in the high socio-economic group (Table: 7.2) who
requested prenatal diagnosis (p =O. 0126).
Educational standard:
The educational standard of the couples who requested prenatal diagnosis was better as
compared to the controls (Table: 7.3).
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Fig: 7.2. Area wise distribution of 158 couples who requested prenatal diagnosis. Most of
the couples came from areas in and around Lahore and Rawalpindi.
Number of children:
Only 2/158 (1.3%) couples who requested prenatal diagnosis did not have an affected
child before the test. In one couple the father was a laboratory technician and therefore
was well informed of thalassaemia. In the other couple the mother was a doctor who had
an affected first cousin. Comparison between the two groups of couples (Fig: 7.3)
showed a near normal distribution of the number of children in the controls. Whereas the
distribution was markedly skewed towards the left in the couples who requested prenatal
diagnosis. This was mainly due to the younger age group of the couples who requested
prenatal diagnosis.
Effect of thalassaemia on family life:
The family life of 69% of the couples who requested prenatal diagnosis was affected a lot
due to thalassaemia as compared to 83% in the controls (Table: 7.4).
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Financial burden of thalassaemia:
There was a significant differences in the number of couples in the high income group
between the cases and the controls (Table: 7.5). Financial burden of thalassaemia was also
significantly different (Table: 7.6). Severe burden was felt by 58% of the couples who
requested prenatal diagnosis as compared to 32% in the control group (p=<0.00I).
Table: 7.2. Comparison of the socio-economic status of the group of couples who
requested prenatal diagnosis and the controls. _________________
Socio-economic status:	 Low:	 Middle:	 High:
Cases (n=158)	 99 (62.7%)	 38 (24.1%)	 21 (13.3%)
Controls (n=141)	 110(78.0%)	 25 (17.7%)	 6(4.3%)
p:	 0.224	 0.279	 0.0126
Table: 7.3. Comparison between the educational standard of the group of couples who
requested prenatal diagnosis and the controls.
Education:	 None	 Primary	 Matric*	 Above matric
Father's education:
Cases (n158)	 12 (7.6%)	 32 (20.3%)	 43 (27.2%)	 71(44.9%)
Controls (n=141)	 35 (24.8%)	 29 (20.6%)	 39 (27.7%)	 38 (27.0%)
p.	 0.0005	 0.956	 0.948	 0.0267
Mother's education:
Cases (n=158)	 36 (22.8%)	 54 (34.2%)	 36 (22.8%)	 32 (20.6%)
Controls (n141)
	 61(43.3%)
	 45(31.9%)	 19(13.5%)	 16(11.3%)
0.0071	 0.768	 0.084	 0.074
matnc is an eaucauonai stanciarci that is equivalent to U-levels.
Table: 7.4. Comparison of the effect of thalassaemia on the family life of couples who
requested prenatal diagnosis and the controls.
Effect on family life:
	 A little:	 Often:	 A lot:
Cases (n=158)	 10 (6.3%)	 39 (24.7%)	 109 (69.0%)
Controls (n=141)
	 2 (1.4%)	 22 (15.6%)	 117 (82.9%)
0.038	 0.112	 0.295
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Table: 7.5. Comparison of the monthly income of the couples who requested prenatal
diagnosis and the controls.
Monthly income (Rs): 	 <5,000:	 5,000-10,000:	 > 10,000:
Cases (n158)	 99(62.6%)	 38(24.1%)	 21 (13.3%)
Controls (n=141)	 108 (76.6%)	 27 (19.1%)	 6(4.3%)
p..	 0.267	 0.410	 0.0126
Table: 7.6. Comparison of the effect of thalassaemia on the financial situation of the
couples who requested prenatal diagnosis and the controls.
Effect on financial	 A little:	 Often:	 A lot:
Situation:	 _________________ _________________ _______________
Cases (n=158)	 19 (12.0%)	 47 (29.7%)	 92 (58.2%)
Controls (n=141)	 48 (34.0%)	 54 (38.3%)	 39 (27.7%)
p..	 <0.001	 0.272	 <0.001
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Fig: 7.3. Comparison of the number of children in the couples who requested prenatal
diagnosis and the control group. The distribution in the control group is near normal
whereas in the couples who requested prenatal diagnosis the distribution is markedly
skewed towards the left. The data is presented as percent of the actual number of couples
in each group.
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Fetal diagnosis:
Chorionic Villus Sampling:
Out of 158 couples who requested prenatal diagnosis 9 (5.7%) used it twice and one
couple used it three times. Seven couples who requested prenatal diagnosis more than
once, had a previous diagnosis of an affected fetus. A total of 169 CVSs were done that
included 148 for the couples who requested the test once, 18 for the couples who
requested it twice and 3 for a couple who requested it thrice. There were 161 single
pregnancies and four twin pregnancies. Of 169 CVSs 89 (53%) were done at Lahore and
the remaining 80 (47%) were done at AFIP, Rawalpindi. Most of the CVSs were done
between 10 and 16 weeks of gestation (Fig: 7.4). Only 11/169(6.5%) were done after 16
weeks and two were done after 18 weeks. In 8 cases CVS was repeated because either
the first attempt was not successful or the sample obtained was inadequate. Five of the
later CVSs were done at AFIP by a CVS biopsy forceps, while the other three were done
at Lahore where the placental aspiration technique was used.
10	 11	 12	 13	 14	 15	 16	 17	 18	 19	 20	 21	 22
Number of weeks at CVS
Fig: 7.4. The number of weeks of gestation in 169 CVSs carried out at Lahore and
Rawalpindi.
Mutation analysis in the parents:
Measurement of red cell indices prior to mutation analysis was found to be useful. In one
couple it indicated an incorrect diagnosis of thalassaemia. This was later confirmed by Hb-
A2
 estimation. Bone marrow aspiration of the affected child showed the features of
congenital dyserythropoietic anaemia. The couple was excluded from the study as CVS
had not yet been carried out. In nine couples one of the parents had either completely
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normal or borderline red cell indices. Five of these had Cap+1 mutation and the remaining
four, who had borderline red cell indices had a severe -thalassaemia mutation.
Standard ARMS PCR.
The five common mutations accounted for 257/3 16 (8 1.3%) of the alleles (Table: 7.7).
After the first round of PCR both members were assigned a mutation in 115/158 (72.8%)
couples. In the second round of PCR another 54 (17%) of the alleles were identified and
153/1 58 (96.8%) of the couples were assigned mutations. After the final round of PCR
313/316 (99.1%) of the alleles were identified and 155/158 (98.1%) couples were
completely assigned their mutations. In two of the remaining three couples only one
parent and in the third couple both parent's mutations could not be characterized. In the
first couple sequencing done at a later stage showed -. 88 (C-T) mutation and in the second
couple sequencing of the entire p3-gene failed to reveal a mutation. The sample from the
third couple awaits sequencing.
Multiplex ARMS PCR.
The multiplex ARMS PCR proved to be technically feasible for mutation detection in all
of the couples tested (Fig: 7.5). The results of multiplex and standard ARMS PCR were
in complete agreement. However, the problem of false positive results with the primers
described in Chapter: 3 became more pronounced because of the sensitivity of silver
staining method. This was overcome by taking precautions already described and by
loading only 1-2 jtl of the amplified product on the gel. The method was quick and the
addition of many different primers, that can be a potential source of error if addition of a
primer is omitted were simplified. The polyacrylamide gels as compared to the agarose
gels were more difficult to prepare and handle. The main advantage was the use of only
six reactions per couple that could screen over 97% of the mutations. This saved a
substantial amount of time and money.
Analysis of mutations in the fetal DNA:
While testing the fetal DNA parental samples were included to reconfirm the findings of
initial screening. This was essential to prevent clerical mistakes. Negative and positive
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controls were also included to safeguard against technical errors. The presence of the
parental mutation and the absence of its normal allele in the test sample indicated a
homozygous fetus (Fig: 7.6a). The presence of mutant and the normal alleles indicated a
heterozygous fetus, a normal allele but no mutation indicated a normal fetus. In cases
where both the parents had different mutations and both were also present in the fetal
sample, a diagnosis of an affected fetus was made. Similarly, the presence of one of the
mutations indicated a heterozygous fetus.
Linkage analysis:
In three couples where one or both of the mutations remained uncharacterized after
screening with the ARMS had linkage analysis done. In two couples one mutation was
known and the same mutation was also present in the fetal DNA. Linkage analysis in
these couples was done as even partially informative markers were also helpful. In the
third couple both mutations remained uncharacterized,, for diagnosis a polymorphism at
5'ji3 was informative and antenatal diagnosis was successfully accomplished (Fig: 7.6b).
Results of fetal diagnosis:
In the 169 fetuses (CVSs) diagnosed, 43 (25.4%) were affected (homozygous/compound
heterozygous), 44 (26.0%) were normal, and 82 (48.5%) were heterozygous for
thalassaemia.
Maternal contamination:
VNTR analysis in the first ten CVSs ruled out maternal contamination. Experience in the
first ten CVSs showed that meticulous cleaning of the CVS is enough to safeguard against
maternal contamination.
Time frame of prenatal diagnosis:
The usual time taken for a prenatal diagnosis varied between one day to one week. In
couples where mutation analysis had previously been done, the CVS results were usually
available the following day. The results were considerably delayed where CVS was done
on the same day as blood was collected. Linkage based diagnosis took up to one week.
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Table: 7.7. Characterization of 3-thalassaemia mutations by ARMS in 158 couples who
reauested Drenatal diagnosis.
ARMSPCR:	 Results:	 _________________
Round:	 Mutations screened:	 Noof alleles detected:	 No of couples resolved:
Fr 8-9	 257/316 (8 1.3%)	 115/158 (72.8%)
IVSI-5 (G-C)
Fr 41-42 (-TFCT)
IVSI-1 (G-T)
Del619 bp	 _______________________ ______________________
2	 Cd5(-CT)	 54/316(17.1%)	 153/158(96.8%)
Cd 30 (G-C)
Cd 30 (G-A)
Cd 15 (G-A)
Fr 16 (-C)
Cap +1 (A-C)
IVSII-1 (G-A)	 _________________ ________________
3'	 Hb-E	 2 (0.6%)	 155/158 (98.1%)
IVSI minus 25 (-25bp)
Fr 47-48 (+ATCT)
IVSI-1 (G-A)
Cd39 (C-T)	 _______________ _______________
-	 Uncharacterized mutations: 	 3 (09	 -
Total:	 313/3 16 (99.1%)	 155/158 (98.1%)
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Fig: 7.5. Silver stained polyacrylamide gel electrophoresis of multiplex ARMS PCR for
13-thalassaemia mutations. Lane-i and 5 show allelic ladders for AD-2 and AD-I
respectively. Lane 2, 3, and 4 show AD-2 multiplex reactions positive for Fr 16, Cd 30,
and Cd 5 respectively. Lanes 6, 7, and 8 show AD-i multiplex reactions positive for del
619, IVSI-5, and Fr 4i-42 respectively. Control bands of 861 bp are visible in all lanes
except lane 6 where it indicates homozygous del 619.
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Fig: 7.6a. Ethidium bromide stained agarose gel electrophoresis of a standard ARMS
PCR for prenatal diagnosis of thalassaemia. All lanes show 861bp control bands. Lanes 1-
4 show 285 bp bands of IVSI-5. Lane 1 and 2 contain parent's samples while lane 3-4
contain fetal DNA in duplicate. Lane 5 is a negative control for IVSI-5. Lanes 6-7 show
absence of bands for the normal allele of IVSI-5 in the fetal DNA. Lane 8 and 9 are
positive and negative controls for the normal allele of IVSI-5. The results indicate a
homozygous fetus.
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Fig: 7.6b. Prenatal diagnosis by linkage analysis at the S 'N43 polymorphism. Figure shows
the Hinc-Il digest of the PCR amplified fragments after electrophoresis on agarose gel.
Lane 1: father (-1+), Lane 2: mother (-1+), lane 3: affected child (+1+) and lane 4 & 5:
CVS (-I-). The findings suggest that thalassaemia mutation is linked to "+" site and the
CVS is "Normal".
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Follow-up:
Complete follow-up was possible in 117/158 couples the rest were lost to follow-up.
Complications of CVS:
In 78 pregnancies that were not terminated and were available for follow-up, 7 (8.9%)
spontaneously terminated within 2 weeks following a CVS. The complications occurred in
3/37 (8.1%) and 4/41 (9.7%) at the centres in Lahore and Rawalpindi respectively. The
miscarriages at Lahore occurred during the first 20 CVSs whereas at Rawalpindi these
were evenly spread over the entire study period.
Termination ofpregnancy:
Out of 43 women diagnosed with an affected fetus, 42 were available for follow-up and
all but three (93%) terminated their pregnancy. In 32/39 (82%) cases termination was
done before 15 weeks of gestation (Fig: 7.7). In three cases termination was done at or
after 17 weeks (17, 18 and 21 weeks). Three couples did not terminate pregnancy due to
religious reasons. In all three the CVS was carried out between 13 and 14 weeks of
gestation and the results were conveyed within one week of the test. These couples felt
that the pregnancy was far too advanced to terminate. In a twin pregnancy one fetus was
affected and the other was normal, as selective termination could not be carried out, the
parents requested termination of pregnancy. It was not possible to access most of the
terminated fetuses, but in two fetuses referred for DNA analysis the diagnosis of
homozygous thalassaemia was reconfirmed.
Post natal outcome:
Sixty two children born after prenatal diagnosis of "normal" or "trait" were available for
follow-up. Twenty five children were brought to AFIP for reconfirmation of prenatal
diagnosis. In the remaining children reconfirmation of diagnosis was not possible as the
couples had come from far off places. Prenatal diagnosis was reconfirmed in 25 children
by Hb-A2
 or DNA analysis. In 3/37 couples that were contacted by letter informed that
the child was tested at a local laboratory and the prenatal diagnosis was correct. The
remaining 34 children were found to be apparently healthy and none required blood
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transfusions. The laboratory reconfirmation of diagnosis in these children was not done.
Since the introduction of prenatal diagnosis no misdiagnosis has been reported. None of
the children born after CVS had any apparent congenital malformation. Three couples
with a fetal diagnosis of thalassaemia major refused termination of pregnancy. One of the
couples was lost to follow up. The other two children have transfusion dependent
thalassaemia major.
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Fig: 7.7. The response of the couples to termination of pregnancy after fetal diagnosis of
thalassaemia major.
Response of the families to prenatal diagnosis:
Knowledge about the availability ofprenaial diagnosis:
Out of 141 randomly interviewed couples, 101 (72%) knew the test was available in
Pakistan. Three couples had no interest in prenatal diagnosis because they had already
completed their families. The remaining 38 (27%) were completely ignorant about the test
facility.
Attitude towards prenatal diagnosis:
During the period when prenatal diagnosis was available 62 couples had a pregnancy.
Two women (3.1%) aborted spontaneously prior to prenatal diagnosis. Twenty five of the
remaining 60 couples (41 .6%) were either not aware of the test or came to know about it
very late and therefore did not request prenatal diagnosis. There were 3/60 (5%) couples
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who were not aware of their risk because they did not have an affected child. In 32
couples who had a pregnancy and were aware of the test facility, 16 (5 0%) requested it
and another two were waiting to use the test (Table: 7.8). Two couples preferred to
terminate the pregnancy rather than use prenatal diagnosis. Twelve out of 32 (37.5%)
couples knew about prenatal diagnosis at the time of pregnancy but did not use it due to
reasons given in Table: 7.9. Six couples had no clear explanation for refusing prenatal
diagnosis, two couples avoided the test due to cost and in another two the mothers were
afraid of the test. There was a serious disagreement between the parents in two couples
i.e. one favoured the test and the other did not.
Response of the couples to the possibility of prenatal diagnosis in a future pregnancy
showed that 29 (20.6%) had completed their families. In the remaining 112 couples, 102
(9 1%) were in favour of prenatal diagnosis, and six (5.4%) were not sure. Only 4/112
couples (3.6%) were not in favour of prenatal diagnosis. Of the 102 couples who
favoured prenatal diagnosis, 75 (73.5%) would request it unconditionally, but 27 (26.5%)
would request it if it were free of cost. Most of the later 27 couples (93%) were from the
low income group.
Attitude towards termination ofpregnancy:
When questioned, 124/141 (87.4%) couples felt they would terminate an affected fetus.
Only 2% had a negative attitude towards termination of pregnancy (Fig: 7.8).
Table: 7.8. Response to prenatal diagnosis of 32 couples who had a pregnancy and were
also aware of the test facility.
Response:	 Number (%):
Requested prenatal diagnosis
	 16/32 (5 0%)
Preparing to request prenatal diagnosis
	 2/32 (6.3%)
Did not request prenatal diagnosis
	 12/32 (37.5%)
Terminated pregnancy prior to prenatal diagnosis
	 2/32 (6.3%)
Total	 32 (100%)
169
Table: 7.9. Reasons for not requesting prenatal diagnosis in 12 couples who had a
pregnancy and also knew that the test was available.
88%	 2%
DYes	 1 Not sure
	
•No
Fig: 7.8. Attitude of the randomly interviewed thalassaemic couples towards termination
of pregnancy.
Discussion:
Technical feasibility:
The first step in fetal diagnosis is the analysis of parent's mutations. In this study direct
mutation analysis was possible in over 98% of the couples. This makes it the method of
choice for fetal diagnosis in most cases. The procedure is quick and reliable and is also
cost effective. The multiplex ARMS can further reduce the time required in mutation
analysis from two days to just one day. Similarly, the cost of mutation analysis per person
can also be reduced considerably (Rs. 500 ($12.5) instead of Rs. 800 ($20); Chapter: 8).
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It is important to ascertain the correct diagnosis of thalassaemia before mutation analysis
is done. Thalassaemia is the commonest cause of transfusion dependent anaemia in
Pakistan. Experience at AFIP shows that congenital dyserythropoietic anaemia (CDA), an
autosomal recessive disorder, is the next most common cause of transfusion dependency
(unpublished observation). Both the disorders have similar clinical picture. Therefore it is
likely that a small proportion of patients having transfusions in Pakistan may actually be
suffering from CDA. It may be useful to screen the couples who request prenatal
diagnosis by red cell indices as it can help in differentiating between thalassaemia and
other causes of transfusion dependency.
Chorionic villus sampling is the best approach for fetal sampling because it can be done in
the first trimester of pregnancy and the associated risk of miscarriage is also less than 1%
(Centre for Disease Control and Prevention, Atlanta 1995). The results of this study
indicate that over 90% of Pakistani couples would request early prenatal diagnosis.
Therefore CVS is the best option for fetal sampling. Procedure related complications in
this study were high (9%). However in the early part of a new programme high
miscarriage rates are not unusual (Old et al, 1986). The use of rigid biopsy forceps is
more traumatic and may be associated with more frequent complications than aspiration
needles (Golbus and Appelman 1990). The rate of complications is also related to the
operator skill. CVS should be done at a centre where good ultrasound support is
available. The samples can be easily transported to a central DNA laboratory either in
RPMI- 1640 or even normal saline.
CVS is often contaminated by maternal decidua and its meticulous cleaning is essential
(Cao and Rosatelli 1993). VNTR analysis can rule out maternal contamination (Rosatelli
et al, 1992a). This also safeguards against errors due to non-paternity, in this study
financial constraints precluded VNTR analysis in most of the cases and meticulous
cleaning of the CVS had to be accepted as adequate in the local circumstances.
In this study fetal diagnosis was possible by direct mutation analysis in over 98% of the
couples. In the remaining couples it was possible to use RFLP as backup support.
Inclusion of appropriate controls and reagent blanks (Kwok and Higuchi 1989) increased
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the confidence in accuracy of diagnosis. The follow-up in 62 children born after a prenatal
diagnosis indicates that the method is accurate and reliable for large-scale application.
Response of the couples to prenatal diagnosis:
Almost all of the couples in this study were retrospectively identified and they had at least
one affected child. Their response to the availability of the test and to termination of
pregnancy was very good. The couples who requested prenatal diagnosis mostly had
small families, better education and higher socio-economic status. The response of the
randomly interviewed at risk couples showed that the majority (72%) knew about the test
and over half of the couples also had a positive attitude towards it. Careless attitude and
the cost of the test were seen as the main reasons for avoiding the test. Sustained efforts
at counselling the at risk couples can substantially improve the attitude of the couples.
Subsidizing the cost of the test can also improve the acceptance rate for prenatal
diagnosis especially amongst the low socio-economic group of couples.
Prenatal diagnosis and termination of pregnancy:
The community would accept the concept of prenatal diagnosis if it is compatible with the
religious and cultural beliefs. Two renowned religious scholars in Pakistan, when asked to
give opinion on permissibility of prenatal diagnosis and termination of pregnancy for
thalassaemia gave a verdict in its favour provided the termination is carried out before 120
days (17 weeks) of gestation. The couples who were reluctant to use prenatal diagnosis
were greatly relieved to learn that terminating a pregnancy is permissible under special
circumstances. Most of the couples who requested prenatal diagnosis in this study had
little hesitation in terminating an affected pregnancy. Only 3/42 (7%) couples refused
termination and all three did so on religious grounds. A high rate of acceptance of
termination may be because only a selected group of couples, who were prepared to
accept termination of pregnancy, requested the test. However most of the prospectively
interviewed couples (87% in this study) would terminate an affected fetus.
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8 Cost and benefit of thalassaemia prevention
Introduction:
An important element in programme development is analysis of the cost and benefit of
different approaches. There is good evidence that implementing policies for prevention of
genetic disorders leads to significant financial savings and that these are particularly marked in
case of thalassaemia (Cao 1987). Alwan and Modell (1997) have worked out the minimum
cost of treatment per patient per year and the cost of prevention of thalassaemia in the Eastern
Mediterranean Region. However, as far as Pakistan is concerned these estimates are a
theoretical exercise. The aim of this chapter is to illustrate the cost of treatment and compare it
with the cost of prevention and to show how such analysis can contribute towards the
development of appropriate policies in Pakistan.
Methods:
In order to analyze the cost effectiveness of thalassaemia prevention the following parameters
were evaluated: (1) estimated number of new births of thalassaemia major per year (N), (2)
cost of treatment (3) cost of carrier screening and (4) cost of prenatal diagnosis. The costs
were calculated in Pak Rupees. Equivalent cost in US dollars, at the rate of Rs. 40.00 per $
was also calculated.
Results:
Estimated number of thalassaemia major births per year (N):
Calculation of the annual number of thalassaemia major patients in Pakistan are discussed in
Chapter: 4. The annual birth rate of thalassaemia major is estimated at approximately 4550. In
addition births of 550 patients of a clinically significant abnormal haemoglobin with or without
thalassaemia are also expected. This number also includes approximately 200 patients of Hb-S
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and Hb-E homozygotes who do not normally require blood transfusions. The total number of
patients (N), who would require transfusions, is estimated at 4900. However, for the sake of
calculations a round figure of 5000 new cases per year is used.
Cost of treatment:
Each year a patient of thalassaemia major on an average requires 26 units of blood and
approximately 364 grams of desferal (Table: 8.1). The cost of one bag of blood (Table: 8.2) is
calculated at Rs. 1540 and the average annual cost on blood transfusions alone is estimated at
Rs. 40,000. The cost of desferal therapy per year is estimated at Rs. 116,000 (Table: 8.1). The
annual cost of investigations per patient (Table: 8.3) is estimated at Rs. 2000. The total cost of
management per patient per year (Table: 8.4) is estimated at Rs. 160,000 ($ 4000).
Cost of screening:
The cost of screening for 13-thalassaemia includes the cost of sample collection tube,
disposable syringe, testing the sample on red cell analyzer, Hb-A 2
 estimation by cellulose
acetate electrophoresis, multiplex ARMS PCR and the labour. In Chapter: 5 it was shown that
all cases do not require every investigation and the number of individuals requiring Hb-A2
estimation or DNA analysis are also different in the two groups of people studied i.e. the
pregnant women and the index families. Therefore the cost per individual would also be
different in these groups. The cost of screening 1000 pregnant women (Table: 8.5) is
calculated at Rs. 60,000 ($ 1500) and that of screening 1000 individuals from thalassaemic
families is Rs. 78,000 ($ 1950).
Table: 8.6 compares the cost of antenatal versus family screening in terms of cost per person
screened, cost per carrier detected and cost per at risk couple detected. In the antenatal set up
50 carriers per 1000 (5%) and in the families 300 carriers per 1000 (30%) are expected. The
expected number of at risk couples in the antenatal set up would be 2.5/1000 (0.25%) whereas
in the family screening it would be 6/1000 (Chapter 5 & 9). The cost per carrier as well as per
at risk couple detected is markedly different between the two groups.
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Table: 8.1. Basic annual requirement for treating one patient with thalassaemia major, related
to age. The figures for donor blood consumption are adopted from Alwan and Modell (1997).
An average dose of desferal (35 mg/kg/day) has been used for all calculations (Cao et al,
1992).	 __________ ____________ ____________________ ________________
Age group Mean	 Units of donor Desferal @35 mg/kg/day Cost @ Rs. 320
(years)	 weight (kg) blood/year *	 X 5 days a week.	 per gram.
1-5	 15	 10	 130g	 42,000
6-10	 25	 17	 230g	 74,000
11-15	 40	 27	 390g	 125,000
16-21	 55	 37	 520g	 167,000
21-25	 60	 40	 550g	 176,000
All ages:	 39	 26	 364 g
	
116,000 ($ 2900)
* at about 300 ml/kglyears: 1 unit = 450m1 donor blood
Table: 8.2. An estimate of the expenditure on preparation of one bag of blood. The prices are
based on calculation by the Armed Forces Institute of Pathology, and the Armed Forces
Institute of Transfusion, Rawalpindi, Pakistan.
. Blood bag and transfusion set:
	
Rs. 80.00
• Screening for Hepatitis B:	 Rs. 150.00
• Screening for Hepatitis C: 	 Rs. 600.00
• Screening for HIV: 	 Rs. 400.00
• Blood grouping:	 Rs. 60.00
• Cross match:	 Rs: 250.00
. Total cost:	 Rs: 1540.00 ($ 38.00)
Table: 8.3. Estimated cost of investigations per patient of thalassaemia major per year. The
investigations include those recommended by Cao et al (1992) and the prices are based on
those calculation by the Armed Forces Institute of Pathology, Rawalpindi, Pakistan.
• Haemoglobin estimation (X 24):	 Rs. 480.00
• Liver function tests (X 2): 	 Rs. 570.00
• Serum ferritin (X 2):	 Rs: 350.00
• Miscellaneous investigations:*	 Rs. 600.00
• Total:	 Rs. 2000.00 ($ 50)
* Miscellaneous investigations: thyroid function tests, growth hormone, blood sugar, ECG and Muga-I scan of
heart etc.
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Table: 8.4. Total cost of treatment for thalassaemia per patient per year.
Blood transfusions X 26 units per year (Table: 8.1 & 8.2):	 Rs. 40,000 ($ 1000)
Desferal (Table: 8.1): 	 Rs. 116,000 ($ 2900)
Investigations (Table: 8.3):
	
Rs. 2000 ($ 50)
Miscellaneous expenditures:*	 Rs. 2000 ($ 50)
Total cost:	 Rs. 160,000 ($ 4000)
* Miscellaneous expenditures include cost of labour, antibiotics, occasional hospital admissions, and
splenectomy if required.
Table: 8.5. Estimated cost of screening for 13-thalassaemia in pregnant women and index
families.
Investigations	 Cost X 1:	 Cost per 1000 individuals screened (Rs):
consumable items	 (Rs)	 Antenatal screening:	 Family screeninF:
and manpower:	 ___________ Requirement:	 Cost:	 Requirement:	 Cost:
Sample tube
	 5	 100%	 5,000	 100%	 5,000
Disposable syringe
	 3	 100%	 3,000	 100%	 3,000
Haematology	 20	 100%	 20,000	 100%	 20,000
Hb-A2
 estimation	 35	 20%	 6,650	 50%	 17,500
DNA analysis	 350	 3.5%	 12,250	 5%	 17,500
Technicians	 3000 pm
	 X 2	 6,000	 X 2	 6,000
Phlebotomist	 2000 pm	 X 1	 2,000	 X 2	 4,000
Doctor:	 5000 pm
	 X 1	 5,000	 X 1	 5,000
Total	 -	
-	 59,900	 -	 78,000
___________________ ___________ _______________ ($ 1500) _______________ (S 1950)
pm: per month salary
Table: 8.6. Comparison of the cost of antenatal versus family screening in terms of cost per
person screened, cost per carrier detected and cost per at risk couple detected.
Cost of screening (Rs.):
Antenatal:	 Index families:
Per person:	 60	 78
Per carrier detected:
	 1200	 260
Per at risk couple detected:
	 24000	 13000
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Cost of prenatal diagnosis:
Chorionic villus sampling (CVS):
All of the CVS in this study were done free of cost. It is therefore difficult to calculate the cost
of each CVS. The cost of a CVS aspiration needle is Rs. 4000 and the cost of a biopsy forceps
is Rs. 22000. However, the needles as well as the forceps can be reused. Therefore the cost of
a CVS is equivalent to the salary of the obstetrician and the ultrasound operator
(approximately Rs. 20,000 per month). If approximately 100 CVSs are done every month then
the cost per procedure will be Rs. 200.
Laboratory diagnosis:
The cost of mutation analysis (Table: 8.7) by the standard ARMS PCR per person is
calculated at Rs. 800 ($ 20) and by multiplex PCR is Rs. 500 ($ 12.5).
Cost of termination ofpregnancy:
Cost of termination involves the cost of the procedure and the cost of hospital admission for
2-3 days. The total cost is calculated at approximately Rs. 4000 ($ 100). Since only about
25% of women who request prenatal diagnosis would require termination, the actual cost per
diagnosis will be Rs. 1000 ($ 25).
Total cost:
The total cost of one prenatal diagnosis (Table: 8.8), including the cost of CYS, mutation
analysis, and termination of pregnancy when required, is estimated at Rs. 3600 ($ 90) by
standard ARMS PCR and Rs. 3000 ($ 75) by multiplex ARMS PCR.
Discussion:
The success of a policy depends on whether genetic counselling is provided retrospectively i.e.
after the birth of an affected child or prospectively i.e. to at risk individuals and couples
without an affected child (Alwan and Modell 1997). The potential effect of a policy also
depends on its acceptability to the families concerned and the society as a whole.
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The concept of thalassaemia prevention is new to Pakistan. This pilot study clearly shows that
carrier screening as well as prenatal diagnosis are technically feasible and also accepted by the
majority of affected families. Consequently, formulation of policies incorporating prenatal
diagnosis is feasible for a large-scale thalassaemia prevention programme in Pakistan. In the
subsequent sections the cost and benefit of three basic policies, including no prevention,
retrospective counselling with prenatal diagnosis and prospective identification of at risk
couples and the offer of prenatal diagnosis, will be discussed. For the purpose of discussion a
hypothetical situation is assumed in which the total number of thalassaemics is equal to the
number of new births of thalassaemia in one year.
Table: 8.7. Estimated cost of mutation analysis for -thalassaemia per person.
Item:	 Cost per person (Rs.):
Standard ARMS PCR:	 Multiplex ARMS PCR:
Sample tube and Syringe 	 8.00	 8.00
Red cell indices	 20.00	 20.00
DNA extraction	 70.00	 70.00
ARMS PCR	 250.00	 75.00
Electrophoresis 	 150.00	 100.00
Photography	 50.00	 -
Subtotal	 548.00	 273.00
Wastage@10%	 55.00	 27.00
Labour	 200	 200
Grand total	 803.00 ($ 20)
	 500.00 ($ 12.5)
Policy-i:
Policy-i is a situation in which all thalassaemics are provided adequate treatment facilities but
no efforts are made for prevention. The cost of providing treatment to the estimated 5000
patients (N) born each year will be Rs. 800 million. The cost will increase at a rate equal to N
x number of years from the start of policy. At ten years it will be Rs. 8.8 billion and at 20 years
it will be Rs. 16.8 billion (Fig: 10.6).
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Table: 8.8. Estimated cost of prenatal diagnosis for thalassaemia. The cost of termination is
included at 1/4 of the actual cost because only I in 4 would actually require termination.
Procedure:	 No: Rate (Rs.):	 Cost (Rs.):
Standard	 Multiplex	 Standard	 Multiplex
____________ ___ 
PCR:	 PCR:	 PCR:	 PCR:
Mutation analysis 	 X2 800	 500	 1600	 1000
CVS:	 X 1 -	 -	 200	 200
Fetal testing	 X 1	 800	 800#	 800	 800
Cost of tennination: 	 Xl	 -	 -	 1000	 1000
Total	 -	 -	 -	 3600($90)	 3000($75)
Fetal DNA is tested by the standard ARMS PCR.
Policy-2:
It is based on providing treatment facilities to the affected children as in Policy-i but at the
same time it also includes counselling of the affected couples. Alwan and Modell (1997) have
suggested that when the final family size is large, if parents have no more pregnancies after the
birth of one affected child, the birth rate of affected children, would fall by as much as 50%.
This hypothesis, however, is subject to the availability as well as to the acceptance of family
planning. A more realistic option would be to offer prenatal diagnosis to such couples.
If it is assumed that Policy-2, including retrospective counselling and the offer of prenatal
diagnosis, would reduce the birth incidence of thalassaemia by about 50%, the number of
children requiring treatment would also be reduced to half. The cost of providing prenatal
diagnosis to 2N (N/2 X 4) number of couples would, however, be added to the net annual cost
for the policy. The estimated total cost for the 1st year of the policy would be Rs. 830 million
that includes Rs. 30 million for carrying out 10,000 prenatal diagnoses at the rate of Rs. 3000
per procedure. At 10th year of the policy the total annual expenditure would be Rs. 4.8 billion
and at 20th year it would be Rs. 8.8 billion (Fig: 8.1).
Policy-3:
This includes all of the features of Policy-2 and in addition it also caters for prospective
identification of couples at risk and the offer of prenatal diagnosis. Table 8.9 gives a
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calculation of the number of individuals who may have to be screened if index thalassaemic
families are targeted. The number of individuals requiring screening in the 0.225 million index
families is estimated at 22 million (average 97 individuals per family). This would identify
approximately 126,500 at risk couples and about 16% of this (20,000) would also require
prenatal diagnosis. The total cost of screening 22 million people would be Rs. 1.7 billion
(Table: 8.11).
The expected number of women who may require screening if approached through an
antenatal clinic is 31 million (Table: 8.10). This would identify 5% (1.55 million) carrier
women whose husbands would also require screening. The total number of individuals who
may require screening would be approximately 32.5 million and the cost of screening would be
Rs. 1.95 billion (Table: 8.11).
Table: 8.9. Calculation of the total number of couples and the number of at risk couples in a
targeted screening approach.
• Population of Pakistan:
• Total number of carriers (at 5% carrier rate):
• Average number of individuals per family:
• Total number of families:
• Percent of carriers per family (Chapter: 5):
• Number of carriers per family:
• Number of families at risk:
• Average number of couples per family:
• Total number of couples in families at risk:
• Proportion of consanguineous couples:
• Estimated proportion of couples at risk at:
45% consanguineous marriages (Chapter 5 & 9)
• Total number of at risk couples:
135 million
6.75 million
97 (Chapter: 5)
135 / 97 = 1.39 million
31%
3 1/100 X 97 = 30
6.75 million / 30 = 0.225 million
22.5
22.5 X 0.225 = 5.0625 million
45% (2nd cousins or closer)
13X 13/100+ 16X5/ 100=2.5%
2.5% of 5.0625 million = 126562
Table: 8.10. Calculation of the number of couples who may require antenatal screening.
• Proportion of females in active reproductive life: 	 46% (31 million)*
• Number of couples in active reproductive life: 3 1 million
• Expected numbers where husband's screening
may be required: 	 5% of 31 = 1.55 million
• Total numbers that may require screening:
	
31 + 1.55 = 32.55 million
• Total number of at risk couples identified:
	 5% of 1.55 = 77500 -
*Annual report of Health Services in Pakistan 1995-96.
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Table: 8.11. The cost of family and antenatal screening for J3-thalassaemia in Pakistan.
Approach:	 No. of	 No of at risk	 Cost of screening for
Individuals required
	
Couples	 -thalassaemia (Rs):
tobe screened:	 identified:	 __________________________________
______________ (millions)
	 _______________ Per 1000:	 Total:
Family:	 21.8	 126500	 78,000	 1.7 billion
Antenatal:	 32.5	 77,500*	 60,000	 1.95 billion
* The number of at risk couples identified by antenatal screening are less as compared to targeted approach
because the later group also includes couples who are not in active reproductive life.
The cost of prospective identification of at risk couples, whether done by screening the index
families or by antenatal screening, will be added to the net initial expenditure for the Policy-3.
However, this can conveniently be spread over the first few years of the policy. The overall
effect of Policy-3 is expected to reduce the number of births of affected children to
approximately 90% of N (Aiwan and Modell 1997). Consequently, the number of affected
children requiring treatment would be reduced to 90%. But at the same time an additional cost
of approximately 54 million for providing prenatal diagnosis (Rs. 3000 per diagnosis) to the at
risk couples (90% of N x 4=18,000) would be added to the total cost for Policy-3. The initial
cost of Policy-3 would be approximately Rs. 1.5 billion that will gradually increase over the
next ten years to Rs. 2.88 billion and to Rs. 4.2 billion till the 20th year of the policy.
Comparison between the three policies:
There is a clear financial benefit in adopting Policy-2 and Policy-3 as compared to Policy-i.
Policy-3 is obviously more cost effective than the Policy-2. The expenditure on Policy-3
would be higher during the initial few years that would be balanced by the huge amount of
savings achieved in the years to follow. A basic assumption in the three policies discussed
includes provision of adequate treatment facilities to all patients. An immediate benefit in
adopting either Policy-2 or Policy-3 lies in the savings achieved on treatment of the affected
children. Since the Government of Pakistan is not spending anything on treatment of
thalassaemia, the immediate benefits of adopting a policy cannot be appreciated. However, it
would certainly result in saving of the resources of non-governmental organizations.
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9 Consanguineous marriage and recessive
disorders
Introduction:
The term "consanguineous" literally means related by blood. A consanguineous marriage
is defined as marriage between individuals who have at least one common ancestor usually
not more than three generations back and the progeny of a consanguineous marriage is
"inbred" (Bittles 1994). All human beings are relatives and our progenitors might even
have been one single couple (Vogel and Motulsky 1986). There is some evidence to
suggest that a relatively small founder population migrated out of Africa to give rise
subsequently to all non African populations (Jones and Rouhani 1986). The long time
period since divergence of human populations has helped several intervening mutations to
cause genetic variability between different human beings. The relatedness of human beings
assumes importance in the context of recessive mutations, as these are expressed only
when inherited in a homozygous state. The chances of inheriting two identical genes,
including neutral as well as pathological genes, at a particular locus are increased if the
parents are close relatives (Bodmer and Cavalli-Sforza 1976).
Genetic effects of consanguineous marriage:
The main genetic consequence of consanguineous marriage is a reduction of genetic
variation and an increase in the proportion of homozygotes. Recessive genes, that are
unable to express in the heterozygous state, are thus brought to the fore (Bodmer and
Cavalli-Sforza 1976). Increase in the proportion of homozygotes should uniformly affect
the pathological, neutral as well as the beneficial traits. However, the effects of increased
homozygosity for all genes are not distributed evenly about the population mean and a
bias towards the pathological end of the spectrum may be observed (Modell and Kuliev
1992). There is no dearth of information on the association of consanguinity and
increased incidence of genetic disorders (Neel and Schull 1962; Klingberg et al, 1971;
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Basu 1975; Naderi 1979; Khlat et a!, 1986; Bundey et a!, 1991; Teebi 1994). A
population inevitably carries a certain load of detrimental genes originating through
mutations. Dominant genes are rapidly eliminated while recessive genes can be hidden and
so can accumulate. Studies on the relationship between consanguinity and genetic
disorders indicate that on an average an individual may be heterozygous for 1.4 lethal
equivalents (Bittles and Neel 1994). The detrimental recessive genes may be unmasked by
marriages between close relatives and this risk is directly proportional to the degree of
relatedness between the mates (Bittles 1980).
The data on association of consanguineous marriages and harmful traits have almost
completely overshadowed the beneficial traits, if any, that might be associated with
consanguineous marriages. A prime example of the absence of inbreeding depression can
be seen in the genealogies of the Egyptian pharaohs, in which brother-sister mating was
practised for many generations without known or reported ill effects (Strickberger 1968).
Some studies of intelligence suggest an association between consanguineous
marriages and reduced cognitive performance (Slatis et a!, 1961; Bashi 1977). Similarly,
there is evidence to suggest higher gross fertility in a consanguineous mating (Bittles
1994).
Inbreeding estimates:
The genetic effects of consanguineous marriage and the resulting inbreeding are measured
by a coefficient (F), first proposed by Sewall Wright (Strickberger 1968). The coefficient
of inbreeding is the probability that an individual receives at a given locus two genes that
are identical by descent (copies of a single gene carried by a common ancestor). A closely
related coefficient of kinship (P) is the probability that a gene taken at random from an
individual is identical by descent to a gene at the same locus taken at random from
another individual (Vogel and Motulsky 1986). The difference between the two
coefficients is that cP applies to two individuals who have common ancestors and F
applies to one individual and measures the degree of relationship between his/her parents.
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The value ofF for a first cousin marriage is 0.0625 i.e. 6.25% of the genes are identical
by descent. In 1½ cousin and 2nid cousin marriage F is 0.03 13 and 0.0156 respectively
(Bodmer and Cavalli-Sforza 1976). In populations where consanguineous marriage is
customary for several generations the estimates that do not take into account antecedent
consanguineous marriages are expected to be less than the actual values (Bittles 1994).
When extensive pedigree records are available and it is possible to go back for many more
generations the value of F may be two or more times as large as obtained through the
usual procedures (Bodmer and Cavalli-Sforza 1976).
Inbreeding estimates based on genetic polymorphism:
Genetic polymorphism may be defined as a trait encoded by a piece of DNA (a locus)
with two or more alleles (sequence variants), of which at least two occur at a frequency of
more than 1% in a given population (Vogel and Motulsky 1986). Blood groups and
protein polymorphisms have been used in the past to estimate inbreeding in human
populations (Workman and Niswander 1970). The estimates are based on the principle
that in a population where mating is not random the heterozygotes are reduced in
comparison to Hardy-Weinberg proportions while homozygotes are increased (Bodmer
and Cavalli-Sforza 1976). The extent of inbreeding in such a population can be measured
by quantifjing the departure from Hardy Weinberg proportions of the frequencies of
polymorphic genes.
Molecular genetic analysis has revealed that about 2% of the total human genome
encodes proteins and the rest does not appear to have any sequence dependent function.
A bulk of the intergenic DNA is unique because it consists of tandemly repeating
sequences whose length may vary between different individuals in the same population.
The polymorphisms created by such elements are termed variable number of tandem
repeats (VNTR) for the larger repeats and short tandem repeats (STR) for 1-6 base pair
repeats (Krawczak and Schmidtke 1994). VNTRs and STRs follow the same rules of
inheritance as the remainder of DNA and therefore are ideal sites as polymorphic genetic
markers (Housman 1995).
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VNTRs and STRs can be analyzed by the Polymerase Chain Reaction (Horn et a!, 1989;
Urquhart et a!, 1994). The STRs offer a better choice as compared to the VNTR loci
because the !arger allele of a VNTR system may be missed in PCR based amplification
(Newton and Graham 1994). The STRs have an added advantage of accurate sizing of the
alleles on automated equipment (Smith 1995). The STR allele frequencies have a potential
for use in estimating the extent of inbreeding in a popu!ation. However, there are no
published data on the use of STR allele frequencies for inbreeding estimates.
Objectives of the study:
This chapter describes the pattern and frequency of consanguineous marriages and their
re!ationship to autosomal recessive disorders in Pakistani families. The effect that an
antecedent consanguineous marriage might have on the inbreeding estimates is also
studied. In addition, an attempt is made to calculate the F values in a population by using
polymorphic STR allele frequencies. The same STR was also studied in the successive
generations of two large families to highlight the genetic effects of consanguineous
marriage.
Material and methods:
The study families:
A total of 14 large families were studied including nine with a known history of
haemoglobin disorder (subjects) and five without such history (controls). The
characteristics of the families studied are described in Chapter 5 (Tables: 5.2 and 5.3).
Drawing pedigrees:
Pedigree information on at least the last three generations in each family was collected.
Information on relationships of the more remote ancestors was also included where
available. The information was obtained from a well informed person in the family.
Information about the 2zd and 3 generations was readily available. However, it was more
difficult to get information about the l generation or earlier. In the urban families
pedigree information had to be collected from multiple sources because the members had
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infrequent contact with each other. Best efforts were made to ensure the reliability of
information.
The pedigree was initially drawn as a sketch on paper. Later, this information was
transferred to a computer by using the software package "Cyrillic Version 2.00" (The
Magdalen Centre, Oxford).
Morbidity and mortality in the family:
Information about the births of children with major congenital malformations or
symptoms suggestive of a genetic disorder was collected from the person who provided
the pedigree information. The result of screening for 13-thalassaemia, where carried out,
was also included in the pedigree.
Consanguineous marriages:
The couples were classified as double first cousins (F=0.1250), first cousins (F0.0625),
first cousins once removed (1'/2 cousins) (F=0.0313), and second cousins (F0.0 156).
Coefficient of inbreeding (F) and coefficient of kinship (P):
The coefficient of inbreeding of each individual and coefficient of kinship for each couple
in a family was calculated using Cyrillic version 2.00. The value ofF and CP for individuals
in one of the families was also calculated by the manual method of path coefficient (Vogel
and Motulsky 1986). All common ancestors were marked and the mates were connected
by all possible pathways leading to the common ancestors. The number of steps in each
path was counted. The F values were calculated by the following formula:
F= '/2 (2 m1 + 2-m2	 2-mo = 1/2 E2'
where m denotes the number of steps connecting an individual with the respective
common ancestor. The average values of F and P in a generation of a family were
calculated by the following formulae:
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F=1,F,
The summations go over various types of consanguineous marriages, with p, , F, and
being the relative frequency, coefficient of inbreeding and coefficient of kinship of the i-th
type of consanguineous marriage (Vogel and Motuisky 1986).
Short tandem repeat (STR) analysis:
Allele frequencies for a polymorphic DNA marker, D2 1 SI 1 (Sharma and Litt 1992), were
used to calculate the coefficient of inbreeding in a randomly selected population sample of
132 unrelated individuals with 13-thalassaemia trait. They presented at the Department of
Haematology, Armed Forces Institute of Pathology, Rawalpindi, for screening of
thalassaemia. The parental consanguinity of the subjects was also noted. A comparison
between the F obtained by STR allele frequencies and the conventional method was made.
D2 1 S11 genotypes were determined for the available members of two subject families. A
total of 140 individuals from Family No: 1 and 85 individuals from Family No: 2 were
studied. The genotypes of 5 dead members in the two families were inferred from their
children. The data on genotypes in various generations were used to investigate the effect
of genetic drift in the successive generations. The allele frequencies in each generation
were calculated by pooling together all individuals in that particular generation because
they were the people who would be passing on their alleles to the next generation.
Theoretical considerations:
Gene frequency can be determined by simply counting the alleles and by remembering that
every individual has two copies of each gene (Bodmer and Cavalli-Sforza 1976). At a di-
allelic locus with 5% carrier rate of -thalassaemia, for example, the thalassaemia gene
frequency will be 0.025 (5 13-thalassaemia genes out of a total of 200 genes at that locus).
A multi-allelic system like STRs gives rise to many genotypes. The frequency of each
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STR allele can also be determined by the method of counting alleles. Each heterozygote
represents one gene and the homozygote represents two genes.
In a randomly mating population, the relation between allele and genotype frequencies is
simple. If the gene frequencies are known the Hardy-Weinberg law can predict the
corresponding genotype frequencies (Vogel and Motulsky 1986). At a di-allelic locus, for
example, if the frequency of allele A isp and that of B is q then the genotype AA, AB, and
BB will have frequencies ofp2, 2pq, and q2 respectively. The same rule can be extended to
predict the genotype frequencies at a multi-allelic locus (Committee on DNA technology
in forensic science 1992). In a five allele system, for example, if the alleles A, B, C, D, and
E have frequencies p, q, r, s, and I respectively then the 15 possible genotype frequencies
(predicted by the formula [n(n+ 1)12] where n is the number of alleles), would be p2, q2, r2,
S2. and ? for the homozygotes, and 2pq, 2pr, 2ps, .2p1, 2qr, 2qs, 2qt, 2rs, 2r1, 2s1 for the
heterozygotes.
In a population where mating is not random, the proportion of heterozygotes is reduced in
comparison to Hardy-Weinberg proportions by an amount 2Fpq, while that of each
homozygote is increased by Fpq. Where F is the inbreeding coefficient, and p and q are
the frequencies of the alleles under consideration (Bodmer and Cavalli-Sforza 1976). The
genotypic proportions at a single di-allelic locus, say (AA, AB, BB) = (P, H, Q), where
P+H+ Q =1, can be represented in terms of the gene frequencies of A and B, denoted by p
and q, by the formulas:
AA	 AB	 BB
P=p2 +pqF;	 H=2pq(1-F);	 Q—q2+pqF
where p = P + '/211, q = I - p = Q + '/211, and F = I - H I 2pq. Here F denotes the
deviation from Hardy-Weinberg proportions due to the joint effect of all forces acting on
the pattern of genetic variation, including non-random mating, selection, and mutation.
'When inbreeding is the only factor, F is identical with the classical inbreeding coefficient
(Workman and Niswander 1970).
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Calculation of gene frequencies and coefficient of inbreeding:
The gene frequencies for the D2 1 Si 1 STR alleles were calculated by the simple method
of counting. The F value in the subject population was estimated by the following
formula:
F = 1 - H / 2pq
where H is the observed proportion of heterozygotes for the allele whose gene frequency
is represented byp, and q=l-p.
Results:
Characteristics of the families:
Characteristics of the 14 families studied were described in Chapter 5 (Table: 5.2 and
5.3). There were 9 Punjabi and 5 Pathan families. Family Nos: 1 and 2 were from the
urban areas whereas all others were from the rural areas.
Drawing pedigrees:
The individuals from the families were divided into generations and only the last three
generations were taken into consideration. The third last generation in a family was called
1st generation and the subsequent generations were labelled 2' and 3rd• Most pedigrees
had complex consanguineous relationships, therefore drawing a pedigree was also
complex. The commonest problem was to keep all individuals in a particular generation at
the same level. In most situations it was not possible without keeping the individuals in
the same generation at split-levels. Another problem was in assigning a generation to the
couple and the children of 1½ cousins. The couple were arbitrarily placed (counted) in the
generation of the parent from the senior generation. Their children were placed (counted)
in the generation of the parent from the younger generation. However, while counting the
number of individuals in a generation, each individual was counted in the generation to
which it actually belonged. Pedigrees of the 9 subject and 5 control families are presented
in Figures 9.4-9.17.
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Pattern of marriages:
There were 319 couples in the three generations of 14 families (Table: 9.1). This included
195 couples in the nine subject families and 124 in the five control families. There were
1.3% double first cousins, 33.2% 1 cousins, 4.1% 1½ cousins, and 3.8% 2' cousins.
There were no statistically significant differences between the pattern of marriages in the
subject and the control families. In 319 couples 165 (5 1.7%) were unrelated but from the
same Biradri/Tribe and only 19/319 (6.0%) couples were completely unrelated.
It was noted that consanguineous marriages were more frequent in the 2t generation than
the l (Table: 9.2). The frequency of l cousin marriages had increased from 12% in the
1st generation to 45% in the 2 generation (p=<O.000I). There were 12 married couples
in the 3' generation and 7 of them were consanguineous. Although its difference from the
previous generation is statistically insignificant due to small numbers but the trend is
obvious. Consanguineous marriages have reduced Biradri marriages from 71% in the 1st
generation to 40% in the 2nd generation (p=O.003). The frequency of consanguineous and
Biradri marriages was similar in the subject as well as the control families. However, in
the 2nd generation there were 51% 1st cousin couples in the subject families as compared
to 3 7.5% in the controls, but the difference was statistically insignificant (pO.25).
Calculation of F and P
The procedure of calculating F and Z' by manual method was very complicated and time
consuming. On the other hand the use of Cyrillic 2.00 was very efficient in calculating F
and P in the complex pedigrees. A complete correlation between the manual and the
computerized method was found.
Coefficient of inbreeding (F).
F for the three generations of the subject families is presented in Table: 9.3. A progressive
increase for the 1st (0.0046), 2 (0.0128) and 3rd (0.0352) generation was observed.
There were no significant differences between F in the three generations of the subject
and the control families. There was a wide variation of F between the individual families.
In the 3d generation, for example, it varied from 0.000 to 0.0782.
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Coefficient of kinship (P):
Observed (P of consanguineous couples in the 2 generation showed a value of 0.1346
for a double first cousin marriage, 0.07 18 for a l cousin marriage, 0.0330 for a 1½
cousin marriage and 0.0242 for a 2 k"' cousin marriage (Table: 9.4). It was noted that the
differences between the observed and the expected value ofF for the close and the distant
consanguineous relationships was similar.
Genetic/congenital disorders in the study families:
Haemoglobin disorders:
There were 170/571 (30%) carriers in the subject families (Table: 9.5). The number of
carriers in each generation varied from 30-34%. In the 2nd generations there were 83/25 1
(33%) carriers and 30 were unmarried (30% of 101 unmarried individuals). In 150
married individuals in 2m1 generation 53 (35.3%) were carriers. In the 2nd generation
32/150 (21%) carriers were married to a 1st cousin, 3/150 (2%) to a 1½ cousin, 2/150
(1.3%) to a 2d cousin and the remaining 16/150 (10.7%) to an unrelated Biradri member.
In 8/37 (21.6%) carriers married to a cousin the spouse was also a carrier. However, the
spouses of 4/16 (25%) carriers married to an unrelated Biradri/Tribe member were also
carriers. No carrier was married to a carrier from a different Biradri/Tribe.
Correlation between the number of carriers, coefficient of kinship and at risk couples:
Table 9.6 summarizes the number of carriers, mean coefficient of kinship, and the number
of at risk couples in the 18t and 2 generations of the subject (index) families. The 3id
generation did not have enough couples so it was not included in the comparison. The
proportion of carriers in the 1st generation of most families was lower than in the 2nd
generation. Similarly, coefficient of kinship was also lower in the I' generation. This
correlated with the absence of at risk couples in this generation. Family No: 10, however,
had 45% carriers and in spite of a low (P two at risk couples were seen. Both of the
couples although unrelated were from the same Tribe. In the 2' generation the number of
at risk couples generally correlated with the number of carriers and the mean (P for the
generation. In most families the carrier rate was above 30% and the kinship coefficient
was also high. In Family No: I four at risk couples were seen in spite of a relatively low (P
(0.0303). However, the carrier rate in the generation was fairly high (33%) and three non-
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consanguineous at risk couples were from the same Biradri all of whom also had the same
r3-thalassaemia mutation (IVSI-1). In Family No: 8, no at risk couple was seen. Although
the carrier rate in the individuals tested was fairly high (29%) but the mean kinship
coefficient was low (0.0208). In Family No: 9 in spite of a low carrier rate and low one
at risk couple was present. The spouses were unrelated but were from the same Tribe. In
Family No: 10 carrier rate (22%) as well as P (0.03 13) were low and there was no at risk
couple in this generation.
Couples at risk of genetic disorders:
In the nine subject families 12/195 (6.2%) couples had affected children and 2/195 (1%)
were at risk but did not have an affected child (Table: 9.7). Out of the 79 consanguineous
couples 11(14%) had an affected child as compared to 3/116 (2.5%) amongst the non-
consanguineous couples (p=O.005). In Family No: 1, four couples were found to have
thalassaemic children. However, the spouse of only one was a first cousin (P=0.0869)
whereas in the other three spouses were unrelated Biradri members. Mutation analysis
revealed that all four couples had the same -thalassaemia mutation (IVSI-1 (G-T). In
Family No: 2, in addition to the index couple (=0.0469), screening for thalassaemia
resulted in detection of one more at risk couple (=0. 1210). The couple did not have an
affected child. In the same family two other consanguineous couples (P=0.0820 and
0.0781) had children with congenital deafness. In Family Nos: 5 and 10, one at risk
couple each (cJ=0.0781 and 0.000), in addition to the index couples, were identified as a
result of screening for a haemoglobin disorder. Both of the couples did not have an
affected child.
In the five control families 4/124 (3.2%) couples had children possibly affected by a
congenital or genetic disorder (Table: 9.7). All 4 couples were consanguineous and they
formed 7% of the 56 consanguineous couples. In contrast, none of the 68 non-
consanguineous couples had children possibly affected by a genetic or congenital disorder
(p=O.O3). In Family No: 11 one consanguineous couple (P=0.0781) had three children
that died during the first month of life due to unknown causes. In Family No: 13 two
consanguineous couples (b=0.0625) had several children that died immediately after birth
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due to unknown causes. In Family No: 14 one couple (P=O.1328) was found to have
deaths of two children due to multiple congenital abnormalities. In Family No: 15 five
consanguineous couples had children who died between 1-5 years of age. The cause of
death in all such children was not similar. There was also no visible evidence to suggest
that they had any congenital malformation. The possibility of a genetic disorder could not
be ruled out.
Table: 9.1. Pattern of marriages in the three generations of the 14 families studied.
Family:	 DIC	 Vt	 1/2	 2	 Biradri	 Non-	 Total
cousins	 cousins	 cousins	 Biradri
Subject Families:
No:1	 -	 15	 2	 3	 30	 2	 52
No:2	 -	 13	 1	 1	 4	 2	 21
No:3	 -	 7	 -	 1	 5	 1	 14
No:4	 -	 6	 -	 -	 4	 2	 12
No:5	 -	 8	 -	 -	 9	 2	 19
No:6	 -	 5	 -	 -	 9	 -	 14
No:8	 -	 6	 2	 -	 15	 5	 28
No:9	 5	 -	 1	 14	 -	 20
No:10	 -	 3	 -	 -	 12	 -	 15
Subtotal	 -	 68	 5	 6	 102	 14	 195
(34.9%)	 (2.6%)	 (3.1%)	 (52.3%)	 (7.2%)	 (100%)
Control families:
No:11	 -	 10	 2	 1	 9	 -	 22
No:12	 -	 -	 -	
-	 11	 -	 11
No:13	 -	 6	 -	 -	 16	 1	 23
No:14	 3	 10	 3	 3	 13	 -	 32
No:15	 1	 12	 3	 2	 14	 4	 36
Subtotal	 4	 38	 8	 6	 63	 5	 124
(3.2%) (30.6%)	 (6.6%)	 (4.8%)	 (50.8%)	 (4.0%)	 (100%)
Grand	 4	 106	 13	 12	 165	 19	 319
total	 (1.3%) (33.2%)	 (4.1%)	 (3.8%)	 (51.7%)	 (6.0%)	 (100%)
L)IC: double first cousins.
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Short tandem repeat (STR) analysis:
D21S1 1 allele frequencies:
Ten alleles were seen at the D21SI1 locus (Fig 9.la). The alleles were named according
to the size in base pairs as determined by an automated fragment size analyzer. Sharma
and Litt (1992) showed that the alleles at D21S11 locus are four base pair repeats. It was
observed that, in addition to the four base pair repeats, alleles varying by two base pairs
were also present. Similar observations have also been made by other workers (Kimpton
et al, 1993; Urquhart et al, 1994).
Table: 9.8 shows the overall genotype frequencies in 132 unrelated individuals. There
were 36 different genotypes as compared to the theoretically predicted 55. The observed
number of homozygotes for all alleles was 26. The observed frequencies for the common
alleles (Table: 9.8) in the descending order were 234 (0.193), 220 (0.174), 224 (0.159),
216 (0.152), and 230 (0.144).
Calculation ofF by the STR allele frequencies.
The F value, calculated by parental consanguinity of the 132 subjects, was found to be
0.0257 (Table: 9.9). The values ofF as calculated by the frequency of the D21 Si 1 alleles,
for which a homozygote was also observed, are presented in Table: 9.10. The values
ranged from 0.0231 with the commonest allele (234) to 0.0313 for the less common allele
(230). The value of F calculated from the uncommon allele frequencies were widely
outside the acceptable range (0.0567 and 0.1285 for the allele 238 and 228 respectively).
The average F calculated from the five common alleles was 0.0272.
D21S11 analysis in the two subject families:
The results of D21S11 allele frequencies in the last three generations of Families No: 1
and 2 are shown in Table: 9.11 and 9.12 respectively. A considerable fluctuation in the
frequency of different alleles in various generations was observed. The frequency of allele
220 in Family No: 1, for example, had progressively gone down from 0.20 to 0.120 to
0.052 in the last generation. The allele 224 in the same family, on the other hand, had
increased in frequency from 0.05 to 0.102 to 0.132 in the last generation. Similar
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fluctuations of the allele frequencies in various generations of Family No: 2 were also
observed. The allele 220 had increased from 0.125 to 0.149 to 0.214 in the three
successive generations. The allele 224 showed a progressive decline in its frequency from
0.20 to 0.149 to 0.095. Similarly the allele 230 was reduced from 0.10 to a complete
extinction in the last generation.
Table: 9.8. D21S1 I observed genotype frequencies in 132 unrelated individuals.
212
216	 -	 3
__________ __________ (0.0227) __________
220	 8	 5
__________ __________ 
(00606)	 (00378)	 __________
224	 2	 10	 6	 4
_________ (0.0151)	 (0.0757)	 (00454)	 (00303)	 _________
226	 3	 -	 1
_________ _________ (00227)	 _________ (00075) _________ _________
228	 1	 2	 2	 1
__________ __________ (00075)
	 (0015!)	 (00151)	 __________ (00075)	 __________
230	 5	 8	 4	 1	 -	 4
__________ ___________ (0 0378)
	 (0 0606)	 (0 0303)	 (0 0075)	 ___________ (0 0303)	 __________
234	 4	 7	 6	 1	 2	 10	 7
_________ _________ (00303)
	 (0,0530)	 (00454)	 (00075)	 (00151)	 (00757)	 (00530)	 __________
238	 1	 3	 5	 2	 1	 1	 -	 5	 2
___________ (00075)
	 (00227)	 (0.0378)	 (0.0151)	 (00075)	 (00075)	 ___________ (0.0378)	 (00151)
242	 -	 1	 2	 2
__________ __________ __________ __________ (0.0075)	 __________ __________ (00151) 	 (0015!)	 ________________
212	 216	 220	 224	 226	 228	 230	 234	 238	 242
2	 3	 4	 5	 6	 7
_____ .----
- ::
-	 _
Fig: 9.la . Results of the PCR amplification of the STR at D2IS1I locus after
electrophoresis on 6% denaturing polyacrylamide gel and silver staining. Lane 1 shows
allele 216/226, lane 2: 216/228, lane 3: 216/226, lane 4: 226/226, lane 5: 216/228, lane 6:
216/234, and lane 7: 226/234. (Note: The same samples were initially run on ALF for
allele sizing).
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Table: 9.9. Coefficient of inbreeding of the 132 subjects calculated by the standard
methods.
Consanguinity:	 Number:	 Percent:	 Coefficient of Inbreeding:
1st Cousins:	 45	 34.1%	 0.0212
lY2Cousins:	 15	 11.4%	 0.0035
Cousins:	 9	 6.8%	 0.0010
Unrelated:	 63	 47.7%	 0.0000
Total:	 132	 100%	 0.0257
Table: 9.10. Calculation ofF values from the D21 SI 1 allele frequencies in a sample of
132 unrelated individuals.
Allele (n): p	 g=1-p	 H:	 1-H:	 2pg:	 F1-H/2pg
212(3)	 0.011	 -	 -	 -	 -	 -
216 (40)	 0.152	 0.848	 34 (0.2575)	 0.7425	 0.2578	 0.0288
220 (46)	 0.174	 0.826	 36 (0.2727)	 0.7273	 0.2874	 0.0253
224 (42)	 0.159	 0.841	 34 (0.2575)	 0.7425	 0.2674	 0.0277
226 (7)	 0.027	 -	 -	 -	 -	 -
228 (10)	 0.038	 0.962	 8 (0.0606)	 0.9394	 0.073 1	 0.1285
230 (38)	 0.144	 0.856	 30(0.2272)	 0.7728	 0.2465	 0.0313
234(51)	 0.193	 0.807	 37(0.2803)	 0.7197	 0.3115	 0.0231
238 (22)	 0.083	 0.917	 18 (0.1363)	 0.8637	 0.1522	 0.0567
242(5)	 0.019	 -	 -	 -	 -	 -
All (264)	 1.00	 -	 -	 -	 -	 -
p= allele frequency; H= observed number of heterozygotes
Table: 9.11. D2 1S1I allele frequencies in the successive generations of Family No: 1.
Alleles:	 1st generation:	 2nd generation:	 3rd generation:
_______________ (F=O.0122) 	 (F=0.0153)	 (F=0.0246)
212	 1(0.05)	 1 (0.009)	 -
216	 4 (0.20)	 30 (0.278)	 39 (0.257)
220	 4(0.20)	 13 (0.120)	 8 (0.052)
224	 1(0.05)	 11(0.102)	 20(0.132)
228	 1 (0.05)	 6 (0.056)	 11(0.072)
230	 5 (0.25)	 30 (0.278)	 45 (0.296)
234	 4(0.20)	 16(0.148)	 28 (0.184)
238	 -	 1 (0.009)	 1 (0.007)
Total:	 20(1.00)	 108(1.00)	 152(1.00)
202
Table: 9.12. D21S11 allele frequencies in the successive generations of Family No: 2.
Alleles:	 i generation:	 2nd generation:	 3rd generation:
______________ (F=O.0125)
	
(F=O.0360)	 (F=O.0782)
216	 8 (0.20)	 23 (0.245)	 10 (0.238)
220	 5 (0.125)	 14 (0.149)	 9 (0.214)
224	 8(0.20)	 14(0.149)	 4 (0.095)
226	 5 (0.125)	 7 (0.075)	 8 (0.190)
230	 4(0.10)	 10 (0.106)	 -
234	 9(0.225)	 22 (0.255)	 11(0.117)
238	 1(0.025)	 2 (0.021)	 -
Total:	 40(1.00)	 94(1.00)	 42(1.00)
Discussion:
The origin of consanguineous marriage on the Indian Subcontinent is not clear. No one
knows what the conventions of the original population of India were, but the lower castes
and tribal populations may well have favoured consanguineous marriage (Reddy 1994).
The population of North India, however, was originally exogamous as much of North
India is today (Sinclair 1972). Islam came to the Subcontinent with the arrival of Arabs
and Turks in the 7th and 8th century A.D (Wolpert 1977). The practice of consanguineous
marriages amongst the Muslims might be related to adoption of Islam. As it was
predominantly the lower castes who were attracted by the Islamic concept of human
equality, some converts might already have favoured consanguineous marriage (Modell
and Kuliev 1992).
Frequency and trends of consanguineous marriages:
Studies on consanguineous marriages in Pakistan show that up to 50% of the marriages
are between close relatives and another 35% take place between Biradri relatives (Bittle
1994). In this study consanguineous marriage was as popular among urban as among the
rural families. The practice varied between the individual families i.e. some favouring it
more while others did not favour it at all.
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Studies on consanguineous marriages are mostly based on a cross-sectional view of the
population (Shami and Zahida 1980; Wahab and Ahmad 1996). The present study is
unique because it provides an opportunity to study individual families and to
retrospectively examine changes in the pattern of marriages with time. The information
derived from almost all families clearly indicates that the frequency of consanguineous
marriages has increased significantly in the youngest generation of couples as compared to
their predecessors (Fig: 9. ib). The changes were similar in the subject (index) as well as
control families. This is contrary to the possibility of finding greater numbers of
consanguineous couples amongst index families because they formed a selected group
with a recessive disorder.
A significant decline in the frequency of consanguineous marriages was observed in the
recent generations of Western Europe, North America, and Japan (Coleman 1980; Lebel
1983; Imaizumi 1986). This is attributed to industrialization, greater population mobility,
a decline in family size, and higher literacy rates. A similar change would also be expected
in other populations. Consanguineous marriage still remains popular without any sign of
decline in its frequency in a vast majority of the population of Middle East, Central Asia,
North Africa, and the Indian Subcontinent (Bittles 1990). Modell and Kuliev (1992) have
anticipated that the absolute number of consanguineous marriages may increase in future
because of a high population growth-rate and a fall in the infant mortality leading to
survival of greater number of children to reproductive age.
Darr and Model! (1988) noted an actual increase in the Pt cousin marriage in British
Pakistanis and it was tentatively attributed to the effect of migration. Wahab and Ahmad
(1996) also observed a similar change in Pakistan. The results of this study also suggest
that consanguineous marriages have significantly increased in the recent past. The first
choice for marriage in Pakistan is mostly confined to a close circle of near relatives or to a
wider circle of kinsmen called Biradri. A marriage outside this circle is considered only
when a suitable match is not available (Punjabi 1976). An increasing trend in
consanguineous marriages observed in the recent generations of the study families, which
in fact is a change from marriages within the Biradri to a closer circle of relatives, may
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well be due to decreased infant mortality and greater availability of cousins. If this is true
then, at least in the immediate future, the trend will increase still further.
lstGen(121)	 2ndGen(186)	 3rdGen(12)
DIC I 1st cousin 0 1 1/2 cousin 02nd cousin 0 Biradri 0 Non Biradri
Fig: 9.lb. Pattern of marriages in the three generations of the study families.
No published data are available on the frequency of consanguineous marriages in the
previous generations of Pakistan. Before the partition of the Subcontinent the population
of present Pakistan was an admixture of Hindus and Muslims. Hindus of Northern India
are mostly exogamous (Sinclair 1972) and consanguineous marriage amongst the Muslims
of the present Northern India is around 33% (Basu 1975). Contemporary figures from the
adjacent part of Punjab in Pakistan show about 50% consanguineous marriages (Shami
and Zahida 1980). Compliance of marriage pattern with the local social pressures may
cause variation in marriage preferences (Malhotra 1979). The marriage pattern amongst
Muslims of Northern India may well have been influenced by a general lack of preference
for a similar trend in the Hindu community. After the partition of the Subcontinent the
Muslims in Pakistan have been relieved from the social pressure which the Muslims in the
Northern India are still experiencing. It is likely that the frequency of consanguineous
marriages amongst the Muslims of pre-partition India were not different from the Muslims
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of present Northern India. An increasing tendency of consanguineous marriages seen in
this study may partly be due to a change in the social circumstances.
The changing pattern of marriages is also reflected in the coefficient of inbreeding for the
last three generations of the study families. The average coefficient of inbreeding by
generation showed a progressive rise with time (Table: 9.13). The pattern was similar in
the subject as well as the control families. For example the value in the youngest
generation was 0.03 52, which is approximately 25% higher than the estimated 0.0280 for
the Pakistani population (Bittles 1994). An extrapolation of the value of F when plotted
against time (Fig: 9.2) shows that with the current pattern of consanguineous marriages
the value ofFby the year 2015 will be something like 0.0575.
Table: 9.13. Coefficient of inbreeding by generation in the study families. A similar
pattern was observed in the subject as well as the control families.
Families:	 Coefficient of inbreeding (F):
i' generation	 2nd generation	 3rd generation
Subjects:	 0.0058	 0.0141	 0.0343
Controls:	 0.0019	 0.0105	 0.0360
All:	 0.0046	 0.0128	 0.0352
0
C)
0
1975	 1995	 2015
Fig: 9.2. Change in the coefficient of inbreeding over time. Extrapolation of the line to
the year 2015 shows that with the current pattern of marriages the F may increase to
0.0575.
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Antecedent consanguineous marriages and inbreeding estimates:
The results of this study clearly show that antecedent consanguineous marriages
significantly affect the inbreeding estimates. For example the kinship coefficient for a 1st
cousin marriage was found to be approximately 15% higher than the theoretically
predicted (Table 9.14). Similarly values for the other consanguineous relations were also
higher. The results also indicate that the increment in F due to antecedent consanguinity
was similar for all degrees of relationship. This suggests that antecedent consanguinity
may be more significant in increasing genetic risk for more distantly related couples.
Normally consanguineous relations more than 2' cousins are considered insignificant
(Bittles 1994). But this may not be so in Pakistan where distant relatives or even Biradri
relatives may be at a significant risk. The results of screening for thalassaemia in the
families investigated showed that unrelated Biradri spouses of four carriers had the same
thalassaemia mutation. But no carrier was married to another carrier from a different
Biradri/Tribe.
A revised calculation of F in different ethnic groups of Pakistan based on the kinship
coefficient calculated in this study shows that the predicted value in Punjabis are closer to
the mean coefficient of inbreeding seen in the youngest generation of the study families
(Table: 9.15).
Table: 9.14. Coefficient of kinship for a consanguineous relationship in the most recent
generation of the study families.
Coefficient of kinship (ti)):
DIC: Double first cousin
DNA based estimate of inbreeding in a randomly selected sample investigated in this study
also showed that the estimates were generally higher than those calculated by the
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conventional methods. However, these were significantly lower than the estimates
obtained by pedigree analysis. It appears that pedigree analysis may be more suitable for
inbreeding estimates. It was also observed that the values obtained for different alleles in
the same sample varied considerably. For a more realistic picture it might have been
appropriate to use a STR locus with fewer number of alleles or to investigate a larger
sample size.
An important factor that is not taken into consideration when making inbreeding estimates
is the practice of marriages within a circle of Biradri. Bittles (11994) has shown that up to
85% of the marriages in Pakistan take place within a Biradri circle. In this study an even
stronger tendency (94%) of marriages within the Biradri or Tribe was observed. The term
Biradri literally means "brotherhood". It is a community of large-scale descendent group
whose members are related either closely or distantly by blood or by marriage so that the
members think of each other as kinsmen (Kolenda 1978). Family members of the spouses
arrange a typical Pakistani marriage. The Biradri or Tribe members are given priority and
a marriage outside this circle remains under criticism for the rest of the life of those
contracting such a relationship (Punjabi 1976). The Biradri circle can be seen as a
relatively isolated population. In one of the families investigated in this study it was
observed that three out of four couples who had children affected by thalassaemia major
were non- consanguineous but were from the same Biradri. Incidentally all of these
couples had the same 13-thalassaemia mutation i.e. IVSI-1, a mutation that is seen in 5%
of the general population. These findings highlight the genetic consequences that a
marriage within a Biradri circle can bring.
The usual methods of calculating inbreeding coefficients, even by drawing extensive
pedigrees, would be unable to incorporate the contributions made by Biradri relationships.
The use of a polymorphic DNA marker on a large number of unrelated Biradri members
may be of help in solving this problem. In the two study families, in whom STR analysis
was carried out, only 12 unrelated Biradri members in Family No: 1 and 4 in Family No: 2
were available for DNA analysis. This number was too small to draw conclusions about
the inbreeding estimates.
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Genetic effects of consanguineous marriage:
Thalassaemia, a recessive disorder whose carriers can be identified by simple blood tests,
can be used as an example to investigate the factors that may determine the number of at
risk couples for a recessive disorder in families where marriages are predominantly
consanguineous. In this study two main factors were identified that correlate with the
number of at risk couples. These include (1) the number of carriers in a generation and (2)
the coefficient of kinship (P) for the generation. In most families at least 30% carriers
were present in a generation where at risk couple was seen.
The situation in Family No: 8 was interesting because the thalassaemia gene was first
introduced in this family by an unrelated Biradri member from the 1st generation (Fig:
9.10). In the 2hidf and 3id generations the number of carriers had increased but it was not
enough to allow marriage between two carriers. If the current pattern of marriages
continues and no efforts are made to avoid marriages between carriers, it is expected that
over the next 2-3 generations a couple at risk might be seen. This suggests that in the
presence of about 45% consanguineous marriages it may take 4-5 generations before a
recessive gene can manifest itself Spontaneous recessive mutations may also take a
similar number of generations to manifest in such families.
Most of the at risk couples were present in the 2' generation of the index families. In the
same generation approximately 30% of the unmarried individuals were also carriers. If a
thalassaemia carrier in Pakistan chooses to marry a close family relative then there is a
theoretical possibility that in about 30% his or her spouse will also be a carrier as
compared to only 5% if he or she marries an unrelated person. The observed risk of
marrying a close cousin was slightly lower than expected which may be due to the small
numbers investigated. It was observed that 25% of the carriers were married to a close
cousin and in about 22% of the carriers married to a cousin the spouse was also a carrier.
In contrast, none of the carriers was married to a carrier from another Biradri/Tribe. In
25% of the carriers married to a BiradrilTribe member the spouses were also carriers. The
actual risk of thalassaemia in a consanguineous marriage in Pakistan would be
approximately four times higher than a completely unrelated marriage. The risk in a
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consanguineous marriage for the rare recessives, that collectively may be more common
than thalassaemia, would be even more marked (Model! and Kuliev 1992).
The relationship between kinship coefficient and the number of at risk couples in a
generation for the common consanguineous relations is straightforward. It is more
complicated for Biradri/Tribe members. Normally inbreeding estimates do not take into
consideration the contribution made by a Biradri or a Tribe member. The data from this
study suggest that, at least for a common recessive disorder, a marriage within the Biradri
or a Tribe circle may also be at a higher risk.
DNA polymorphism data from the two study families indicate that genetic drift, due to a
small number of the family members, may also contribute towards fluctuation in the
carrier rate and the number of at risk couples. Fig: 9.3 shows how random drift can
influence gene frequencies between generations. The allele frequency can vary from one
generation to another and some alleles may change significantly to a higher or a lower
level within the span of relatively few generations. A typical Pakistani family can be seen
as a small population isolate. The size of this isolate is maintained and partitioned from
the rest of the population due to frequent consanguineous marriages. Consanguineous
marriage in it self does not affect gene frequencies (Modell and Kuliev 1992). However, it
may act indirectly by maintaining the finite size of the population. In a small population
group like this, drift may help to cause fluctuation in the frequency of a particular gene
(Bodmer and Cavalli-Sforza 1976).
In the five control families, 4/56 (7%) of the consanguineous couples had deaths of
children due to causes that were possibly genetic in origin. In contrast, none of the 68
non-consanguineous couples from these families had deaths of children due to genetic
causes (p=O.O3). However, there is only circumstantial evidence that the children of the
consanguineous couples had a genetic disorder. The studies on association of
consanguineous marriages and increased mortality carried out in less developed regions
face a major problem in diagnosing cause of death and under such circumstances it is
difficult to partition mortality into genetic and non genetic components with any
confidence (Bittles 1994). Interaction between consanguinity and social variables can also
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complicate to a significant extent assessment of the genetic effects of consanguinity.
Consanguineous marriage is more likely to be favoured by the poorest and least educated
families, whose children are at greatest risk of elevated rates of infant and childhood
mortality from the effects of infections and nutritional deficiencies. Failure to control for
socio-economic differentials can readily lead to biased estimates of the adverse effects of
consanguinity (Bittles 1995). A recent study from Pakistan shows that the frequency of
both consanguinity and birth defects were related with the socio-economic levels of the
study groups, but there was no association between inbreeding and birth defects (Yaqoob
et al, 1993). The apparent lack of association, when correction for other confounding
factors is applied, may be due to elimination of the deleterious recessive genes over time
from a community where consanguineous marriages are customary for several generations
(Sanghvi 1966). The deleterious recessives, however, cannot be completely eliminated
because of new mutations, reproductive compensation and heterozygote advantage
(Bittles 1980). Studies on consanguinity and genetic disorders indicate that the average
mortality in the progeny of a Pt cousin marriage is 4.4% higher than an unrelated
marriage. The excess mortality is due to the presence of about 1.4 recessive genes per
person that are lethal in the homozygous state (Bittles and Neel 1994). The results from
this study support the later observations because the affected and the unaffected couples
from the families, especially the controls, were living under identical socio-economic
conditions that largely rules out the possibility of involvement of confounding variables.
The subject families were a selected group because of a history of recessive disorder in
the family whereas the controls were randomly selected families. A comparison between
the number of affected couples in the two groups showed that in the subjects there were
11/79 (14%) consanguineous couples who had children affected by a genetic disorder and
in the controls there were 4/56 (7.1%) couples with affected children. The difference
between the two groups was statistically insignificant (p=O.26).
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Fig: 9.3. Variation in D2 iS 11 allele frequencies in the three generations of Family No: I
(top) and Family No: 2 (bottom).
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Fig: 9.16 Coefficient of inbreeding and screening for thalassaemia in the members of Family No: 14. (NAnot available for testing).
o 1st Generation (n33): 0.0019
• 2nd Generation (n55) 0.t)149
0 3rd Generation (n 74): 0.0576
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Fig : 9.17 Coefficient of inbreeding and screening for thalassaemia in the members of Family No: 15. (NA=not available for testing).
0 3rd&4thGeneration(n=100): 0.0237
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1 0 Final discussion
Introduction:
There is a long standing experience of preventive programmes at the national level in
many Mediterranean countries. This is illustrated in the Cyprus thalassaemia prevention
programme that has been highly cost effective and has resulted in almost complete control
of thalassaemia. In principle, a programme on similar lines could be applied in any country
where haemoglobin disorders are common (Alwan and Modell 1997). This would involve
improvement of treatment facilities through adoption of a common management protocol,
awareness and involvement of the community, population screening and counselling, and
availability of prenatal diagnosis. The success of the Cyprus programme is attributed to
low infant mortality, small size and small population, high standard of living and health
care, high literacy and low birth rate, existence of a national health infrastructure and
Government's involvement (Angastiniotis et al, 1986).
Haemoglobin disorders in Pakistan are of sufficient public health importance to justif' a
disease-oriented control programme (WHO 1993). However, development of a
prevention programme on the lines of a Mediterranean programme is largely precluded at
present in a developing country like Pakistan by a large population, high birth rate, low
rate of literacy, limited resources, and lack of organization of health services. Another
issue of fundamental importance is the attitude of a Muslim community towards various
options for prevention.
At least five "policies" for thalassaemia exist in different countries of the Eastern
Mediterranean Region (EMR) including Pakistan (Aiwan and Modell 1997). These
include:
1. No treatment, counselling or prevention.
228
2. Best possible patient care, plus retrospective genetic counselling after the birth of
an affected child.
3. Same as 2 plus the option for prenatal diagnosis in subsequent pregnancies.
4. Same as 2 plus prospective screening and counselling but no prenatal diagnosis.
5. Same as 2 plus prospective screening, genetic counselling with prenatal diagnosis.
An ideal "policy" for thalassaemia should include measures to provide adequate treatment
facilities, genetic counselling and prospective identification of at risk couples before they
give birth to an affected child. Until recently, the "policy" of no treatment, counselling or
prevention was widely prevalent in the EMR including Pakistan. At present in many
countries of the region treatment facilities are more widely available and retrospective
counselling is also being provided to many families. Prenatal diagnosis is available to only
a limited number of the families. The response of most of the affected families to prenatal
diagnosis is therefore mostly unknown. The ideal "policy" for Pakistan is a long way in
the future because of the general low level of development in the country and the limited
resources available. Therefore, a basic question at present is where and how to start?
Keeping in view the infant mortality of around 90/1000 in Pakistan (Burney 1993) the
Government's priority is to reduce it with basic programmes of primary health care,
immunization and nutrition etc. (Annual report of health services in Pakistan 1995-96).
Effective implementation of such programmes has caused a very rapid fall in infant
mortality in many countries. As a result chronic disorders including thalassaemia very
rapidly became more important and even in some countries the health priorities also
changed e.g. Iran, Maldives and Thailand. This tends to happen when infant mortality falls
to below 40/1000 because (a) more vulnerable children survive (b) they become
conspicuous, get diagnosed and their management can be very costly (Prof B. Modell
personal communication). Pakistan is far away from a situation where mortality due to
genetic disorders will become conspicuous. But the problem is important and will emerge
in due course of time (Fig: 10.1). Therefore, some form of planning must begin now.
The population of Pakistan is very diverse because a small urban section with better
education is more developed as compared to a large rural and mostly uneducated section
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(Fig: 10.2). Most thalassaemic children are diagnosed and get treated in the developed
section of the population whereas affected children born in the less developed section
usually die undiagnosed and parents often replace them with healthy children. A
demographic transition would occur when people have better education and fewer
children who survive. With this the problem which is emergent only in the developed
section would also become prominent in rest of the population. Since the problem is only
emerging the Government is unlikely to become interested at present. The important
questions at present are:
What level of Government interest should realistically be promoted at present?
It should include:
a. An awareness of the problem and its scale and the awareness that it will become a
major problem when the present health policies succeed.
b. Support (at least moral) for research and appropriate approaches for treatment
and prevention of thalassaemia in Pakistan.
c. Encouragement for formation of nuclei and centres from which appropriate
services can spread in due course when needed.
d. Willingness to have a dialogue with the NGOs and others to ensure progress.
e. Ensuring that the programme enters into planning at Government level.
How to achieve political will?
The usual route for achievement of political will is through increasing the Government
interest in the problem (Fig 10.3). National experts, leading clinicians and thalassaemia
support associations of the parents and patients can positively influence the Government
authorities (Alwan and Modell 1997). The availability of epidemiological data collected
through reliable sources can be effective in presenting the problem to the health
authorities. The NGOs could write a report on the state of thalassaemia in Pakistan every
year and send it to the ministry of health. An increasing number of patients who would
survive with the availability of treatment facilities can also attract Government's attention.
Collaboration of all interested parties is a key element. As long as different people tell the
Government different things they will never listen.
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Pakistan at present is in the earliest stage of developing a programme for thalassaemia.
The work carried out in this pilot study is essential for forward planning. The results have
brought forward guidelines to formulate a realistic future policy for thalassaemia in
Pakistan.
Communicable diseases	 /Present Health
o Malnutntion	 .	 /
Genetic disorders 	 Priority
,,,, /
High infant mortality
(90/1000)
Primary Health t!)Immunization	 NutritionCare
Fall in infant mortality
(<40/1000)
Genetic disorders 	 Future Health
Communicable diseases	 Priority
& Malnutrition	 j
4
Treatment Prevention(very costly)__F '	________________
Fig: 10.1. The usual route of creating Government's interest in genetic disorders. The
present health priority of the Government is to reduce the infant mortality by preventive
health policies. With the success of these measures, genetic disorders will emerge as an
important health priority. Therefore some planning must begin now.
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Demographic transition
when people have fewer children who survive, and are educated
Most thalassaemic children 	 Most thalassaemic children born here
born here will be diagnosed 	 will die undiagnosed and parents will
and may be treated. 	 replace them often with healthy children.
This group must be dealt
	
The best that can be done for this
with because the problem
	
group is to improve primary care and 	 /
here is emergent.	 demographic transition.
Fig: 10.2. The population of Pakistan is diverse which has a small more developed and a
large under developed section. At present most thalassaemics are seen in a smaller section
of the population that is mostly urban and has better education. With demographic
transition the problem is likely to become more and more obvious (Prof. B. Modell
personal communication).
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Motivated Patients	 NGOsProfessionals .
Patients
4.6'4
Informal National Group
(Thalassaemia association)
Presentation of Information
to Government
Gradual increase in
Government's interest
Advice from
WHO
Start of formal interest in
Ministry of Health
Dialogue "Ministry of Health"
& "Thalassaemia association" .
/ / / // / //	 /;'
Fig: 10.3. The usual route for achievement of political will. Pakistan at present is in the
earliest stage of developing a programme for thalassaemia (Prof. B. Modell personal
communication).
233
Epidemiology of haemoglobin disorders in Pakistan:
WHO (1985) has estimated that the carrier rate for 13-thalassaemia in Pakistan is around
5%. The study of haemoglobin disorders by Khattak and Saleem (1992a) gave the first
indication that the carrier rates for 13-thalassaemia may be different in various ethnic
groups. It is important to investigate carrier rate in the ethnic groups because 3-
thalassaemia genes have an uneven distribution. Moreover, the frequency of
consanguineous marriage is also different in the ethnic groups of Pakistan (Bittles 1994;
Wahab and Ahmad 1996). This would affect the calculation of annual birth rate of
thalassaemia major in each group. The overall carrier rate for f3-thalassaemia in this study
was found to be 5.3% (95% confidence limits: 4.1-6.5%). The carrier rate also varied in
the ethnic groups (Table: 10.1). The abnormal haemoglobins could not be screened in this
study. However, other published reports on abnormal haemoglobins indicate that they are
not significant as compared to 13-thalassaemia. The largest study of 5000 Pakistani
individuals by Sharma et al, (1976) showed that 0.78% had an abnormal haemoglobin
including Hb-D (0.42%), Hb-E (0.18%), and Hb-S (0.18%).
The carrier rate of thalassaemia is used to calculate the annual number of births of
affected children. This information is essential for planning a national programme for
control and prevention of the disorder (Alwan and Modell 1997). The estimated annual
number of thalassaemia major births in Pakistan, based on the carrier rate and the
frequency of consanguineous marriages in each ethnic group, would be approximately
4550 (1.2/1000 new births) (Table: 10.1). Maximum affected births are expected in
Punjabis (1.12/1000) which also is the largest ethnic group (80 million). The highest birth
rate, however, is expected in Baluchis (4.3/1000). This is due to a high carrier rate
combined with a high frequency of consanguineous marriage. The affected birth rate
amongst Sindhis (0.324/1000) is low because of a low carrier rate (1.3%) in this group.
The annual births of children with an abnormal haemoglobin, based on the figures of
Sharma et al, (1976), are estimated at 99 new cases each of homozygous Hb-S and Hb-E.
An additional 181 cases each of Hb-S/13-thalassaemia and Hb-E/f3-thalassaemia are also
expected every year. Therefore the overall annual number of children born with a
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clinically significant haemoglobin disorder is estimated at 5116 (approximately 1.35 per
1000 births) and its major portion (89%) is represented by 13-thalassaemia. The total
number of pregnancies at risk would be approximately 20500. The estimated total number
of births of children affected with a clinically significant haemoglobin disorder and the
number of at risk pregnancies in Pakistan (Fig: 2.2 and 2.6) is the highest in the Eastern
Mediterranean Region (Alwan and Modell 1997).
Table: 10.1. Carrier rates for 13-thalassaemia and the estimated number of births with
thalassaemia major in the five major ethnic groups of Pakistan.
Ethnic group:
	 Population:	 Carrier rate: F:	 Estimated	 Annual cases:
births/1000:
Punjabi	 80 million	 4.5%	 0.0280	 1.12	 2454
Pathan	 20 million	 5.2%	 0.0164	 2.09	 610
Sindhi	 15 million	 1.3%	 0.0437	 0.32	 136
Baluchi	 7 million	 9.0%	 0.0532	 4.31	 844
Mohajir	 15 million	 5.2%	 0.0209	 1.21	 506
Total:	 137 million	 5.3%	 0.0287	 1.35	 4550
Awareness campaign:
An essential prerequisite of a thalassaemia prevention programme would be to educate the
public as well as the health professionals about the basic concept of thalassaemia
prevention. The adult literacy rate in Pakistan is 35% and the rates for the urban and rural
areas are 58% and 28% respectively (Economic survey 1995-96). In a predominantly
illiterate community special means of educating the public would be required. This study
shows that treating physicians are the most important source of information for the
affected families. Therefore, the first and the most important aspect of educating the
population would be to educate the doctors. At present very little genetics is taught in the
undergraduate medical colleges in Pakistan (Hassan et al, 1997). Even at the postgraduate
level genetics is a neglected speciality. Physicians, nurses, and social workers in practice
need to be informed of new technologies and approaches. Special courses in genetics may
235
be arranged. Medical genetics newsletter may be a good idea for the busy medical
professionals where selected topics may be regularly discussed. Education for the young
population can be achieved through education in schools. It is also worth noting that
because of the young age structure of the population, education efforts focused on
schools can have a relatively greater impact than in most developed societies (Alwan and
Modell 1997). Regular programmes about thalassaemia on radio and television can also
be useful.
A simple and effective first step would be to focus on informing the families reporting at
the treatment centres. Experience has shown that most of the affected families have very
little information about the disease and they readily lend their ears to any advise that could
be useful for them. The use of television for disseminating information on thalassaemia
was quite effective. Easy to understand booklets on thalassaemia, although not as
effective as television due to low rate of literacy, were also useful. The experience of the
couples who have used prenatal diagnosis was also an important medium of information
for other families.
Provision of improved treatment facilities:
The affected parents are unlikely to become attracted to prevention unless they are
assured about the health of the sick child. An essential step before prevention can be
offered, would be to improve the treatment facilities. Since thalassaemia is not the
Government's health priority at present the treatment is mostly left to Non-Governmental
Organizations (NGOs) who are looking after over 7500 registered thalassaemics in the
country. Unfortunately, there is no uniformity in management protocols at the centres run
by the NGOs. There is also no audit on the quality of treatment being offered (Saleem
1996). Till such time that thalassaemia becomes Government's health priority the NGOs
would be required to improve the standard of treatment at their centres. It can be
improved substantially by agreement amongst the health professionals involved, adoption
of a common management protocol, and their audit at frequent intervals (Angastiniotis et
al, 1986).
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National co-ordination committee for thalassaemia:
The National co-ordination committee may be required when the importance of
thalassaemia is recognized. This may be a long time in the future. Since the problem is
emergent some planning must start now. Competent leadership and effective co-
ordination between various governmental and non- governmental organizations is
essential. A national co-ordination committee is required for planning, monitoring, and
evaluation of the progress of the work. The responsibilities of the committee should be to
focus on formulation of policies, preparation of a national plan and mechanisms for co-
ordination. The committee should include a programme co-ordinator, specialists in
medical genetics, haematology, paediatrics, community medicine, public health and health
education. The programme co-ordinator should be a highly motivated and knowledgeable
person. He or she should either be based in the Ministry of health or work in co-
ordination with the responsible health officers (Aiwan and Modell 1997).
Carrier screening for haemoglobin disorders:
Carrier screening has played a major role in thalassaemia prevention programmes in the
Mediterranean (Cao 1987). The Mediterranean experience clearly demonstrates the value
of incorporating a community based control programme into the primary health care
system to ensure effective delivery to the population (Angastiniotis et al, 1986). Since the
primary health care system is not well developed in Pakistan (Burney 1993) thalassaemia
prevention through this would be unrealistic. Screening of the whole population is also
not reasonable due to administrative and financial constraints. A common approach for
identifying at risk couples in Europe is the screening in pregnancy (Cao 1987). A major
limitation of this approach in a developing country like Pakistan is that the vast majority
of the pregnant women, especially in the rural areas, cannot be screened because they do
not report to an antenatal clinic. According to a survey, trained personnel attend only
26% of pregnant women in Pakistan (Burney 1993). Under these circumstances it is very
unlikely for antenatal screening to be practically feasible. The approach may be suitable
for countries like the UK where most women attend antenatal care in early pregnancy
(Modell and Berdoukas 1984). Another important aspect of screening during pregnancy is
the gestation at which the risk is discovered. If it is discovered late it is unlikely that it
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would lead to abortion even if the fetus were affected.
Clearly, an alternative approach for Pakistan is needed. It may be appropriate to have a
selective approach for (a) more developed part of the population within reach of the
services (b) families who already know about thalassaemia. The idea of targeting a
selective population of index families is attractive (Aiwan and Modell 1997). However,
of
there are no reports on the success this approach. In this pilot study, that is the first of its
kind in which the families affected by thalassaemia were targeted, many points of interest
were highlighted. The study is not big enough to lead to a real conclusion as yet and
further research e.g. long-term follow-up of the families is required.
Identification of at risk couples:
One of the objectives of thalassaemia screening is the identification of at risk couples. The
majority of thalassaemic couples in Pakistan are identified retrospectively when they
already have one or more affected children. In communities where family size is small
retrospective identification of the couples and offering them prenatal diagnosis is unlikely
to reduce the incidence of new births of thalassaemia major (Cao 1987). By contrast,
when the final family size is large, retrospective counselling may lead to either cessation of
reproduction or prenatal diagnosis. This can reduce the affected birth rate in the
community by up to 50% (Alwan and Modell 1997). However, further reduction in the
birth rate of the affected children would require prospective identification of at risk
couples. In this study the alternative approaches of screening in pregnancy and screening
the index families were investigated.
Antenalal screening:
In this study screening of 350 pregnant women could not identify any at risk couple as
compared to a theoretical possibility of I in 200. This could be due to the small numbers
studied. But there is a clear indication that screening of a large number of individuals
would be required to identify only a few at risk couples. Another difficulty may arise due
to late identification of at risk couples when prenatal diagnosis or termination of
pregnancy may not be acceptable to the couples. Only 18% of the pregnant women
screened were in the first trimester. The late discovery of risk may also produce dramatic
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emotional stress on the families (Petrou et a!, 1990).
Screening in the index families.
The results of screening in several small to large families show that the approach is
technically feasible and acceptable to almost 213id of the families. Screening the index
families on an average identified 31% carriers per family. By contrast, there was not a
single carrier amongst 397 members of the five families without a known history of a
haemoglobin disorder. Screening in a similar number from the general population would
have identified at least 20 (5%) carriers. This suggests that very frequent marriages
between close relatives or Biradri/Tribe members "traps" normal as well as abnormal
genes within the family. These results strongly support that screening in the affected
families would be the most rewarding in this setting. Interestingly, the carrier rate
amongst consanguineous Pakistani families is not higher compared to a non-
consanguineous Cypriot family with history of thalassaemia (Mouzouras et al, 1980). This
is because approximately 50% of the l' degree relatives of a carrier would be carriers
whether the marriage pattern is consanguineous or non-consanguineous. Consanguineous
marriage as such would have little effect on the carrier rate of an abnormal recessive gene
in the family. However, in a family with predominant consanguineous marriages the key
factor is the general high risk of relatives who may marry each other.
There were approximately 29% unmarried carriers in a family. If all marriages in a family
are consanguineous then at 29% carrier rate 8.4% of the carriers would be married to
another carrier. The frequency of consanguineous marriages in these families was around
45%. At this rate 13% (29% of 45%) of the carriers would be married to 13% of the
related carriers while the remaining 16% of the carriers would be married to 5% of the
unrelated carriers in the general population. This would mean a total of 2.5% (1.7% plus
0.8%) of the couples in a family would be at risk. On an average there were 22.5 couples
per family. It is estimated that 2.5% of the 22.5 couples (0.56 couples per family) would
be at risk. The observed number of at risk couples per family, however, was higher (1.7
per family). The difference is because the study families are selected and all but one had at
least one affected child. In the family without an affected child the index person was a
thalassaemia carrier. It means that all families that are targeted because of a history of
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haemoglobin disorder may not have at risk couples. This may be especially true when the
index person is a carrier rather than an affected child.
Effect of screening on the marriage choices:
The main objective of population screening for thalassaemia is the identification of
carriers early enough for marriage choices to be affected. Experience from a research
study in Greece shows that premarital screening has had very little effect on the choice of
partner (Gosden 1993). Studies from Cyprus also show that discouraging marriages
between carriers had proved unacceptable and was abandoned (Wald et al, 1988). The
follow-up for one year after screening in the index families studied shows that there was
some impact on the marriage choices. However, this is too short a period to draw firm
conclusion and clearly further research on this subject is needed. Preliminary results
suggest that premarital screening and preventing marriages between carriers may present
itself as an acceptable approach in a Pakistani setting. This may be particularly important
for the families who do not accept prenatal diagnosis on religious ethical or cultural
grounds. Premarital screening may be expected to have a long term benefit if the carriers
are suitably informed. Premarital screening is being considered in a number of countries of
the Eastern Mediterranean Region and has already been mandated in Iran (Alwan and
Modell 1997).
Other advantages of screening the index families:
There are several other advantages in screening the index families. For example, the
screening can be initiated by counselling of one or a few individuals in a family. The rest
of the family members are likely to follow the guidance of the leading members. A critical
step would be to identify the right person as the starting point. The key person in a family
can be identified by asking others to whom they go for advice. Some of the families who
refused the offer for screening mostly did so because of the lack of a key person. The
social set up in most Pakistani families, particularly in the rural areas, is such that a few
family elders handle most of the important affairs (Punjabi 1976). The obedience of the
younger generations is considered obligatory. Therefore it would be appropriate to
involve the family elders in the screening exercise. Marriage in a Pakistani set up is mostly
planned by women, but the final decision whether to accept or to reject the proposal may
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lie with the men. While carrying out screening inclusion of both men and women would be
essential.
There also are technical advantages in carrying out a targeted screening. For example it
can be started from the eldest available members. The children may be screened only
when one or both of their parents are found to be carriers. A practical problem may arise,
because in a field trip to a rural area it may be difficult to screen the elders first and
sample the children at a later stage. One tube osmotic fragility test (Kattamis et al, 1981)
can be very useful for guiding on the spot whether to include or exclude a person from
screening. This may substantially reduce the number of individuals requiring screening.
Genetic counselling:
At present most of the couples who seek genetic counselling in the Eastern Mediterranean
Region, including Pakistan, are already married and have one or more affected children
(Alwan and Modell 1997). Once the genetic diagnosis is made the couples learn that the
treatment of the child is complex and life long and there are chances of recurrence of the
disorder in future pregnancies. A choice to have no further children may be relatively
simple for couples who have several healthy children. The choice may be difficult for the
young couples. The study shows that prenatal diagnosis is technically feasible and is also
accepted by the majority of the retrospectively identified couples. This may reduce stress
within the families by broadening choices away from focus on choice of partner. It
therefore would reduce stigma, stress and fear. Continuing and sustained efforts are
needed for counselling the affected couples who report to the treatment centres. This is
not only important for the couple itself but it also provides an opportunity to access a
large number of other family relatives who may be at risk. Aiwan and Modell (1997) have
suggested that retrospective counselling of the affected couples where the final family size
is large may reduce the birth incidence of thalassaemia major to almost 50%. The offer of
prenatal diagnosis to such couples can further reduce the birth rate of affected children.
The response of the prospectively identified at risk couples to genetic counselling could
not be assessed in this study as this is a long term undertaking. Clearly more research is
needed to investigate this aspect.
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Genetic counselling aims at replacing misunderstandings with correct information about
the cause of genetic disease and resources available for its diagnosis, treatment and
prevention. It is usually done according to the internationally accepted guidelines (Harper
1993). The approach however may be modified according to the local cultural, social and
religious beliefs (Aiwan and Modell 1997). The issues that need consideration while
formulating an approach for counselling Pakistani families include (1) illiteracy (2)
confidentiality (3) stigmatisation and (4) consanguineous marriages.
Illiteracy:
Comprehension of the genetic concepts correlates with the level of education (Yuen et al,
1988). However, even in well educated communities the effect of counselling on the
knowledge of carrier state and its implications may be small (Barrai and Vullo 1980b).
The situation may be worse in a predominantly uneducated community as in Pakistan
where it may be difficult to grasp even the basic concept of a genetic disorder. The aim of
providing an informed choice can be achieved only if the parents understand the
implications of the choices. Therefore the genetic counsellor in addition to providing
information and giving an informed choice, may have to help in making the right choice.
The counsellor should not be over-directive or the individuals may feel guilty about their
choice. Counselling may be made more effective by using visual aids and illustrated
booklets.
Counselling would be easier if the person has already seen affected children. While
screening the index families most members would have at least some knowledge about the
affected child's illness. This is a significant advantage when the literacy rate is very low. It
would be unrealistic to expect an illiterate Pakistani lay person to understand or believe
they carry a very severe disease, which they have never seen or heard about previously.
Counselling therefore would be easier and more effective when delivered to members of a
thalassaemic family.
Confidentiality:
Confidentiality of results would be a key factor in counselling of individuals in a family.
During screening in the families it was observed that some individuals had reservations
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about screening because they thought it might cause difficulties in arranging marriages of
their children. The marriage in a traditional Pakistani family is arranged by agreement
between the parents of the spouses. The parents try their best to find a match within the
family or the Biradri (Punjabi 1976). Therefore if the carrier status of a boy or a girl was
known within the family, then these individuals may be rejected as spouses. In one of the
families, the mother of a thalassaemic child, who herself was under considerable stress due
to the illness of her child, preferred to hide the carrier status of her younger brother while
arranging his marriage with another close relative. The targeted screening is attractive but
its actual impact on making decisions about marriage preferences in a family may be
complicated. In cases where rejection of a carrier is feared, prenatal diagnosis may work
as an acceptable solution. Rejection of heterozygotes does not happen in Cyprus because
the population is educated and prenatal diagnosis is freely available (Prof. B. Modell
personal communication).
Stigma:
Thalassaemia carrier status may be taken as a stigma for the affected person or families.
The counselling of carriers should also include efforts to reduce the element of
stigmatisation. It may help to inform the carriers of the benefits associated with the
disease. The knowledge that the carriers have a natural resistance to falciparum malaria
(Weatherall et al, 1989) or ischaemic heart disease (Crowley et al, 1987; Gallerani et al,
1991; Wang and Schilling 1995) may be helpful to reduce stigmatisation.
Consanguineous marriage and implications for counselling:
In populations where consanguineous marriage is customary, an understanding of its
genetic implications is essential for developing appropriate genetic services. Numerous
studies provide supporting evidence that consanguineous marriage is associated with
increased risk of genetic disorders (Bittles 1980). However, the data supports some harm
but clearly shows it is far less than generally believed. It is important to understand that
the outcome of consanguineous marriage should not be assessed solely in terms of the
restricted horizon of medical audit (Bittles 1995). There are numerous social and
economic benefits associated with this practice (Aiwan and Modell 1997). Our current
state of knowledge tends to be overly focused on the undesirable clinical outcome of close
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kin marriage, which affect only a minority of families and individuals (Panter-Brick 1991).
There is a much larger proportion of couples whose children do not show identifiable
deleterious biological effects and to whom the social and economic benefits of a
consanguineous marriage appear obvious and natural (Bittles 1995).
This leaves a dilemma for the medical geneticists and others, whether to discourage the
practice on medical grounds or not. Attempts to discourage the practice on genetic
grounds alone can do more harm than good (Modell and Kuliev 1992). A more
appropriate and acceptable solution would be the establishment of educational
programmes and to provide counselling and carrier screening if available for the families
who already have a child with a recognizable genetic disorder or where there is an
unfavourable family history. In Pakistan the progress in developing screening programmes
for genetic disorders may be slow because of the limited resources available. A strategy to
identify and diagnose genetic risk may be required, that can be gradually developed over
time. Haemoglobin disorders are a good group to pilot and develop the approach.
Prenatal diagnosis:
Molecular genetics of haemoglobin disorders:
Plenty of data are available on thalassaemia mutations in people from the Indian
subcontinent (Kazazian et al, 1990). But most of the studies have been done on selected
individuals settled in the Western countries. Varawalla et al (1991a; 1991b) have studied
13-thalassaemia mutations in British Pakistanis from the northern parts of Pakistan. But
this study is inadequate for epidemiological purposes because of a small sample size and
lack of representation of all ethnic groups. The present study of over 1200 mutant alleles
provides a comprehensive picture of 3-thalassaemia mutations in the major ethnic groups
of Pakistan.
A total of 19 different mutations were identified. The five common mutations, IVSI-5 (G-
C) (37%), Fr 8-9 (+G) (25%), del 619bp (7%), Fr 41-42 (-TTCT) (7%), and IVSI-1 (G-
T) (5%) account for 81% of the alleles. In each ethnic group four or five common
mutations account for over 80% of the alleles (Fig: 10.4).
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The spectrum of mutations is heterogenous in all of the ethnic groups except in Baluchis
where IVSI-5 alone comprises 75% of the alleles. Several factors e.g. the time since
appearance of a mutation, population migrations, and random genetic drift might have
contributed to the genetic heterogeneity.
Technicalfeasibility ofprenatal diagnosis.
Prenatal diagnosis by direct mutation analysis was possible in over 98% of the couples. In
the remaining couples linkage analysis can be used as a backup support. The method is
quick, reliable and cost effective. Mutation analysis by multiplex ARMS PCR was also
technically feasible and very effective in reducing the cost.
Response of the families to prenatal diagnosis:
There is very little information about the reaction of Muslim families in general and
Pakistanis in particular to prenatal diagnosis. Initial information for British Pakistanis
suggested a low uptake rate of prenatal diagnosis (Modell et al, 1981). Recent results in
the UK show that late referrals, inadequate counselling and a preconception amongst
health professionals that Pakistanis do not terminate pregnancies because of religious
reasons are the main reasons for low utilization (Petrou 1994). The data from British
Pakistanis cannot be extrapolated to Pakistan as British Pakistanis mostly represent
people from the Mirpur district in the north of Pakistan that migrated to the UK in the
sixties and maintain limited contact with the people back home.
The vast majority of the affected couples in this study (96%) were in favour of prenatal
diagnosis and said they would request it in the future pregnancies. Only 56% of the
families who had a pregnancy when prenatal testing was available actually used prenatal
diagnosis. This finding is not unusual because many people may not actually do what
they might have thought of doing in the future (Aiwan and Modell 1997). The behaviour
of the couples was related to their educational level and socio-economic status. For
example, in a randomly selected sample 27% of the couples said they would request
prenatal diagnosis in future pregnancies only if the test were free of cost because they
could not afford it otherwise. This was probably an important factor in the lower than
expected uptake of the test which costs Rs. 3000 ($75). The families may not have been
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worried about the cost of treating a thalassaemic child as this was free of charge (blood
transfusions only).
This study clearly shows that prenatal diagnosis is accepted by most thalassaemic families
in Pakistan. There are two important issues that may determine the long term outcome of
prenatal diagnosis and need further discussion. These are (1) termination of pregnancy for
a serious genetic disorder and (2) cost of prenatal diagnosis.
Termination ofpregnancy for serious genetic disorders.
Islam is the leading religion of Pakistan and it is the faith of about 97 percent of the
people. A vast majority of the population follows the Islamic rituals. The low rates of
adult literacy in Pakistan make it difficult for the people to distinguish between their
religious, traditional and cultural beliefs. This can easily lead to misconceptions about the
permissibility or prohibition of anything in religion. In the context of prenatal diagnosis of
genetic disorders the most important question is whether termination of pregnancy is
permissible in Islam, if the fetus is affected by a serious genetic disorder?
Induced abortion has always been frowned upon in all human societies. As early as the
dawn of medical history abortion was taboo. Its proscription was included in the
Hippocratic oath and therefore it has been part of the professional heritage from
generation to generation up to our own times. The semblance of unanimity on prohibition
of abortion however excludes cases where a continuing pregnancy can be harmful for the
mother's well being or when the fetus is seriously deformed or defective (Hathout 1974).
The views of Islamic jurisprudence on the subject are unanimous in prohibiting abortion if
it is carried out on the embryo after animation unless there is a valid reason or excuse
justifying it. Concerning abortion before animation the views differ and range from
permissibility and disfavour to prohibition (Makdur 1974). The concept of animation is
explained in a Quranic verse as follows:
"Then We made the sperm into a clot of congealed blood; then of that clot
We made a lump (fetus); then We made out of that lump bones and
clothed the bones with flesh; then We developed out of it another
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creature" (Al-Quran, Sura Al-Momenoon verse 14).
There is consensus of opinion that "development of another creature" means breathing of
soul in to the inanimate fetus (Shafi 1980). However, a difference of opinion is found in
the timing of animation. Some people think it coincides with the start of fetal heartbeat
(40 days). Most Islamic scholars consider 120 days of embryonic age as the timing of
animation, which is based on the following Hadith:
"Each one of you is put together in the womb of his mother for forty days,
and then turns into a clot for an equal period (of forty days) and turns
into a piece offlesh for a similar period (offorty days) and then the soul
is breathed into him" (Abdullah, Sahih Al-B ukhari, 8.593).
The community would accept the concept of prevention of thalassaemia if it were seen to
be compatible with religious as well as cultural beliefs. Therefore it is important to
consider the views of religious scholars, doctors, and the affected families. Two renowned
religious scholars in Pakistan, when asked to give an opinion on the subject of
permissibility of prenatal diagnosis for thalassaemia gave a clear verdict that it is
permissible provided termination of pregnancy is carried out before 120 days (17 weeks)
of pregnancy. Whether the time period specified is gestation or the embryonic age is not
clear. But as a general policy we have taken the upper limit as the fetal age determined by
ultrasound examination. Both the scholars had based their opinion on the above quoted
Quranic verse and the Hadith.
Obstetricians have different views on termination of pregnancy. The two obstetricians
who did CVSs in this study are of the opinion that termination can be done at any stage of
pregnancy regardless of religious interpretations. They have in fact done CVS for couples
reporting late and have also terminated pregnancies in such cases. Although there is no
legislation in Pakistan defining an upper limit of permissibility of termination, it is
important to work within the framework defined by consensus of opinion. We have not
encountered criticism from any religious or social organization since introducing the
service for prenatal diagnosis. However if a debate on this subject should arise in future,
248
the service can be defended if it has the backing of prominent religious scholars. Leaving
such sensitive issues to each individual's own judgement in the absence of consultation
with religious leaders and the community can have harmful effects for the whole
programme.
Several couples in this study who were hesitant in using prenatal diagnosis were greatly
relieved to learn that Islam permits termination of pregnancy under special circumstances.
During the two study years three couples requested prenatal diagnosis after the 17th week
of gestation. They were counselled and informed about the Islamic view on terminating a
pregnancy at this stage. All three couples were greatly disappointed to know about this,
but all opted to refrain from using the test.
Most of the couples who requested prenatal diagnosis in this study had little hesitation in
terminating a pregnancy. Only 3/42 (7%) couples refused termination on religious
grounds. An important reason for the high rate of acceptance of termination is that the
couples had already made up their minds before requesting the test. It is likely that those
who had reservations about the acceptance of termination had avoided the test. Most of
the prospectively interviewed couples (87%) would have a termination of pregnancy if
required in future.
Cost ofprenatal prenatal diagnosis:
There is no allocation for thalassaemia in the National health budget and the affected
families have to bear the cost themselves. Therefore the cost of treatment and diagnostic
procedures is of fundamental importance in Pakistan. It was observed that the socio-
economic status of over 2/3'' of the couples whose children were receiving treatment at a
centre in Lahore was low (income <Rs. 5000 per month). This is also reflected by the
response of 24% of the couples who would be willing to use prenatal diagnosis only if it
were done free of cost. The total cost of one prenatal diagnosis including CVS, laboratory
diagnosis and possible termination in selected cases is Rs. 3600 ($90) by the standard
method and it can be reduced to Rs. 3000 ($75) by the multiplex ARMS method. The
cost is very low as compared to $ 900-1000 per diagnosis in the UK (Petrou et al, 1990).
This is mainly because of the very cheap cost of labour in Pakistan. Our experience shows
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that even at such a low cost many patients are unable to afford the test. Clearly there is a
need to subsidize the cost of prenatal diagnosis by the government or NGOs.
National thalassaemia prevention programme:
Short-term measures:
The "ideal" approach for thalassaemia prevention in Pakistan is a long way in the future.
The most important first step would be the organization and utilization of the existing
resources. The NGOs have a very important role to play. From the point of view of
prevention, the most effective simple and cheap step would be to focus on informing the
affected families at the treatment centres about carrier screening and prenatal diagnosis.
This step alone may bring about 50% reduction of new births in the families who come to
treatment centres (Alwan and Modell 1997). Offering prenatal diagnosis to the couples
would further reduce the birth rate. However, the cost of prenatal diagnosis might have to
be subsidized to make its full utilization.
Long-term measures:
The long term solution for thalassaemia lies in the adoption of a National policy. A
suggested plan for the programme is presented in Fig: 10.5. This includes establishment of
a cell for prevention and control of genetic disorders in the ministry of health and the
appointment of a National programme co-ordinator who should co-ordinate the activities
of the Governmental and the non-governmental organizations. A joint approach for all
genetic disorders may be more appropriate to get Government support. Separate expert
panels should be appointed under the supervision of the National co-ordinator to organize
prevention and treatment activities of the important genetic disorders including
thalassaemia.
The expert panel on treatment for thalassaemia should include paediatricians,
haematologists, and psychologists. The panel should formulate and ensure adoption of a
uniform protocol for thalassaemia management and do research studies on new and
cheaper treatment options. For example the trial of oral iron chelators can be a useful
study. Provision of screened blood for transfusion should be ensured by compulsory
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screening of blood for hepatitis and HIV. A regular audit of the treatment facilities at the
centres run by NGOs and charity organizations should be mandated.
Cell for genetic disorders
(Ministiy of Health)
WHO	 Programme Co-ordinator	 .-	 NGOs
4
Haemoglobin Disorders 	 Other genetic & Congenitalj
Disorders
WE4
Expert Panel on
Treatment
Paediatrician
Haematologist
Psychologist
Blood Banks
Transfusion/Chelation
Psychological Support
BMT
Fig: 10.5. A suggested layout of a National plan for prevention and control of genetic
disorders in Pakistan.
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The panel on prevention should comprise geneticists, haematologists, and experts on
public health and community medicine. The National plan for prevention should include
training of manpower and establishment of diagnostic centres. Basic facilities for
screening of haemoglobin disorders should be established at each district hospital
laboratory. Additional units for carrying out screening of haemoglobin disorders should
also be established at each treatment centre. The latter should be equipped with sufficient
staff to carry out screening in the families and provide genetic counselling to the affected
couples and the carriers.
A centre for carrying out CVS should be established at each thalassaemia treatment
centre. The samples collected at these centres can be transported to a central DNA
laboratory. A DNA laboratory should also be established in the South of the country. The
two laboratories should be able to handle the prenatal diagnostic work for the whole
country.
Monitoring the outcome ofprogramme:
The success of the programme can be monitored at regular intervals by evaluating the
following parameters (Alwan and Modell 1997) at the treatment centres:
1. Improvement in survival of patients monitored through a central registry of the
number and age distribution of patients.
2. Improvement in quality of life of the patients (e.g. growth, school attendance etc.).
3. Reduction in birth prevalence of new cases (also assessed through patient
register).
4. Documenting the circumstances of the birth of new thalassaemic children.
5. Impact on the family life of the parents (assessed by measuring the number of
healthy children they have relative to the population norm).
Funding for the thalassaemia prevention programme:
In view of the meagre health budget it is unlikely that a major share for funding would be
provided by the Government. Therefore fund raising by voluntary donations and NGOs
would be important. A National Thalassaemia Fund can be established. The help of
252
philanthropists and the Zakat Foundation, which is already sponsoring many useful
projects in the health sector, can significantly contribute towards initiating a programme
as well as its recurring expenditures. Zakat is a Muslim tax of 2.5% that is levied on the
total income and fixed assets of the well to do Muslims. The beneficiaries of the Zakat
fund are the poor and deserving people.
Cost and benefit of various policies for thalassaemia:
For the purpose of comparing cost effectiveness three policies for thalassaemia in Pakistan
are considered. Policy-i is based on providing only treatment facilities but no measures
for prevention. Policy-2, in addition to treatment, includes retrospective genetic
counselling and provision of prenatal diagnosis for all future pregnancies. Policy-3, in
addition to the features of Policy-2, includes screening the index families with a view to
prospectively identify at risk couples and offer prenatal diagnosis. A comparison of the
cost of the three policies (Fig: 10.6) clearly demonstrate the benefits of adopting policies
that include prevention.
Most of the savings in adopting preventive policies are done on the cost of treatment.
Since the Government is not spending anything directly on the treatment of thalassaemics,
the cost of initiating a prevention programme is likely to be an additional liability rather
than a relief for the Government. Keeping in view the limited health budget and the health
priorities of the Government, the role of NGOs and the private sector becomes important.
A co-ordinated activity and recruitment of more NGOs working for thalassaemia would
be of fundamental importance.
Application of the results to other EMR countries:
Consanguineous marriage and clinically significant haemoglobin disorders are common in
most countries of the Eastern Mediterranean Region (Alwan and Modell 1997). Table
10.2 summarizes the frequency of consanguineous marriages and the annual births of
children affected with haemoglobin disorders in the EMR countries. The majority
population of these countries is Muslim. Prevention programmes for thalassaemia do not
exist in any of these countries except Iran. Therefore the response of the population to
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various options of prevention is mostly unknown. The cultural social and religious
background of the entire EMIR has several things in common. However, the socio-
economic conditions, education and organization of the health care system varies
considerably in different countries of the region.
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Number of years from the start of policy
Fig: 10.6. Cost effectiveness of the three policies for thalassaemia in Pakistan. A basic
feature of all policies is the provision of adequate treatment facilities to all patients.
Policy-i includes only treatment but no measures for prevention. Policy-2, in addition to
treatment, includes retrospective genetic counselling and provision of prenatal diagnosis
for all future pregnancies. Policy-3, in addition to the features of Policy-2, includes
screening the index families with a view to prospectively identify at risk couples and offer
prenatal diagnosis.
The following general guidelines based on the results of this pilot study can be helpful in
formulating policies for other EMIR countries:
1. Screening the index families is the most cost effective approach to identify at
risk couples and unmarried carriers i.e. "premarital testing" well in advance.
2. Screening the index families provides the best opportunity for counselling of
the carriers as most members of the family have at least some knowledge of
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the illness of the affected child.
3. Antenatal screening may be feasible if most at risk pregnancies can be
monitored in the l trimester.
4. Prenatal diagnosis is technically feasible by cost effective methods and is also
accepted by the affected families provided at risk pregnancies are identified in
the l trimester.
5. Most religious scholars consider that termination of pregnancy is permissible
for a serious genetic disorder provided it is done before 17 weeks of gestation.
Efforts to discourage consanguineous marriages on medical grounds can do more harm
than good. The best approach would be to encourage carrier screening in the families at
risk and take the information and availability of prenatal diagnosis into account when
planning marriages.
Table: 10.2. Frequency of consanguineous marriage and annual number of children
affected by haemoglobin disorders in the EMIR countries (Based on Alwan and Modell
1997).	 _____________________ _____________________________
Country:	 Total consanguineous	 Annual number of children affected
_______________________ marriages:	 with Haemoglobin disorders:
Bahrain	 39%	 126
Egypt	 29%	 808
Iran	 37%	 1,896
Iraq	 58%	 1,501
Jordan	 50%	 97
Kuwait	 54%	 47
Lebanon (muslims)	 30%	 110
Libya	 166
Moroco	 1,824
Pakistan*	 45%	 5100
Saudi Arabia	 54%	 2,845
Sudan	 2,314
Syria	 1,043
UAE	 54%	 46
Yemen	 ?	 1,571
! 2UU'Yo consanguineous marnages
* this study
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Appendix-B
QUESTIONNAIRE FOR THE PARENTS OF THALASSAEMICS
Reference:
Father's education:	 [None]	 [Primary]	 [Matric]	 [Above
matric]
Mother's education:	 [None]	 [Primary]	 [Matric]	 [Above
matric]
Monthly income of the family:
	 [<Rs. 5,000] [Rs. 5,000-10,000] [>Rs. 10,0001
Total No of children:	 [ ______ I
No of thalassaemic children: [ ______ I
Does thalassaemia affect your family life?	 [A little]	 [Often]	 [A lot]
Does thalassaemia affect your financial situation? [A little] 	 [Often]	 [A lot]
Do you know that prenatal diagnosis is available in Pakistan?
	 [Yes] [No]
Who told you about prenatal diagnosis?
[	 I
Did you have a pregnancy in the last 2 years?
	 [Yes] [No]
If yes, did you request prenatal diagnosis?
	 [Yes] [No]
If no, then why not?
[	 I
Would you request prenatal diagnosis in your future pregnancies?
[	 I
Do you agree with termination of pregnancy for thalassaemia?
	
[Yes] [No]
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Summary. Thalassaemia is the most common inherited
disorder in Pakistan and there are very inadequate treat-
ment facilities for over 4000 homozygotes born each year.
Prevention of these disorders therefore forms an essential
part of the management of this enormous health problem.
We have characterized 1216 3-thalassaemia alleles from the
five major ethnic groups of Pakistan. The complete spectrum
comprised 19 different mutations. There are important
ethnic and regional differences in the prevalence of muta-
tions. The five most common mutations. IVSI-5 (C-C)
(37'3%), Fr 8-9 (+G) (259%). del 619 (7'O%). Fr 41-42
(—TTCT) (6'7%) and IVSI-1 (G-T) (5'4%), constitute 82'3%
of the total. Fr 8-9 (+G) is the most common mutation in
Northern Pakistan (41'3%). whereas P/SI-S (C-C) is the
most frequent mutation in Southern Pakistan (52'2%). Six
subjects with transfusion-dependent thalassaemia major
showed only a single mutant allele. One subject with
transfusion-dependent thalassaemia major showed a novel
17 bp deletion involving Cd126-1 31. Our findings provide a
comprehensive basis for carrying out prenatal diagnosis of
thalassaemia in a geographical area where it is found in high
frequency.
Keywords: thalassaemia. mutations, ARMS. DGGE. prenatal
diagnosis.
Pakistan has a population of 120 million people. The annual
rate of population growth is 3% and almost 40% of the
population is below 15 years of age. There are four major
ethnic groups: Punjabis and Pathans living in the North, and
Sindhis and Baluchis living in the South. In addition.
Mohajirs. a large number of immigrants from various parts
of Northern India who migrated after the partition of the
subcontinent, are settled mainly in the South. Each ethnic
group is subdivided into Casts or 'Biradris' of people ranging
from a few thousand to millions. There is a very strong
tendency for people to marry within their ethnic group, and
particularly their 'Biradri'. Another very common custom is
marriage between close relatives, especially first cousins
(Shami & Zahida. 1981: Dan & ModeIl. 1988). This peculiar
situation results in an unusually high frequency of
autosomal recessive disorders.
Infant mortality is falling as the major communicable
diseases are coming under control and, consequently,
inherited disorders are becoming a recognized problem.
/3-Thalassaemia is the most common inherited disorder in
Pakistan and studies on its carrier frequency have shown an
Correspondence: Dr Mary Petrou. University College London Medical
School. Perinatal Centre. Department of Obstetrics and Gynaecol-
ogy, 86-96 Chenies Mews, London WC1E 6HX.
average rate of 5% (Khattak & Saleem. 1992). It is estimated
that over 4000 thalassaemic children are born in Pakistan
each year. and the available health facilities are inadequate
to cope with the number of sick children. The essential part
of the approach to this problem is therefore a community-
based preventive programme including carrier screening,
genetic counselling, and the offer of prenatal diagnosis (Cao.
1987). Prenatal diagnosis will depend on knowledge of the
local mutations causing thalassaemia (Kazazian et al. 1990).
but to date there has been no systematic study of the
molecular genetics of thalassaemia in relation to ethnic
groups in Pakistan. The only information available is derived
from a limited number of Pakistani subjects residing in the
U.K. (Varawalla et a!, 1991a, b). In this study we have
investigated a large number of mutant alleles causing 3-
thalassaemia in the five major ethnic groups of Pakistan.
MATERIALS AND METHODS
Subjects
The material of this study is derived from a total of 703
unrelated subjects including 184 /3-thalassaemia minor
cases and 519 cases of transfusion-dependent thalassaemia
major. The thalassaemia major patients ranged from 3
476	 1996 Blackwell Science Ltd
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months to adult. Representation by ethnic group was as
follows: Punjabi 256, Pathan 135, Sindhi 132, Baluchi 89,
and immigrants from various parts of India (Mohajirs) 91.
The subjects were identified by the Department of Haemat-
ology, Armed Forces Institute of Pathology, Rawalpindi, by
the Fatimid Foundation's Thalassaemia Treatment Centres
at Peshawar, Lahore, Karachi, and by the Flussaini Blood
Bank, Karachi.
Mutation analysis
Amplification refractory mutation system (ARMS). The
samples were first tested by the method of Amplification
Refractory Mutation System (Newton eta!, 1989; Kwok et al,
1990) for the 15 known mutations previously reported in
Pakistani and Indian subjects (Varawalla et a!, 1991 a, b).
The list and the sequence of the primers used is given in
Table I. Subjects with thalassaemia major found to be
positive for any mutation were then tested for the presence of
the normal allele. Those found to have the normal allele
(double heterozygotes) were further tested for other muta-
tions. All of the homozygotes and double heterozygotes were
counted as representing two thalassaemic alleles.
PCR was carried out on a 25 yl reaction mixture
containing 5 pmol of each primer, 03 units of Taq
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polymerase (Advanced Biotechnologies, U.K.), 30MM of
each dNTP (Boehringer Manheim), lOmmol Tris HCI
(pH 83), 50mmol KC1, 15 mmol MgCl 2, 100 pg/mI gelatin
and 0'3-O5pg of genomic DNA. The thermal cycling
consisted of 25 cycles of denaturation at 94 C for 1 mm,
primer annealing at 65 C for 1 mm and DNA extension
reaction at 72 C for F5 mm. In the final cycle, the extension
reaction was prolonged to 3 mm. The PCR products were
electrophoresed in 4% NuSieve Agarose gel (Flowgen, U.K.),
stained in ethidium bromide and photographed under
302 urn UV light.
Denaturing gradient gel elect rophoresis. The samples that did
not reveal any mutation by ARMS were subjected to
Denaturing Gradient Gel Electrophoresis (DGGE) (Myers et
a!, 1987). Four overlapping regions of the /3-globin gene
were amplified as described by Cal & Kan (1990). PCR was
carried out on a 5Opl reaction mixture containing 10 pmol
of each primer, 1O unit of Taq polymerase (Perkin Elmer,
U.K.), 2OOp of each dNTP (Boehnnger Manheim),
lOmmol Tris HCI (pH 8'3), 5Ommol KCI, i5mmol MgCl2,
lOOpg/ml gelatin and 03-OSpg of genomic DNA. The
thermal cycling regimen consisted of initial denaturation for
5 mm at 95 C and then 40 cycles of denaturation at 94°C for
30s, primer annealing at 55 C for 30 s, and DNA extension
Table I. List of the mutations screened and the ARMS primers used for their identification.
Mutation
IVSI-5 (C-C)
IVSI-5
Fr 8-9 (+G)
Fr 8_9*
IVSI-1 (G-T)
IVSI1*
Fr 41-42 (-TrCT)
Fr 41_42*
Del 619bp
Cd 15 (C-A)
Cd 15*
Cd 5 (-Cr)
Cd 5*
Cd 30 (G-C)
Cd 30 (C-A)
Cd 30*
Fr 16 (-C)
IVSII-1 (C-A)
1VSll1*
Cd 26 (G-T)(Hb-E)
Cap +1 (A-C)
Fr 4 7-48 (+ ATCT)
1VS1-25 (25b del)
1. Control
2. Control
3. Common
4. Common
Primer
CFC err AAA CCF GTC TrG TAA CCF TCT TAG
CFC CTF AAA CCF CTC rFG TAA CCF TCT TAC
CCT TGC CCC ACA CCC CAG TAA CCC CAC ACC
CCT TCC CCC ACA CCC CAG TAA CCC CAC ACF
TFA AAC CTC TCT TCT AAC err CAT ACC AAA
CAT CAA Gil' GGT CGT CAG CCC CFC CCT ACC
GAG TCC ACA CAT CCC CAA AGC ACT CAA CCT
GAG TCC ACA CAT CCC CAA ACC ACT CAA ACA
CAA TCT ATC ATG Ccl' err TCC ACC
TGA GCA GAA GTC TGC CCT TAC TGC CCA CTA
TGA CGA CAA GTC TCC CCT TAC TCC CCA CTC
ACA CCC CAC TAA CCC CAC ACT TCT CCC CCA
ACA CCG CAG TAA CCC CAC ACT TCT CCC CAC
TAA ACC TCT CTI' CTA ACC TFG ATA CCF ACG
TAA ACC TGT err CTA ACC TFG ATA CCF ACT
TAA ACC TGT CTT CTA ACC 1l'G ATA CCF ACC
TCA CCA CCA ACT TCA TCC ACG TFC ACC TrC
AAG AAA ACA TCA ACC CTC CCA TAG ACT CAT
AAG AAA ACA TCA ACG GTC CCA TAG ACT CAC
TAA Cer TCA TAC CAA CCT CCC CAG CCC Gil'
ATA ACT CAC CCC AGA GCC ATC TAT TGC T1'C
ATA ACA CCA TCA CCA CTC CAC AGA TAG ATC
CrC TGC CTC CAA CCC TAG ACC ACC ACC ATA
CAA TGT ATC ATG CCT err TGC ACC
GAG TCA ACC CFC ACA CAT CCA GCA
ACC TCA CCC TCT GGA CCC AC
CCC err CCF ATC ACA TGA ACT TAA
* Primers for the normal alleles.
c 1996 Blackwell Science Ltd. British Journal of Haematology 94: 476-482
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861bp
439bp	 Fig 1. Elhidium bromide stained agarose gel
electrophoresis of ARMS PCR products. All
lanes show 861 bp amplified products of PCR
242bp internal control. Lanes 2. 3 and 5 show 215 bp
21 Sbp fragment of Fr 8-9 mutation. The sample in
lane 2 also has a 242 bp fragment representing
del 619. Lanes 7 and 9 show 439bp fragment
of Fr 4 1-42 mutation. Lane 10 contains Hae
Ill digest of 0X174.
reaction at 70 C for 1 mm. In the final cycle, the extension
reaction was prolonged to 3 mm. At the end of thermal
cycling 10tl of the amplified product was run on 2%
agarose gel to determine the quality of amplification.
DCCE was carried out on 7% polyacrylamide gel contain-
ing 32% formamide and 56 M urea as denaturants. Varying
degrees of gradients ranging from 25% to 80% ere
prepared by a gradient mixer. The gels were run at 60 C
overnight at 40 V.
Genoniicsequencirzg. The region of the /3-globin gene shown
by DCCE to have a mutation was amplified by a set of
primers flanking the mutation. 5 ;tl of the amplified product
was incubated at 37°C for 15mm with 10 units of
Exonuclease-I and 2 units of Shrimp Alkaline Phosphatase
(United States Biochemical). The Exonuclease-I removes
residual single-stranded primers and any extraneous single-
stranded DNA produced during PCR. The Shrimp Alkaline
Phosphatase removes the remaining dNTPs from the PCR
mixture which would interfere with labelling reactions of
sequencing. The enzymes were inactivated by heating at
80 Cfor 15mm.
DNA sequencing was done by the dideoxy chain termina-
tion method (Sangeretal, 1977). The Sequenase Version 2.0
DNA sequencing kit (United States Biochemical) was used.
The enzyme-treated double-stranded amplified product was
denatured at 100 C for 2 mm with 10 pmol of an internal
sequencing primer. The mixture was cooled by placing on ice
for 5 mm. Labelling was done using 5 1iCi 35S-dATP
(Amersham. U.K.) and 2 units of Sequenase Version 2.0.
The labelled DNA was run on 6% polyacrylamide gel
containing 7M urea at a constant power of SOW for 2-
3 h. The results were read after autoradiography for 48 h.
RESULTS
A total of 1222 mutant alleles were investigated. It was
possible to characterize a /3-thalassaemia mutation in 1216
alleles. The results of ARMS, DGGE, and genomic seq uencirig
are shown in Figs 1. 2 and 3, respectively. Six transfusion-
dependent thalassaemia major cases revealed only one
mutation. It was not possible to demonstrate the second
mutation even after sequencing the entire /3-globin gene and
its immediate 5' and 3' flanking regions. The 1216 mutant
alleles comprised of 19 different mutations. The results of
mutations in different ethnic groups is presented in Table II.
The live most common mutations, i.e. IVSI-5 (G-C), Fr 8-9
(±G), IVSI-1 (C-Ti, del bl9bp, and Fr 41-42 (—TTCT)
accounted for 82 3% of the alleles. Many regional and ethnic
differences in the distribution of mutations were noted
(Fig 4). Fr 8-9 (+ C) was found to be the most common
mutation in Northern Pakistan. The two major ethnic
groups of this region. i.e. Pathans and Punjabis, had Fr 8-9
(+C) in 491% and 372% of the alleles respectively. IVS1-5
(C-C) was found to be the predominant mutation in
Southern Pakistan. Sindhis. the major ethnic group of
Southern Pakistan, had IVSI-5 (C-C) in 439% and Baluchis
had IVS1-5 (C-C) in 762% of the alleles. Del 619bp was
1	 2	 34	 5	 67
Fig 2. Ethidium bromide stained DGCE of a 286 bp fragment of 13-
globmn gene extending from position —123 to Cd24. Samples in lanes
1 and 5 are homozygous for the normal sequence. Lanes 2 and 4 are
heterozygous for a polymorphism at Cd2. Lane 3 is heterozygous for
Cap + 1 mutation. Lane 6 is heterozygous for Cdl 5 and lane 7 is
homozygous for polymorphism at Cd2.
C 1996 Blackwell Science Ltd. British Journal of Haematology 94: 476-482
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Fig 3. DNA sequencing gel showing the non-
coding strand of exon III containing the 17 bp
deletion. Sequence of the normal DNA is also
shown.
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Table II. Prevalence of 3-thaIassaemia mutations In the major ethnic groups of Pakistan.
Mutation	 Punjabi	 Pathan	 Sindhi	 Baluchi
Common mutations
JVSI-5 (C-C)
Fr 8-9 (+G)
Del 619bp
Fr 41-42 (—TTCT)
IVSI-1 (G-T)
Uncommon mutations
Cd 15 (G-A)
Cd 30 (C-C)
Cd 5 (—CT)
Fr 16 (—C)
Cap+1 (A-C)
Hb-E
Cd 30 (C-A)
IvSII-1 (C-A)
Rare mutations
—88 (C-T)
IvSI-1 (G-A)
Fr 4 7-48 (+ ATCT)
Fr 126-131 (—l7bp)
Cd 39 (C-T)
IVSL minus 25
Total
107 (272%)
146 (372%)
14 (36%)
36 (92%)
19 (48%)
14 (36%)
15 (38%)
11 (28%)
6 (15%)
9 (23%)
3 (08%)
3 (08%)
6 (F5%)
1 (03%)
1 (03%)
2 (05%)
0 (00%)
0 (ftO%)
0 (00%)
393 (100%)
27 (129%)
103 (491%)
4 (F9%)
18 (86%)
4 (19%)
13 (62%)
1 (&5%)
16 (76%)
8 (38%)
8 (38%)
0 (00%)
2 (10%)
1 (05%)
2 (F0%)
0 (00%)
0 (00%)
2 (10%)
1 (05%)
0 (00%)
210 (100%)
114 (439%)
29 (1F2%)
36 (139%)
16 (62%)
33 (127%)
5 (19%)
19 (73%)
0 (00%)
6 (23%)
0 (00%)
0 (00%)
0 (0O%)
0 (00%)
0 (00%)
1 (04%)
0 (00%)
0 (00%)
0 (00%)
1 (04%)
260 (100%)
131 (762%)
14 (81%)
2 (12%)
1 (06%)
2 (12%)
9 (52%)
3 (17%)
1 (06%)
6 (35%)
0 (00%)
0 (00%)
2 (F2%)
1 (06%)
0 (00%)
0 (00%)
0 (00%)
0 (00%)
0 (00%)
0 (00%)
172 (100%)
Mohajir
75 (4F4%)
23 (127%)
29 (160%)
11 (61%)
7 (3•9%)
' 8 (44%)
4 (22%)
2 (F1%)
3 (F7%)
3 (F7%)
10 (55%)
4 (22%)
2 (11%)
0 (00%)
0 (00%)
0 (00%)
0 (00%)
0 (00%)
0 (00%)
181 (100%)
All
454 (37•3%)
315(259%)
85 (70%)
82 (67%)
65 (5.4%)
49 (40%)
42 (35%)
30 (25%)
29 (24%)
20 (16%)
13 (11%)
11 (09%)
10 (08%)
3 (03%)
2 (02%)
2 (02%)
2 (02%)
1 (01%)
1 (01%)
1216 (100%)
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Related but not first cousins 	 Unrelated
Different	 Same	 Different	 Same	 Different
mutation	 Total	 mutation	 mutation	 Total	 mutation	 mutation	 Total
10 (52-6%)
7(41-2%)
7 (28-0%)
7 (875%)
16 (4ft0%)
47 (43-1%)
9 (4740%)	 19
10 (588%)	 17
18 (720°)	 25
1 (125%)	 8
24 (600%)	 40
62 (56-9%)	 109
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PATHAN:
Fr8-9 49%
IVSI-5 13%
Fr41 -42 9'
Cd5 8%
AFGHANISTAN
PUNJA8I:
Fr8-9 37%
IVSI-5 27%
Fr41-42 9'
IVSI-1 5%j
PAKISTAN
BALUCHI:
IVSI-5 76%
Fr8-9 8%
Cc115 5%
Fr16 4%
SINDHI: LMOHAJIR:	 IVSI-5 43%
IVSI-5 41%	 De1 9 14%
DelGi 916% IVSI-1 1 3'4
FrS-9 13%	 Cd30 7".
Fr41 -42 6%
INDIA
Fig 4. Distribution of 1-thalassaemia
mutations in different regions and ethnic
groups of Pakistan.
seen predominantly in immigrants from India (16-0%) and
in native Sindhis (13-9%). CdS (—CT), CdlS (C-A) and
Cap+ 1 (A-C) were seen predominantly in Northern
Pakistanis. Fr47/48 (+ ATCT). a mutation previously
found in a Pakistani subject (Dr Mary Petrou, personal
communication), was detected in a Punjabi subject who had
thalassaemia intermedia phenotype. Three subjects had
typical Mediterranean mutations including IVS1-1 (C-A)
and Cd39 (C-T). A Pathan patient. who had consanguineous
parents and had severe transfusion-dependent thalassaemia,
was found to be homozygous for a novel 3-thalassaemia
mutation resulting in 17 bp deletion extending from Cd 126
to Cd131 (-TGCACCCTGCCTATCAG) (Fig 3).
The relationship between parental consanguinity and
inheritance of mutations in the subjects with thalassaemia
major, excluding the six subjects where only one mutant
allele was identified, is presented in Table III. Out of the 513
subjects, 315 (61-4%) were offsprings of first cousin
marriages. Another 89/513 (17-3%) were born to parents
who were related but were not first cousins (relationship not
beyond second cousins). In the consanguineous group 330/
404(81-7%) subjects had inherited the same mutation from
both parents. The remainder were double heterozygotes for
two different mutations. In the non-consanguineous group
only 47/109 (43-1%) had inherited the same mutation from
both parents.
Table HI. Relationship between consanguinity and inheritance pattern of thalassaemia mutations in individuals with two copies of 3-
thalassaemia genes.
16 (16-5%)
3 (67%)
8 19-4%)
8 (12-9%)
2 (7-7%)
37 (117%)
First cousins
Ethnic groups	 Same
(n)	 mutation
Punjabi (137)	 81 (83-5%)
Pathan (75)	 42 (933%)
Sindhi (128)	 77 (90-6%)
Baluchi (83)	 54 (871%)
Mohajir (90)	 24 (92-3%)
AU groups (513) 278 (88'3%)
97	 15 (71'4°A,)	 6 (28-6%)	 21
45	 4 (308%)	 9 (692°)	 13
85	 10 (556°)	 8 (44-4%)	 18
62	 11(84-6%)	 2 (15-4%)	 13
26	 12 (500%)	 12 (50-0%) 24
315	 52 (584%)	 37(41-6%)	 89
' 1996 Blackwell Science Ltd. British Journal of Haernaiology 94: 476-482
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[SCUSSION
ihe results of thalassaemia prevention programmes in the
Mediterranean (Cao, 1987) have provided a new incentive
to overcome the problem of thalassaeniia in countries such
as Pakistan. Experience in the Mediterranean has shown
that preventive programmes for thalassaemia based on
heterozygote carrier detection and genetic counselling alone
are not effective in reducing the incidence of new births of
children with thalassaemia major (Barrai & Vullo, 1980).
Prenatal diagnosis of thalassaemia has given a new
dimension to thalassaemia prevention. In order to carry
out prenatal diagnosis it is most important to have a
comprehensive knowledge of the prevalent mutations
(Kaxazian et a!, 1990). The molecular genetics of thalassae-
mia has been studied extensively in subjects from the Indian
subcontinent (Kazaxian et a!, 1984; Them et a!, 1988;
Varawalla et al, 1991a, b); however, most of this work has
been done on families settled in the West. There has been no
well-planned study on the ethnic groups in Pakistan. This
study gives a comprehensive picture of the molecular
genetics of 3-thalassaemia in Pakistan. The spectrum of
mutations in all of the ethnic groups studied is heterogenous,
and we have found 19 different mutations. An important
reason for heterogeneity of the mutations appears to be the
geographic location of Pakistan, particularly Northern
Pakistan, which has been the gateway for most invasions
of the Indian subcontinent. There is a strong possibility that
many of the mutations were brought to this region by
population migrations.
The results of this study partly conform with a previous
study on immigrant Pakistanis who migrated to U.K. from
some areas of Northern Pakistan (Varawalla et a!, 199 la, b);
however, we have found a much wider spectrum of
mutations. In addition, del 619, previously reported to be
present in 56% of Sindhis (Them et a!, 1984; Varawalla et a!,
1991a), represented only 139% of alleles from the native
Sindhi subjects. Previous studies showing a high prevalence
of del 619 were probably carried out on selected groups of
patients and were not a true representative of the Sindhi
population. We have identified a novel 17 bp deletion in
exon Ill of 3-globin gene. The deletion is located between
two copies of a CAG sequence present in Cdl 25/126 and
Cd131. It is not possible to ascertain whether the actual
breakpoint is before or following the CAG sequence in Cd
125/126. In either case Cd 125 is left intact. Sequence
characteristics, such as a reiterated nucleotide sequence of
two to eight base pairs (e.g. CAG in this case), separated by a
few nucleotides, appear to be involved in almost all small
deletions leading to haemoglobin disorders (Bunn & Forget,
1986). As a result of the deletion the reading frame is shifted
and a premature stop signal (TAA) is encountered in the
new Cd 133. Another interesting aspect of this study is the
finding of six subjects who had transfusion-dependent
thalassaemia and yet possessed only one thalassaemic allele.
It is suspected that transfusion dependency in these appar-
ently heterozygous subjects may in part be due to co-
inheritance of triplicated a-globin genes (Garewal eta!, 1994).
The relationship of mutation pattern and consanguinity
shows that mutation analysis in consanguineous couples
would be considerably easier, because there is over an 80%
chance that both the parents in such couples would have the
same mutation. It should be pointed out that the figures of
parental consanguinity (614%) amongst the thalassaemic
families is high because these families are selected and do not
represent the overall level of consanguineous marriages in
the population. In the Punjabi population, consanguinity
has been reported to be around 40% (Shami & Zahida,
1981).
This study provides a comprehensive basis for prenatal
diagnosis of thalassaemia in all ethnic groups in Pakistan,
which has been introduced recently (Ahmed et al, 1994).
The service has been offered primarily to parents with
affected children. The preliminary results of the first 70 cases
diagnosed prenatally at the Armed Forces Institute of
Pathology (AFIP), Rawalpindi, indicate that this is tech-
nically feasible and is also accepted amongst these families
(unpublished observation).
Studies in the U.K. (Petrou, 1994) have shown that British
Pakistani couples have particular problems with late
termination of pregnancy and only about 23% of couples
accept prenatal diagnosis and selective abortion of affected
fetuses in the second trimester of pregnancy (Modell et a!,
1980; Petrou, 1994). However, when counselled in the first
trimester of pregnancy, they often make use of prenatal
diagnosis. Almost all prenatal diagnoses done at AFIP in
Pakistan have been in the first trimester of pregnancy and
>95% of the women with a fetus having thalassaemia
major opted for termination of pregnancy. However, there is
little awareness amongst the general population and health
professionals about the role of prenatal diagnosis in the
prevention of thalassaemia. Mediterranean programmes
have shown that large-scale community-based thalassaemia
prevention programmes can be implemented effectively if
they are incorporated into a primary health-care programme
(Angastiniotis et a!, 1986; Cao, 1987). Since no primary
health-care system exists in Pakistan, a different approach
would be required for this purpose and this needs to be
developed.
In a prospective study we will be evaluating the number of
couples making use of prenatal diagnosis offered during
pregnancy. Studies are also under way to determine suitable
approaches for identifying at-risk couples prospectively, with
a view to eventually offering them prenatal diagnosis.
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